OBO_ID (LABEL):	UBERON_0001013 (adipose tissue)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1937008	7/2007	S96-PMC1937008	['Adipose Tissue acts as a reservoir for Steroid Hormones and is also a site of Steroid Production and Metabolism [52,53].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_26763', 'steroid glucosiduronic acid', 39, 'steroid hormones'), ('CHEBI_35341', 'steroid', 78, 'steroid'), ('GO_0006706', 'steroid catabolic process', 78, 'steroid production ... metabolism')]
PMC2670501	4/2009	S177-PMC2670501	['fetal growth restriction compromises growth of Nutrient storage Organs such as Adipose Tissue and this is compensated by Adaptive Metabolic changes such as greater Insulin sensitivity to favour energy efficiency and utilization of alternate source of substrates.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 47, 'nutrient'), ('UBERON_0000062', 'organ', 64, 'organs'), ('UBERON_0001013', 'adipose tissue', 79, 'adipose tissue'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 121, 'adaptive'), ('GO_0008152', 'metabolic process', 130, 'metabolic'), ('PR_000045358', 'insulin family protein', 164, 'insulin')]
PMC2671035	5/2009	S36-PMC2671035	['b : white Adipose Tissue mass (Wat mass represents sum of Epididymal, perirenal, and Flank subcutaneous fad Pads), age 3 weeks.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 10, 'adipose tissue'), ('UBERON_0006337', 'distal early tubule', 31, 'WAT'), ('UBERON_0004360', 'cauda epididymis', 58, 'epididymal ...'), ('UBERON_0001012', 'head of radius', 85, 'flank ... pads')]
PMC2671035	5/2009	S66-PMC2671035	['this protocol requires a minimum of ∼0.1–0.2 g of Adipose Tissue; 6 weeks is the earliest age at which this could readily be harvested from all four experimental groups.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 50, 'adipose tissue')]
PMC2671035	5/2009	S123-PMC2671035	['no individual Genes were significantly upregulated in Adipose Tissue as a function of Birth weight (u-c versus c-c Mice) (sam, fdr ≤0.25).']	N/A	N/A	[('SO_0000704', 'gene', 14, 'genes'), ('UBERON_0001013', 'adipose tissue', 54, 'adipose tissue'), ('GO_0007567', 'parturition', 86, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 115, 'mice')]
PMC2671035	5/2009	S208-PMC2671035	['c : histologic sections of Formalin-fixed Gonadal Adipose Tissue, Hematoxilin and eosin stained, shown at ×600 magnification.']	N/A	N/A	[('CHEBI_16842', 'formaldehyde', 27, 'formalin'), ('UBERON_0000991', 'gonad', 42, 'gonadal'), ('UBERON_0001013', 'adipose tissue', 50, 'adipose tissue'), ('CHEBI_36166', '5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid', 66, 'hematoxilin')]
PMC2671035	5/2009	S232-PMC2671035	['in parallel, Lipogenic Genes and pathways were markedly upregulated in Adipose Tissue of lbw Mice with cug (u-c).']	N/A	N/A	[('GO_0008610', 'lipid biosynthetic process', 13, 'lipogenic'), ('SO_0000704', 'gene', 23, 'genes'), ('UBERON_0001013', 'adipose tissue', 71, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 93, 'mice')]
PMC2671035	5/2009	S262-PMC2671035	['Lpin1 Overexpression in Adipose Tissue increases diet-induced obesity (24).']	N/A	N/A	[('PR_000002061', 'lysosome-associated membrane glycoprotein 2', 0, 'Lpin1'), ('GO_0007308', 'oocyte construction', 6, 'overexpression'), ('UBERON_0001013', 'adipose tissue', 24, 'adipose tissue')]
PMC2707610	7/2009	S87-PMC2707610	['Rp Fat and Skeletal Muscles were kept to provide peripheral Metabolic markers.']	N/A	N/A	[('PR_000013773', 'retinoblastoma-associated protein', 0, 'Rp'), ('UBERON_0004369', "Reichert's membrane", 0, 'Rp'), ('UBERON_0001013', 'adipose tissue', 3, 'fat'), ('UBERON_0004833', 'lip skeletal muscle', 11, 'skeletal muscles'), ('GO_0008152', 'metabolic process', 60, 'metabolic')]
PMC2726293	9/2009	S20-PMC2726293	['females also have a greater up-regulation of 11Β-Hydroxysteroid Dehydrogenase-1 in obesity than do males (paulsen et al., 2007), leading to relatively increased activity of Glucocorticoids in Adipose Tissue.']	N/A	N/A	[('CHEBI_36858', '2alpha-hydroxy steroid', 45, '11β-hydroxysteroid'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 45, '11β-hydroxysteroid dehydrogenase-1'), ('CHEBI_36597', 'phthalazine', 173, 'glucocorticoids'), ('UBERON_0001013', 'adipose tissue', 192, 'adipose tissue')]
PMC2825514	1/2010	S41-PMC2825514	['Bone Marrow from the Femur Of the hind Limb (flushed by 0.9%-Nacl-Water using a 25g-needle-seringe), Adipose Tissue, and Liver were collected (about 50 mg) and weighed.']	N/A	N/A	[('UBERON_0002371', 'bone marrow', 0, 'Bone marrow'), ('UBERON_0002421', 'hippocampal formation', 21, 'femur of ... limb'), ('CHEBI_26710', 'sodium chloride', 61, 'NaCl'), ('CHEBI_15377', 'water', 66, 'water'), ('UBERON_0001013', 'adipose tissue', 101, 'adipose tissue'), ('UBERON_0002107', 'liver', 121, 'liver')]
PMC2825514	1/2010	S44-PMC2825514	['Retroperitoneal, Epididymal, Interscapular and Subcutaneous Adipose Tissue, as well as the Liver and the Pancreas were collected and weighed.']	N/A	N/A	[('UBERON_0003693', 'retroperitoneal space', 0, 'Retroperitoneal'), ('UBERON_0004360', 'cauda epididymis', 17, 'epididymal ...'), ('UBERON_4200094', 'inner digits of hand', 29, 'interscapular ...'), ('UBERON_0002023', 'claustrum of brain', 47, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0001264', 'pancreas', 105, 'pancreas')]
PMC2825514	1/2010	S71-PMC2825514	['Eicosanoid analysis\nAdipose Tissue (50 mg) was homogenized with distilled Ethanol (3 ml) as previously detailed [9].']	N/A	N/A	[('CHEBI_4683', 'dolasetron methanesulfonate', 0, 'Eicosanoid'), ('UBERON_0001013', 'adipose tissue', 20, 'Adipose tissue'), ('CHEBI_16236', 'ethanol', 74, 'ethanol')]
PMC2825514	1/2010	S83-PMC2825514	['the fractional Proliferation rate Of Adipose Tissue Cells (fractional Synthesis rate, fsrcellin % new cell/5 d) identical to the fraction of newly Synthesized dna was calculated as the2h-enrichment in Adipose Tissue dna divided by2h-enrichment in Bone Marrow dna [11,22].']	N/A	N/A	[('GO_0008283', 'cell proliferation', 15, 'proliferation ... of ... cells'), ('CL_0002617', 'adipocyte of breast', 37, 'adipose tissue cells'), ('UBERON_0001013', 'adipose tissue', 37, 'adipose tissue'), ('GO_0009057', 'macromolecule catabolic process', 70, 'synthesis'), ('GO_0010198', 'synergid death', 147, 'synthesized'), ('UBERON_0001013', 'adipose tissue', 201, 'adipose tissue'), ('UBERON_0002371', 'bone marrow', 247, 'bone marrow')]
PMC2825514	1/2010	S84-PMC2825514	['the principle for calculating the fractional synthesis rate of tg (fsrtg) in Adipose Tissues is that tg that were synthesized from endogenous alpha-Glycerol Phosphate Before2H2O was present, do not contain covalent c-2H label in their Glycerol Moiety, thereby allowing the proportion of newly synthesized vs. pre-existing tg to be assessed [20].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 77, 'adipose tissues'), ('CHEBI_24366', 'glycidyl group', 148, 'glycerol phosphate'), ('CHEBI_52452', 'tellurium-125 atom', 167, 'before2H2O'), ('CHEBI_29238', 'tritium atom', 217, '2H'), ('CHEBI_17754', 'glycerol', 235, 'glycerol'), ('CHEBI_29357', 'methanediyl', 244, 'moiety')]
PMC2825514	1/2010	S126-PMC2825514	['no difference was observed in dnl or Synthesis rate Of Tg in Hepatic or Adipose Tissues between groups at d136 (table 5, additional file5).']	N/A	N/A	[('GO_0007416', 'synapse assembly', 37, 'synthesis ... of TG'), ('UBERON_0001133', 'cardiac muscle tissue', 61, 'hepatic ...'), ('UBERON_0001013', 'adipose tissue', 72, 'adipose tissues')]
PMC2825514	1/2010	S146-PMC2825514	['indeed, the fat mass and Adipose Tissue weight at d21 were not different between the high, moderate and low ala Fed guinea pigs.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 25, 'adipose tissue'), ('GO_0007631', 'feeding behavior', 112, 'fed')]
PMC2825514	1/2010	S180-PMC2825514	['this was not associated with an increased Adipose Tissue fsr of total tg in the high ala group.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue')]
PMC2825514	1/2010	S210-PMC2825514	['caption (media)\n\nclick here for file\n\ncaption (supplementary-material)\nadditional file 3\ntable s3 on "Adipose Tissue (At) weight (% body weight) at d21 and d136" .']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 102, 'Adipose tissue'), ('UBERON_0001273', 'ilium', 118, 'AT')]
PMC2825514	1/2010	S212-PMC2825514	['caption (media)\n\nclick here for file\n\ncaption (supplementary-material)\nadditional file 4\ntable s4 on "fractional Proliferation Rate Of Cells (in % new cells/5 days) in Adipose Tissue (at) at d21 and d136" .']	N/A	N/A	[('GO_0030261', 'chromosome condensation', 113, 'proliferation rate of cells'), ('UBERON_0001013', 'adipose tissue', 168, 'adipose tissue')]
PMC2825514	1/2010	S214-PMC2825514	['caption (media)\n\nclick here for file\n\ncaption (supplementary-material)\nadditional file 5\ntable s5 on "de novo Lipogenesis (dnl) and fractional synthesis rate (fsr) of tg in the Liver and Adipose Tissues (at) at d21 and d136" .']	N/A	N/A	[('GO_0008610', 'lipid biosynthetic process', 110, 'lipogenesis'), ('UBERON_0002107', 'liver', 177, 'liver'), ('UBERON_0001013', 'adipose tissue', 187, 'adipose tissues')]
PMC2872349	4/2010	S122-PMC2872349	['people of the same genotype who were in the highest third for Birth weight had a lower Spine bmd compared to subjects in the same Birth weight category (p = 0.04).']	N/A	N/A	[('GO_0007567', 'parturition', 62, 'birth'), ('UBERON_0001013', 'adipose tissue', 87, 'spine'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC2888576	6/2010	S51-PMC2888576	['all Adipose Tissue analyses including histological and Gene Expression with microarrays and qrt-pcr were performed with the Inguinal Fat Depot because it is the only macroscopically visible white fat Depot in the Mouse from about 1–2 day of age, when it first becomes detectable, until about 9 days of age when the Visceral fat depots begin to emerge.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 4, 'adipose tissue'), ('GO_0010467', 'gene expression', 55, 'gene expression'), ('SO_0000704', 'gene', 55, 'gene'), ('UBERON_0010410', 'inguinal fat pad', 124, 'inguinal fat depot'), ('UBERON_0002387', 'pes', 200, 'depot'), ('NCBITaxon_10088', 'Mus <genus>', 213, 'mouse'), ('UBERON_0002075', 'viscus', 315, 'visceral')]
PMC2888576	6/2010	S127-PMC2888576	['the subset of Genes, listed for each of the Gene clusters, represents Genes of interest to Adipose Tissue biology.10.1371/journal.pone.0011015.g002\n\ncaption (fig): figure 2\nheat maps of selective k-means clusters.']	N/A	N/A	[('SO_0000704', 'gene', 14, 'genes'), ('SO_0000704', 'gene', 44, 'gene'), ('SO_0000704', 'gene', 70, 'genes'), ('UBERON_0001013', 'adipose tissue', 91, 'adipose tissue')]
PMC2888576	6/2010	S143-PMC2888576	['the heat map of k-means clusters for Genes resembling Mest and Bmp3 and a list of candidate Genes for functions related to Adipose Tissue expansion.']	N/A	N/A	[('SO_0000704', 'gene', 37, 'genes'), ('PR_000010229', 'membrane-bound transcription factor site-1 protease', 54, 'Mest'), ('PR_000000165', 'BMP4', 63, 'Bmp3'), ('SO_0000704', 'gene', 92, 'genes'), ('UBERON_0001013', 'adipose tissue', 123, 'adipose tissue')]
PMC2888576	6/2010	S154-PMC2888576	['the major variations in Adipose Tissue mass occurred between lun Mice and control at 5 (group a) and 10 days of age (group b) and between Mice at 56 days of age Fed Chow diet for 5 weeks and Mice at 112 days of age after being Fed a high fat diet for 8 weeks, irrespective of the nutritional environment during Suckling (groups c, d and e).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 24, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 138, 'mice'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('CHEBI_33290', 'food', 165, 'chow'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'mice'), ('GO_0007631', 'feeding behavior', 227, 'fed'), ('GO_0001967', 'suckling behavior', 311, 'suckling')]
PMC2888576	6/2010	S158-PMC2888576	['4a.10.1371/journal.pone.0011015.g004\n\ncaption (fig): figure 4\ndevelopmental Expression profiles of candidate Genes of Adipose Tissue expansion.']	N/A	N/A	[('GO_0010467', 'gene expression', 76, 'expression'), ('SO_0000704', 'gene', 109, 'genes'), ('UBERON_0001013', 'adipose tissue', 118, 'adipose tissue')]
PMC2888576	6/2010	S235-PMC2888576	['discussion\nthe Development and differentiation Of Adipose Tissue in a mammalian organism is determined by an Adipogenic processes involving the Proliferation of Adipocyte Stem Cell precursors and Cellular Differentiation that activates Genes for the synthesis of the repertoire of Adipocyte specific enzymes and structural proteins required for Adipocyte function.']	N/A	N/A	[('GO_0042748', 'circadian sleep/wake cycle, non-REM sleep', 15, 'development ... of adipose tissue'), ('UBERON_0001013', 'adipose tissue', 50, 'adipose tissue'), ('GO_0060612', 'adipose tissue development', 109, 'adipogenic'), ('GO_0008283', 'cell proliferation', 144, 'proliferation'), ('CL_0002617', 'adipocyte of breast', 161, 'adipocyte stem cell'), ('GO_0030154', 'cell differentiation', 196, 'cellular differentiation'), ('SO_0000704', 'gene', 236, 'genes'), ('CL_0000136', 'fat cell', 281, 'adipocyte'), ('CL_0000136', 'fat cell', 345, 'adipocyte')]
PMC2888576	6/2010	S254-PMC2888576	['we searched among these Genes for determinants of variable Adipose Tissue expansion.']	N/A	N/A	[('SO_0000704', 'gene', 24, 'genes'), ('UBERON_0001013', 'adipose tissue', 59, 'adipose tissue')]
PMC2889879	5/2010	S62-PMC2889879	['the validity of pufa estimated by means of the ffq was r = 0.5 in comparison to Adipose Tissue composition [26].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 80, 'adipose tissue')]
PMC2992766	12/2010	S77-PMC2992766	['total rna was isolated from starting material (stored at −80°c) using one of three commercially available kits: rnaqueous micro kit (ambion) for Blastocysts; rna easy Lipid kit (quiagen) for Adipose Tissue; and rna easy Tissue kit (quiagen) for Placenta.']	N/A	N/A	[('UBERON_0000358', 'blastocyst', 145, 'blastocysts'), ('CHEBI_18059', 'lipid', 167, 'lipid'), ('UBERON_0001013', 'adipose tissue', 191, 'adipose tissue'), ('UBERON_0000479', 'tissue', 220, 'tissue'), ('UBERON_0001987', 'placenta', 245, 'placenta')]
PMC3001618	1/2011	S20-PMC3001618	['2009), together with molecular markers of inflammation in the Kidney and Adipose Tissue (sharkey et al .']	N/A	N/A	[('UBERON_0002113', 'kidney', 62, 'kidney'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue')]
PMC3001618	1/2011	S24-PMC3001618	['2009) and impaired function of the Endoplasmic Reticulum in Adipose Tissue (sharkey et al .']	N/A	N/A	[('GO_0005783', 'endoplasmic reticulum', 35, 'endoplasmic reticulum'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue')]
PMC3001618	1/2011	S44-PMC3001618	['de Novo synthesis, Uptake Of Nefa released from Adipose Tissue Lipolysis, Uptake of dietary Tag, reduced Hepatic Fatty Acid Oxidation and reduced release of Tag in the form of very low-density lipoproteins.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'novo'), ('GO_0043652', 'engulfment of apoptotic cell', 19, 'uptake of NEFA ...'), ('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('GO_0016042', 'lipid catabolic process', 63, 'lipolysis'), ('GO_0098657', 'import into cell', 74, 'uptake'), ('CHEBI_17855', 'triglyceride', 92, 'TAG'), ('UBERON_0002107', 'liver', 105, 'hepatic'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 113, 'fatty acid oxidation'), ('CHEBI_17855', 'triglyceride', 157, 'TAG')]
PMC3028947	11/2010	S75-PMC3028947	['sarcopenic adiposity refers to the situation of less muscle mass and more Adipose Tissue for the same body mass index60–63.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 74, 'adipose tissue')]
PMC3117679	5/2011	S21-PMC3117679	['in Rats and Mice, N-3 Pufa supplementation through a high-fat diet reduces the Plasma leptin concentration, leptin mrna Expression in Adipose Tissue, and changes the Gene Expression of Brain satiety regulators [15,16].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 12, 'mice'), ('CHEBI_80445', '9,10-EOT', 18, 'n-3 PUFA'), ('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('GO_0010467', 'gene expression', 120, 'expression'), ('UBERON_0001013', 'adipose tissue', 134, 'adipose tissue'), ('GO_0010467', 'gene expression', 166, 'gene expression'), ('SO_0000704', 'gene', 166, 'gene'), ('UBERON_0000955', 'brain', 185, 'brain')]
PMC3156909	9/2011	S52-PMC3156909	['Adipose Tissue and Liver samples were paraffin embedded.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0002107', 'liver', 19, 'liver')]
PMC3156909	9/2011	S54-PMC3156909	['Rat anti-F4/80 Antibody (abcam, cambridge, uk) was used to stain Adipose Tissue Macrophages and the immunostaining was revealed by an anti-Rat hrp (invitrogen, basel, switzerland).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rat'), ('PR_000001900', 'neuropilin-1', 9, 'F4/80'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CL_0002617', 'adipocyte of breast', 65, 'adipose tissue macrophages'), ('UBERON_0001013', 'adipose tissue', 65, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rat')]
PMC3183498	8/2011	S6-PMC3183498	['the two most common, anencephaly (a total or partial absence of the Brain Tissue, Skull, and overlying skin) and Spina bifida (herniation of Spinal Cord, Meninges, or both through a defect in the Spine), comprise >90% of cases.']	N/A	N/A	[('UBERON_0000955', 'brain', 68, 'brain'), ('UBERON_0000479', 'tissue', 74, 'tissue'), ('UBERON_0003129', 'skull', 82, 'skull'), ('UBERON_0001130', 'vertebral column', 113, 'spina'), ('UBERON_0001130', 'vertebral column', 141, 'spinal'), ('UBERON_0002240', 'spinal cord', 148, 'cord'), ('UBERON_0002360', 'meninx', 154, 'meninges'), ('UBERON_0001013', 'adipose tissue', 196, 'spine')]
PMC3208550	11/2011	S16-PMC3208550	['Gcs Regulate, among other processes, Adipose Tissue differentiation, cellular Lipid accumulation, and fat distribution.']	N/A	N/A	[('CL_0000740', 'retinal ganglion cell', 0, 'GCs'), ('GO_0065007', 'biological regulation', 4, 'regulate'), ('UBERON_0001013', 'adipose tissue', 37, 'adipose tissue'), ('CHEBI_18059', 'lipid', 78, 'lipid')]
PMC3208550	11/2011	S20-PMC3208550	['11Β-Hsd1 is mainly distributed in the Liver, Adipose Tissue, and Brain[9].']	N/A	N/A	[('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 0, '11β-'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 4, 'HSD1'), ('UBERON_0002107', 'liver', 38, 'liver'), ('UBERON_0001013', 'adipose tissue', 45, 'adipose tissue'), ('UBERON_0000955', 'brain', 65, 'brain')]
PMC3208550	11/2011	S28-PMC3208550	['Adipose Tissue 11Β-Hsd1 Expression[13]and enzyme activity (Urinary Terahydrocortisol [Thf] and 5Α-Thf/Tetrahydro-Cortisone [the] ratio) increases with age, particularly in boys[18].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 15, '11β-HSD1'), ('GO_0010467', 'gene expression', 24, 'expression'), ('UBERON_0001088', 'urine', 59, 'urinary'), ('CHEBI_26874', 'terpenol', 67, 'terahydrocortisol'), ('CHEBI_17038', 'fecosterol', 86, 'THF'), ('CHEBI_28741', 'sodium fluoride', 95, '5α'), ('CHEBI_17038', 'fecosterol', 98, 'THF'), ('CHEBI_26935', 'tetraterpenoid', 102, 'tetrahydro'), ('CHEBI_16962', 'cortisone', 113, 'cortisone')]
PMC3208550	11/2011	S43-PMC3208550	['Adipose Tissue was weighed and frozen, except for a portion of Adipose Tissue, which was fixed for determination of Adipocyte cross-sectional areas[25].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0001013', 'adipose tissue', 63, 'adipose tissue'), ('CL_0000136', 'fat cell', 116, 'adipocyte')]
PMC3208550	11/2011	S44-PMC3208550	['histology\nAdipose Tissues were fixed in 10% Formaldehyde in phosphate buffered saline (pbs), ph 7.4, for 24–48 h at room temperature.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 10, 'Adipose tissues'), ('CHEBI_16842', 'formaldehyde', 44, 'formaldehyde')]
PMC3208550	11/2011	S47-PMC3208550	['at least 3 slices per Adipose Tissue sample, and 10 fields of vision each slice were accomplished to determine Adipocyte cross-sectional areas.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 22, 'adipose tissue'), ('CL_0000136', 'fat cell', 111, 'adipocyte')]
PMC3208550	11/2011	S54-PMC3208550	["quantitative real-time pcr\ntotal rna was isolated from Adipose Tissue and Liver with trizol (invitrogen, carlsbad, ca, usa) according to the manufacturer's instructions and quantified spectrophotometrically at od260."]	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 55, 'adipose tissue'), ('UBERON_0002107', 'liver', 74, 'liver')]
PMC3208550	11/2011	S66-PMC3208550	['samples of Adipose Tissue (0.5 mg protein/ml) or Liver (10 µg protein/ml) homogenate were incubated with 2 mm Nadp and 100 nm 1,2,6,7-[3H]4-Corticosterone (amersham, berkshire, uk).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 11, 'adipose tissue'), ('UBERON_0002107', 'liver', 49, 'liver'), ('CHEBI_25524', 'NAD(P)', 110, 'NADP'), ('CHEBI_29238', 'tritium atom', 135, '3H'), ('CHEBI_52029', 'dilC18(3) dye', 138, '4-'), ('CHEBI_16827', 'corticosterone', 140, 'corticosterone')]
PMC3208550	11/2011	S67-PMC3208550	['after incubation in a shaking Water bath at 37°c for 2 h or 1 h for Adipose Tissue or Liver, respectively, the reaction was interrupted; Steroids were extracted with Ethyl Acetate and then dried, dissolved in Ethanol, separated by thin-layer chromatography (mobile phase Chloroform∶Ethanol [92∶8]), and exposed to a phosphorimager tritium screen (ge healthcare europe, freiburg, germany).']	N/A	N/A	[('CHEBI_15377', 'water', 30, 'water'), ('UBERON_0001013', 'adipose tissue', 68, 'adipose tissue'), ('UBERON_0002107', 'liver', 86, 'liver'), ('CHEBI_35341', 'steroid', 137, 'steroids'), ('CHEBI_27750', 'ethyl acetate', 166, 'ethyl acetate'), ('CHEBI_16236', 'ethanol', 209, 'ethanol'), ('CHEBI_35255', 'chloroform', 271, 'chloroform'), ('CHEBI_24870', 'ion', 281, '∶'), ('CHEBI_16236', 'ethanol', 282, 'ethanol')]
PMC3208550	11/2011	S71-PMC3208550	['Adipose Tissues were homogenized in ice-cold radio immunoprecipitation assay (ripa) buffer to make whole cell lysates.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissues')]
PMC3208550	11/2011	S120-PMC3208550	['11Β-Hsd1 mrna Expression and activity in Adipose Tissue of nl and sl Rats\nin Retroperitoneal Adipose Tissue, 11Β-Hsd1 mrna Expression increased with Postnatal age in both nl and sl Rats; the nl group peaked at w5 ( p<0.05 vs. w3), while the sl group peaked at w6 ( p<0.05 vs. w3).']	N/A	N/A	[('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 0, '11β-HSD1'), ('GO_0010467', 'gene expression', 14, 'expression'), ('UBERON_0001013', 'adipose tissue', 41, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rats'), ('UBERON_4000104', 'ganoine', 77, 'retroperitoneal adipose tissue'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 109, '11β-HSD1'), ('GO_0010467', 'gene expression', 123, 'expression'), ('GO_0007567', 'parturition', 149, 'postnatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 181, 'rats')]
PMC3208550	11/2011	S152-PMC3208550	['Gr mrna and protein Expression in Adipose Tissue and Liver of nl and sl Rats\nthere were no significant differences in Gr mrna and protein Expression in Liver, Retroperitoneal and Epididymal Adipose Tissue, with regard to either age or litter size (data not shown).']	N/A	N/A	[('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 0, 'GR'), ('GO_0010467', 'gene expression', 20, 'expression'), ('UBERON_0001013', 'adipose tissue', 34, 'adipose tissue'), ('UBERON_0002107', 'liver', 53, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 72, 'rats'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 118, 'GR'), ('GO_0010467', 'gene expression', 138, 'expression'), ('UBERON_0002107', 'liver', 152, 'liver'), ('UBERON_0003693', 'retroperitoneal space', 159, 'retroperitoneal'), ('UBERON_0004360', 'cauda epididymis', 179, 'epididymal adipose tissue')]
PMC3264579	1/2012	S1-PMC3264579	['leptin, a major adipokine Secreted by Adipose Tissue, circulates in direct proportion to body fat stores, enters the Brain and Regulates Food Intake and energy Expenditure.']	N/A	N/A	[('GO_0046903', 'secretion', 26, 'secreted'), ('UBERON_0001013', 'adipose tissue', 38, 'adipose tissue'), ('UBERON_0000955', 'brain', 117, 'brain'), ('GO_0065007', 'biological regulation', 127, 'regulates'), ('CHEBI_33290', 'food', 137, 'food'), ('GO_0007631', 'feeding behavior', 137, 'food intake'), ('GO_0010467', 'gene expression', 160, 'expenditure')]
PMC3264579	1/2012	S52-PMC3264579	['Adipose Tissue\nadipose Tissue was dissected on 5 months-old Rats from three localizations: Visceral, Retroperitoneal and Epididymal Fat.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0000479', 'tissue', 23, 'tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 60, 'rats'), ('UBERON_0004082', 'cerebellum vermis lobule VIII', 91, 'visceral ...'), ('UBERON_0003693', 'retroperitoneal space', 101, 'retroperitoneal'), ('UBERON_0004359', 'corpus epididymis', 121, 'epididymal fat')]
PMC3264579	1/2012	S54-PMC3264579	['Adipose Tissue was fixed in 4% phosphate-buffered Formalin, and then paraffin embedded.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_16842', 'formaldehyde', 50, 'formalin')]
PMC3264579	1/2012	S113-PMC3264579	['(a) % total fat mass, (b) Adipocytes area (µm2), (c) representative photomicrographs of Adipose Tissue morphology viewed at magnification ×10, barre scale: 100 µm, (d) Adipocytes size repartition evaluated in 5 months-old Rats.']	N/A	N/A	[('CL_0000136', 'fat cell', 26, 'adipocytes'), ('UBERON_0001013', 'adipose tissue', 88, 'adipose tissue'), ('CL_0000136', 'fat cell', 168, 'adipocytes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 222, 'rats')]
PMC3264579	1/2012	S114-PMC3264579	['(e) relative leptin mrna Expression in Adipose Tissue, (f) fast Plasma leptin concentrations (ng/ml), values are means ± s.e.m.']	N/A	N/A	[('GO_0010467', 'gene expression', 25, 'expression'), ('UBERON_0001013', 'adipose tissue', 39, 'adipose tissue'), ('UBERON_0001969', 'blood plasma', 64, 'plasma')]
PMC3316748	10/2011	S5-PMC3316748	['the Expression patterns of Pparα, Pparγ, and Lxrα in the Liver and Adipose Tissue were examined by real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 27, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 34, 'PPARγ'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 45, 'LXRα'), ('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0001013', 'adipose tissue', 67, 'adipose tissue')]
PMC3316748	10/2011	S16-PMC3316748	['furthermore, the Expression of Lxrα , Pparα , and Pparγ in the Liver and Adipose Tissue largely depends on the protein and Folic Acid content in the maternal diet during Gestation.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expression'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 31, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 38, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 50, 'PPARγ'), ('UBERON_0002107', 'liver', 63, 'liver'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue'), ('CHEBI_30751', 'formic acid', 123, 'folic acid'), ('GO_0007565', 'female pregnancy', 170, 'gestation')]
PMC3316748	10/2011	S167-PMC3316748	['Gene Expression—Adipose Tissue\nexposure to protein restriction was reflected by lowered Lxrα Gene Expression—0.039\xa0±\xa00.004 versus 0.058\xa0±\xa00.005, p \xa0<\xa00.01.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0001013', 'adipose tissue', 16, 'adipose tissue'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 88, 'LXRα'), ('GO_0010467', 'gene expression', 93, 'gene expression'), ('SO_0000704', 'gene', 93, 'gene')]
PMC3316748	10/2011	S173-PMC3316748	['the relative levels of Expression of Lxrα and Pparγ in Adipose Tissue in all maternal dietary groups are presented in fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 23, 'expression'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 37, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 46, 'PPARγ'), ('UBERON_0001013', 'adipose tissue', 55, 'adipose tissue')]
PMC3316748	10/2011	S179-PMC3316748	['5\n\nquantification of mrna levels of Lxrα ( a ) and Pparγ ( b ) in Adipose Tissue of Rats belonging to different maternal dietary groups.']	N/A	N/A	[('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 36, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 51, 'PPARγ'), ('UBERON_0001013', 'adipose tissue', 66, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 84, 'rats')]
PMC3316748	10/2011	S206-PMC3316748	['decreased Expression of Pparγ in the Liver and Adipose Tissue leads to reduced body weight, reduced total fat mass, and dyslipidemia (tsai et al.2009).']	N/A	N/A	[('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 24, 'PPARγ'), ('UBERON_0002107', 'liver', 37, 'liver'), ('UBERON_0001013', 'adipose tissue', 47, 'adipose tissue')]
PMC3316748	10/2011	S227-PMC3316748	['Prenatal protein restriction induced downregulation of Lxrα in Adipose Tissue.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 55, 'LXRα'), ('UBERON_0001013', 'adipose tissue', 63, 'adipose tissue')]
PMC3322122	4/2012	S21-PMC3322122	['at later stages offspring of both groups became similar in terms of Organismal phenotype, including body weight, body composition, and cellularity of muscle and Adipose Tissue[13],[14].']	N/A	N/A	[('NCBITaxon_1', 'root', 68, 'organismal'), ('UBERON_0001013', 'adipose tissue', 161, 'adipose tissue')]
PMC3347028	3/2012	S134-PMC3347028	['the Adipose Tissue serves as a repository for Vitamin D that does not get into the circulation.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 4, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D')]
PMC3355895	1/2011	S133-PMC3355895	['after adjusting for age, gender, and Adult weight Individuals in the lowest third for Birthweight had a higher Spine bmd if they were of the bb genotype ( p \u2009=\u20090.01).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 37, 'adult'), ('NCBITaxon_1', 'root', 50, 'individuals'), ('GO_0007596', 'blood coagulation', 86, 'birthweight'), ('UBERON_0001013', 'adipose tissue', 111, 'spine')]
PMC3355895	1/2011	S134-PMC3355895	['people of the same genotype who were in the highest third for Birth weight had a lower Spine bmd compared to those of bb genotype in the same Birth weight category ( p \u2009=\u20090.04).']	N/A	N/A	[('GO_0007567', 'parturition', 62, 'birth'), ('UBERON_0001013', 'adipose tissue', 87, 'spine'), ('GO_0007567', 'parturition', 142, 'birth')]
PMC3357266	6/2012	S42-PMC3357266	['the Intraperitoneal and Subcutaneous Fat Tissue was assessed by the region-of-interest (roi) analysis.']	N/A	N/A	[('UBERON_2001932', 'sensory canal tubular ossicle', 4, 'intraperitoneal'), ('UBERON_0002023', 'claustrum of brain', 24, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 37, 'fat'), ('UBERON_0000479', 'tissue', 41, 'tissue')]
PMC3357266	6/2012	S130-PMC3357266	['assessment of Visceral and subcutaneous Fat.']	N/A	N/A	[('UBERON_0002075', 'viscus', 14, 'visceral'), ('UBERON_0001013', 'adipose tissue', 40, 'fat')]
PMC3406997	5/2012	S184-PMC3406997	['Hmb treatment in Pregnant sows for 2\u2009weeks before the Partum increased Serum gh and Igf-1 levels by 38\u2009% and 20\u2009% in the offspring [14].']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 0, 'HMB'), ('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('GO_0007567', 'parturition', 54, 'partum'), ('UBERON_0001013', 'adipose tissue', 54, 'partum'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('PR_000008929', 'interferon-related developmental regulator 1', 84, 'IGF-1')]
PMC3407995	7/2012	S487-PMC3407995	['Folic Acid is necessary for Cell Division, Synthesis Of Amino Acids and Nucleic Acids and ultimately for normal Development Of the foetal Spine, Brain and Skull in particular during the first four weeks of Pregnancy to prevent Neural Tube defects including Spina bifida and anencephaly.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('GO_0051301', 'cell division', 28, 'cell division'), ('GO_0019915', 'lipid storage', 43, 'synthesis of amino acids'), ('CHEBI_48310', 'apiitol', 56, 'amino'), ('GO_0005634', 'nucleus', 72, 'nucleic'), ('GO_0070997', 'neuron death', 72, 'nucleic acids'), ('GO_0043695', 'detection of pheromone', 112, 'development of ... spine'), ('UBERON_0001013', 'adipose tissue', 138, 'spine'), ('GO_0007567', 'parturition', 145, 'brain'), ('UBERON_0000955', 'brain', 145, 'brain'), ('UBERON_0003129', 'skull', 155, 'skull'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy'), ('UBERON_0001049', 'neural tube', 227, 'neural tube'), ('UBERON_0001130', 'vertebral column', 257, 'spina')]
PMC3465343	10/2012	S7-PMC3465343	['anteroposterior (ap) Spine radiographs were obtained at week 2 after Delivery to evaluate the presence of the Skeletal abnormalities especially of Spinal deformities.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 21, 'spine'), ('GO_0007567', 'parturition', 69, 'delivery'), ('UBERON_0004288', 'skeleton', 110, 'skeletal'), ('UBERON_0001130', 'vertebral column', 147, 'spinal')]
PMC3465343	10/2012	S65-PMC3465343	['representative radiographs of a normal and a deformed Spine from each group are shown infig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 54, 'spine')]
PMC3465343	10/2012	S210-PMC3465343	['radiographic examination\nat week 2 after Birth, all the Rats had standard anteroposterior (ap) radiographs of the Spine under anesthesia for the evaluation for the presence of Spinal deformities.']	N/A	N/A	[('GO_0007567', 'parturition', 41, 'birth'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rats'), ('UBERON_0001013', 'adipose tissue', 114, 'spine'), ('UBERON_0001130', 'vertebral column', 176, 'spinal')]
PMC3518064	11/2012	S7-PMC3518064	['introduction\nobesity refers to excessive Adipose Tissue accumulation and is defined by the world health organization (who) as a body mass index (bmi: weight (kg)/length (m2)) greater than or equal to 30 [1].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 41, 'adipose tissue')]
PMC3518064	11/2012	S30-PMC3518064	['Adipose Tissue\n\n3.1.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose Tissue')]
PMC3518064	11/2012	S31-PMC3518064	['the different types of Adipose Tissue\ntwo types of Adipose Tissue, White Adipose Tissue (Wat) and Brown Adipose Tissue (Bat), Coexist in most Mammalian species.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 23, 'Adipose Tissue'), ('UBERON_0001013', 'adipose tissue', 51, 'adipose tissue'), ('UBERON_0001347', 'white adipose tissue', 67, 'white adipose tissue'), ('UBERON_0006337', 'distal early tubule', 89, 'WAT'), ('UBERON_0001348', 'brown adipose tissue', 98, 'brown adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 120, 'BAT'), ('GO_0007620', 'copulation', 126, 'coexist'), ('NCBITaxon_40674', 'Mammalia', 142, 'mammalian')]
PMC3518064	11/2012	S41-PMC3518064	['in Humans, subcutaneous depots consist of Adipose Tissue under the skin in primarily the Buttocks, Thighs, and Abdomen.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('UBERON_0002436', 'primary visual cortex', 89, 'buttocks'), ('UBERON_0000376', 'hindlimb stylopod', 99, 'thighs'), ('UBERON_0000916', 'abdomen', 111, 'abdomen')]
PMC3518064	11/2012	S48-PMC3518064	['the second type of Adipose Tissue, the Bat, is specialized in the Dissipation Of Energy through the Production Of Heat [19].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 39, 'BAT'), ('GO_0006212', 'uracil catabolic process', 66, 'dissipation of energy'), ('GO_0019230', 'proprioception', 100, 'production of heat')]
PMC3518064	11/2012	S62-PMC3518064	['for example, Lambs are Born with almost 100% Bat [52,53], with majority of this Adipose Tissue located around the Kidneys [33,34].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 13, 'lambs'), ('GO_0007567', 'parturition', 23, 'born'), ('UBERON_0001348', 'brown adipose tissue', 45, 'BAT'), ('UBERON_0001013', 'adipose tissue', 80, 'adipose tissue'), ('UBERON_0002113', 'kidney', 114, 'kidneys')]
PMC3518064	11/2012	S69-PMC3518064	['Fat Lobules are the earliest structures to be identified before the appearance of typical vacuolated Fat Cells [55].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Fat lobules'), ('CL_0000136', 'fat cell', 101, 'fat cells')]
PMC3518064	11/2012	S72-PMC3518064	['after the 23rd week, the total number of Fat Lobules remains approximately constant, while from the 23rd to 29th week, the growth of Adipose Tissue is determined mainly by an increase in size of the Fat Lobules.']	N/A	N/A	[('UBERON_0000323', 'late embryo', 41, 'fat lobules'), ('UBERON_0001013', 'adipose tissue', 133, 'adipose tissue'), ('UBERON_0000323', 'late embryo', 199, 'fat lobules')]
PMC3518064	11/2012	S128-PMC3518064	['leptin, iugr and later Adipose Tissue Development\nleptin, a 16\u2009kda protein hormone, stimulates a negative energy balance by increasing energy expenditure and reducing Food Intake [96].']	N/A	N/A	[('GO_0006953', 'acute-phase response', 23, 'Adipose'), ('UBERON_0001013', 'adipose tissue', 23, 'Adipose Tissue'), ('GO_0008584', 'male gonad development', 31, 'Tissue Development'), ('CHEBI_33290', 'food', 167, 'food'), ('GO_0007631', 'feeding behavior', 167, 'food intake')]
PMC3518064	11/2012	S129-PMC3518064	['leptin mainly acts by binding to specific central and peripheral receptors in the Hypothalamus, Adipose Tissue, Liver, and Pancreatic Β -Cells [97].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 82, 'hypothalamus'), ('UBERON_0001013', 'adipose tissue', 96, 'adipose tissue'), ('UBERON_0002107', 'liver', 112, 'liver'), ('CL_0000173', 'pancreatic D cell', 123, 'pancreatic β -cells'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic')]
PMC3518064	11/2012	S140-PMC3518064	['indeed, the Adipose Tissue from early Nutrient-restricted Sheep fetuses displays alterations in Glucocorticoid signalling (increased Glucorticoid receptor and 11- Β -Hydroxysteroid dehydrogenase 1 (11 Β -Hsd1) Expression, but decreased 11 Β -Hsd2 abundance) at day 140 of Gestation and at 6 months Postnatally [110].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 12, 'adipose tissue'), ('CHEBI_33284', 'nutrient', 38, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'sheep'), ('CHEBI_24261', 'glucocorticoid', 96, 'glucocorticoid'), ('CHEBI_24261', 'glucocorticoid', 133, 'glucorticoid'), ('CHEBI_36844', '7-hydroxy steroid', 159, '11- β -hydroxysteroid'), ('PR_000002314', 'caspase-5', 201, 'β -HSD1'), ('GO_0010467', 'gene expression', 210, 'expression'), ('PR_000009339', 'killer cell immunoglobulin-like receptor 3DL3', 239, 'β -HSD2'), ('GO_0007565', 'female pregnancy', 272, 'gestation'), ('GO_0007565', 'female pregnancy', 298, 'postnatally')]
PMC3533960	10/2012	S100-PMC3533960	['caption (table-wrap): table 2\n\ndata collection and measurementsmeasurementspre-pregnancypregnancybirthpost-Partum \xa0\xa0 6-12 weeks23-28 weeks30-36 weeks \xa0\xa0 maternal \xa0\xa0\xa0\xa0\xa0\xa0demographics, ses status√\xa0\xa0\xa0\xa0\xa0obgyn history√\xa0\xa0\xa0\xa0\xa0Food frequency questionnaire√\xa0\xa0\xa0\xa0\xa0helminthic infections√\xa0\xa0\xa0\xa0\xa0mental health√√√√\xa0√morbidity\xa0√√√\xa0√periodontitis screening\xa0√√√\xa0\xa0workload\xa0√√√\xa0\xa0Blood pressure√√√√\xa0\xa0anthropometry√√√√\xa0√hematological measures\xa0\xa0\xa0\xa0\xa0\xa0Hemoglobin√√√√\xa0√Serum ferritin√√√\xa0\xa0√Transferrin Receptor√√√\xa0\xa0√infection indicators (crp, agp)√√√\xa0\xa0√other biological indicators\xa0\xa0\xa0\xa0\xa0\xa0Vitamin A√√√\xa0\xa0√Blood Glucose\xa0√√\xa0\xa0\xa0Urine protein\xa0√√√\xa0\xa0 Fetal Development (ultrasound) \xa0√√√\xa0\xa0 Birth information \xa0\xa0\xa0\xa0√\xa0 child measurement \xa0\xa0\xa0\xa0\xa0\xa0Gestational age\xa0\xa0\xa0\xa0√\xa0anthropometry\xa0\xa0\xa0\xa0√√hematological measures\xa0\xa0\xa0\xa0\xa0\xa0hemoglobin\xa0\xa0\xa0\xa0\xa0√Serum ferritin\xa0\xa0\xa0\xa0√\xa0Transferrin Receptor\xa0\xa0\xa0\xa0√\xa0infant Feeding practices\xa0\xa0\xa0\xa0\xa0√ supplement information \xa0\xa0\xa0\xa0\xa0\xa0supplement consumption√√√√\xa0\xa0side effects√√√√\xa0\xa0\n\nmeasurement of key outcomes\nBirth size : infant anthropometry is measured as early as possible within seven days after Birth and at one and three months Postpartum using standard procedures [34,35].']	N/A	N/A	[('GO_0007567', 'parturition', 107, 'partum'), ('UBERON_0001013', 'adipose tissue', 107, 'partum'), ('CHEBI_33290', 'food', 217, 'Food'), ('GO_0007596', 'blood coagulation', 355, 'Blood'), ('UBERON_0000178', 'blood', 355, 'Blood'), ('CHEBI_5679', 'herniarin', 422, 'Hemoglobin'), ('UBERON_0001977', 'blood serum', 438, 'Serum'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 458, 'Transferrin receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 554, 'Vitamin A'), ('CHEBI_33290', 'food', 569, 'Blood'), ('UBERON_0000178', 'blood', 569, 'Blood'), ('CHEBI_17234', 'glucose', 575, 'Glucose'), ('UBERON_0001088', 'urine', 588, 'Urine'), ('GO_0060132', 'prolactin secreting cell development', 608, 'Fetal development'), ('GO_0007567', 'parturition', 646, 'Birth'), ('GO_0007565', 'female pregnancy', 695, 'Gestational'), ('UBERON_0001977', 'blood serum', 779, 'Serum'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 799, 'Transferrin receptor'), ('GO_0007631', 'feeding behavior', 832, 'feeding'), ('GO_0007567', 'parturition', 961, 'Birth'), ('GO_0007567', 'parturition', 1052, 'birth'), ('GO_0007565', 'female pregnancy', 1086, 'postpartum')]
PMC3549390	1/2013	S34-PMC3549390	['grossly, the tumor was a 12 × 9.5 × 7\u2009cm mass weighing 457\u2009g, ovoid in shape, firm in consistency, covered by a smooth glistening Layer with some attached Adipose Tissue in areas.']	N/A	N/A	[('UBERON_0000974', 'neck', 130, 'layer'), ('UBERON_0001013', 'adipose tissue', 155, 'adipose tissue')]
PMC3574039	1/2013	S3-PMC3574039	['compared to the cc and lc groups, the co and lo groups had higher relative and absolute Food Intakes, oxygen Consumption and Carbon Dioxide Production; lower brown Adipose Tissue weight and Lipid content and greater weight gain and absolute and relative White Adipose Tissue weight and absolute Lipid content.']	N/A	N/A	[('CHEBI_33290', 'food', 88, 'food'), ('GO_0007631', 'feeding behavior', 88, 'food intakes'), ('GO_0007631', 'feeding behavior', 109, 'consumption'), ('CHEBI_16526', 'carbon dioxide', 125, 'carbon dioxide'), ('GO_0001502', 'cartilage condensation', 125, 'carbon dioxide production'), ('UBERON_0001013', 'adipose tissue', 164, 'adipose tissue'), ('CHEBI_18059', 'lipid', 190, 'lipid'), ('UBERON_0001347', 'white adipose tissue', 254, 'white adipose tissue'), ('CHEBI_18059', 'lipid', 295, 'lipid')]
PMC3574039	1/2013	S114-PMC3574039	['caption (table-wrap): table 4\n\nweight and Lipid content in the White and Brown Adipose Tissues (Bat) of Rats maintained with the control (cc and lc) or overfeeding diets (co and lo)variablesgroups \xa0 cccolclo \xa0 nmeansemnmeansemnmeansemnmeansem weight ibat (g)60.4680.160.391#0.160.652*0.160.501*#0.1lipid content ibat (g/total Tissue)60.200.160.16#0.160.34*0.160.23*#0.1lipid content ibat (g/100g Tissue)648.73.2650.13.4661.3*2.1652.5*4.4weight rwat (g)69.10.5612.1#0.8610.10.4612.5#0.9weight Rwat (g/ 100g bw)62.50.162.6#0.362.7*0.163.10*#0.1lipid content Rwat (g/total Tissue)83.50.374.9#0.473.70.484.1#0.3lipid content Rwat (g/100g Tissue)839.62.1738.01.5738.62.5833.61.3weight ewat (g)66.60.568.7#0.768.30.769.7#0.8weight Ewat (g/ 100g bw)61.8b0.162.2a0.162.4a0.162.2a0.2lipid content Ewat (g/total Tissue)82.80.183.3#0.272.70.383.2#0.2lipid content Ewat (g/100g Tissue)835.70.8836.40.6634.31.2734.30.7\nbw, body weight; Rwat, Retroperitoneal White Adipose Tissue; Ewat, Epididymal white Adipose Tissue.']	N/A	N/A	[('CHEBI_18059', 'lipid', 42, 'lipid'), ('UBERON_0006134', 'nerve fiber', 63, 'white ...'), ('UBERON_0001348', 'brown adipose tissue', 73, 'brown adipose tissues'), ('UBERON_0001348', 'brown adipose tissue', 96, 'BAT'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 104, 'rats'), ('UBERON_0000479', 'tissue', 326, 'tissue'), ('UBERON_0000479', 'tissue', 396, 'tissue'), ('UBERON_0013641', 'external cheek pouch', 492, 'RWAT'), ('UBERON_0013641', 'external cheek pouch', 556, 'RWAT'), ('UBERON_0000479', 'tissue', 570, 'tissue'), ('UBERON_0013641', 'external cheek pouch', 621, 'RWAT'), ('UBERON_0000479', 'tissue', 634, 'tissue'), ('UBERON_0007376', 'outer epithelium', 725, 'EWAT'), ('UBERON_0007376', 'outer epithelium', 788, 'EWAT'), ('UBERON_0000479', 'tissue', 802, 'tissue'), ('UBERON_0007376', 'outer epithelium', 853, 'EWAT'), ('UBERON_0000479', 'tissue', 866, 'tissue'), ('UBERON_0013641', 'external cheek pouch', 923, 'RWAT'), ('UBERON_0007274', 'crista of ampulla of anterior semicircular duct of membranous laybrinth', 929, 'retroperitoneal white adipose tissue'), ('UBERON_0007376', 'outer epithelium', 967, 'EWAT'), ('UBERON_0001301', 'epididymis', 973, 'epididymal'), ('UBERON_0001013', 'adipose tissue', 990, 'adipose tissue')]
PMC3585827	1/2013	S21-PMC3585827	['further, south asians have more Adipose Tissue and develop abnormal Glucose, Lipids, and Blood pressure at a significantly lower body mass index (bmi) compared to white caucasians [13].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 32, 'adipose tissue'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('CHEBI_18059', 'lipid', 77, 'lipids'), ('UBERON_0000178', 'blood', 89, 'blood')]
PMC3586494	2/2013	S225-PMC3586494	['Triglycerides, free Fatty Acids, overall Glucose tolerance, and the Insulin sensitivity of Adipose Tissue were comparable in both groups [92].']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'Triglycerides'), ('CHEBI_35366', 'fatty acid', 20, 'fatty acids'), ('CHEBI_17234', 'glucose', 41, 'glucose'), ('PR_000045358', 'insulin family protein', 68, 'insulin'), ('UBERON_0001013', 'adipose tissue', 91, 'adipose tissue')]
PMC3608974	2/2013	S65-PMC3608974	['pre-existing axial rotation of the normal Spine.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 42, 'spine')]
PMC3608974	2/2013	S67-PMC3608974	['Neurocentral junction (Ncj) in the normal Growing Spine.']	N/A	N/A	[('GO_0043005', 'neuron projection', 0, 'Neurocentral'), ('UBERON_2005053', 'nasal ciliary artery', 23, 'NCJ'), ('GO_0040007', 'growth', 42, 'growing'), ('UBERON_0001013', 'adipose tissue', 50, 'spine')]
PMC3650171	2/2013	S145-PMC3650171	['for example, persistent Organic Pollutants, which include Polychlorinated Dibenzo- P -Dioxins, Polychlorinated Dibenzofurans, and Polychlorinated Biphenyls (Pcbs) can accumulate in the Human body, especially in Adipose Tissue because of their lipophilic nature.']	N/A	N/A	[('CHEBI_72564', 'temozolomide', 24, 'organic pollutants'), ('CHEBI_51135', 'poly(acrylamide) macromolecule', 58, 'polychlorinated dibenzo- p -dioxins'), ('CHEBI_50535', 'tin coordination entity', 95, 'polychlorinated dibenzofurans'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 130, 'polychlorinated biphenyls'), ('CHEBI_26199', 'polyprenol', 157, 'PCBs'), ('NCBITaxon_9606', 'Homo sapiens', 185, 'human'), ('UBERON_0001013', 'adipose tissue', 211, 'adipose tissue')]
PMC3699531	7/2013	S65-PMC3699531	['furthermore, Insulin resistance, Macrophage infiltration and increased inflammation in Adipose Tissue of un offspring was observed (data not shown).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 13, 'insulin'), ('CL_0000235', 'macrophage', 33, 'macrophage'), ('UBERON_0001013', 'adipose tissue', 87, 'adipose tissue')]
PMC3720837	7/2013	S86-PMC3720837	['the ib females were lighter (131.1±2.6 vs. 164.7±9.5 kg, p \u200a=\u200a0.01), but had more Back-Fat depth (36.9±0.7 vs. 16.7±1.5 mm, p \u200a=\u200a0.0005).']	N/A	N/A	[('UBERON_0001137', 'dorsum', 82, 'back'), ('UBERON_0001013', 'adipose tissue', 87, 'fat')]
PMC3740243	8/2013	S133-PMC3740243	['as with Tlr4, there is increased Tlr3 Expression in neonatally overfed Rat Adipose Tissue (clarke et al.,2012).']	N/A	N/A	[('PR_000001155', 'Toll-like receptor 4', 8, 'TLR4'), ('PR_000001155', 'Toll-like receptor 4', 33, 'TLR3'), ('GO_0010467', 'gene expression', 38, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 71, 'rat'), ('UBERON_0001013', 'adipose tissue', 75, 'adipose tissue')]
PMC3740243	8/2013	S165-PMC3740243	['neonatally overfed Rats also have increased Expression of the gr and increased Glucocorticoid signaling in Adipose Tissue as Adults (boullu-ciocca et al.,2005).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 19, 'rats'), ('GO_0010467', 'gene expression', 44, 'expression'), ('CHEBI_24261', 'glucocorticoid', 79, 'glucocorticoid'), ('UBERON_0001013', 'adipose tissue', 107, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 125, 'adults')]
PMC3743734	9/2013	S43-PMC3743734	['the cv of Spine phantom measurements over the period encompassing the trial and follow-up study was 0.6%, and there was no evidence of significant drift.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 10, 'spine')]
PMC3743734	9/2013	S90-PMC3743734	['caption (table-wrap): table 3\n\nchanges from L52 in maternal body weight and bone measures at the Whole Body and Lumbar Spine at npnl and f52 1percentage change from l52npnlf52v p2 Calcium groupplacebo groupcalcium groupplacebo grouptimegrouptime × group interactionweight (kg) 3 4.0 ± 1.5 4 3.4 ± 1.63.4 ± 1.71.0 ± 1.80.004≤0.00010.6whole body 5 , 6 \u2003bmc (g)1.8 ± 0.95.0 ± 0.9 7 −0.2 ± 1.02.1 ± 1.1≤0.0001≤0.00010.04\u2003ba (cm2)0.8 ± 0.72.2 ± 0.7 4 0.2 ± 0.81.1 ± 0.90.02≤0.00010.4\u2003bmd (g/cm2)1.0 ± 0.52.9 ± 0.5 7 −0.4 ± 0.50.9 ± 0.5≤0.0001≤0.00010.02\u2003sa-Bmc (g)1.0 ± 0.52.7 ± 0.5 7 −0.4 ± 0.50.8 ± 0.5≤0.0001≤0.00010.03lumbar Spine 5 , 8 \u2003bmc (g)4.8 ± 1.0 7 8.8 ± 1.0 7 −0.1 ± 1.12.4 ± 1.2≤0.0001≤0.00010.02\u2003ba (cm2)2.0 ± 0.4 7 2.3 ± 0.5 7 1.1 ± 0.51.2 ± 0.5≤0.0001≤0.00010.9\u2003bmd (g/cm2)2.8 ± 0.7 7 6.6 ± 0.8 7 −1.2 ± 0.81.2 ± 0.9≤0.0001≤0.00010.002\u2003sa-bmc (g)1.6 ± 0.85.2 ± 0.8 7 −1.8 ± 0.80.4 ± 0.8≤0.0001≤0.00010.002\nall values are means ± ses.']	N/A	N/A	[('UBERON_0005416', 'zone of polarizing activity of pelvic appendage', 44, 'L52'), ('UBERON_0000468', 'multicellular organism', 97, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 112, 'lumbar spine'), ('CHEBI_31341', 'calcium dihydroxide', 180, 'Calcium'), ('CL_0002028', 'basophil mast progenitor cell', 552, 'BMC'), ('UBERON_0001013', 'adipose tissue', 624, 'spine')]
PMC3743734	9/2013	S108-PMC3743734	['caption (table-wrap): table 5\n\ndifferences in maternal body weight and bone measures at the Whole Body and Lumbar Spine between the calcium and placebo groups at each of the 3 time points 1percentage difference between calcium and placebo groupsl52npnlf52calcium vs placebo group p2 Calcium vs placebo group p2 Calcium vs placebo group p2 weight (kg) 3 −2.4 ± 1.50.3−1.9 ± 1.60.5−0.1 ± 2.01.0whole body 4 , 5 \u2003bmc (g)−4.0 ± 0.9≤0.0001−7.2 ± 1.0≤0.0001−6.2 ± 1.2≤0.0001\u2003ba (cm2)−1.9 ± 0.70.03−3.3 ± 0.80.0002−2.8 ± 0.90.01\u2003bmd (g/cm2)−2.1 ± 0.4≤0.0001−3.9 ± 0.5≤0.0001−3.4 ± 0.6≤0.0001\u2003sa-bmc (g)−1.9 ± 0.5≤0.0001−3.6 ± 0.5≤0.0001−3.2 ± 0.6≤0.0001lumbar Spine 4 , 6 \u2003bmc (g)−3.4 ± 0.90.002−7.5 ± 1.1≤0.0001−5.8 ± 1.3≤0.0001\u2003ba (cm2)0.3 ± 0.40.70.1 ± 0.51.00.2 ± 0.60.9\u2003bmd (g/cm2)−3.7 ± 0.7≤0.0001−7.5 ± 0.8≤0.0001−6.1 ± 1.0≤0.0001\u2003sa-bmc (g)−3.9 ± 0.7≤0.0001−7.5 ± 0.7≤0.0001−6.2 ± 0.9≤0.0001\n1 all values are means ± ses.']	N/A	N/A	[('UBERON_0000468', 'multicellular organism', 92, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 107, 'lumbar spine'), ('CHEBI_31341', 'calcium dihydroxide', 283, 'Calcium'), ('CHEBI_31341', 'calcium dihydroxide', 311, 'Calcium'), ('UBERON_0001013', 'adipose tissue', 653, 'spine')]
PMC3774699	10/2013	S8-PMC3774699	['this process is Regulated primarily by hormonal factors such as the Catecholamines and glucagon.6,8\nunder conditions of Food restriction, a number of Metabolic adaptations take place throughout the body in order to mobilize energy stored in Adipose Tissue.']	N/A	N/A	[('GO_0065007', 'biological regulation', 16, 'regulated'), ('CHEBI_33567', 'catecholamine', 68, 'catecholamines'), ('CHEBI_33290', 'food', 120, 'food'), ('GO_0008152', 'metabolic process', 150, 'metabolic'), ('UBERON_0001013', 'adipose tissue', 241, 'adipose tissue')]
PMC3774699	10/2013	S138-PMC3774699	['determination of Fat Pad weight was accomplished by later thawing these Carcasses and dissecting and weighing the Perigonadal, Mesenteric, Retroperitoneal, Subcutaneous White Adipose Tissue, and the Inter-Scapular brown Adipose Tissue.']	N/A	N/A	[('UBERON_0003916', 'fat pad', 17, 'fat pad'), ('UBERON_0008979', 'carcass', 72, 'carcasses'), ('UBERON_0001179', 'peritoneal cavity', 114, 'perigonadal'), ('UBERON_0000080', 'mesonephros', 127, 'mesenteric'), ('UBERON_0003693', 'retroperitoneal space', 139, 'retroperitoneal'), ('UBERON_0002023', 'claustrum of brain', 156, 'subcutaneous'), ('UBERON_0001347', 'white adipose tissue', 169, 'white adipose tissue'), ('UBERON_2000452', 'urohyal', 199, 'inter-scapular'), ('UBERON_0001013', 'adipose tissue', 220, 'adipose tissue')]
PMC3794936	10/2013	S62-PMC3794936	['Lipolysis activity is the amount of Glycerol (mg) released per gram of Adipose Tissue per hour.']	N/A	N/A	[('GO_0019468', 'nopaline catabolic process', 0, 'Lipolysis'), ('CHEBI_17754', 'glycerol', 36, 'glycerol'), ('UBERON_0001013', 'adipose tissue', 71, 'adipose tissue')]
PMC3794936	10/2013	S113-PMC3794936	['the activities of key lipoprotein lipases responsible for Lipid Uptake into peripheral Tissues were normal in the Liver, Adipose Tissue, and muscle of Gcn2 ko Mice (fig.']	N/A	N/A	[('CHEBI_18059', 'lipid', 58, 'lipid'), ('GO_0051626', 'regulation of epinephrine uptake', 58, 'lipid uptake'), ('UBERON_0000479', 'tissue', 87, 'tissues'), ('UBERON_0002107', 'liver', 114, 'liver'), ('UBERON_0001013', 'adipose tissue', 121, 'adipose tissue'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 151, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice')]
PMC3794936	10/2013	S277-PMC3794936	['pparγ2, Fsp27 , and Cidea Expression was not altered in Adipose Tissue or Brain in brgcn2 ko (fig.']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 8, 'Fsp27'), ('PR_000004968', 'calretinin', 20, 'Cidea'), ('GO_0010467', 'gene expression', 26, 'expression'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissue'), ('UBERON_0000955', 'brain', 74, 'brain')]
PMC3794936	10/2013	S296-PMC3794936	['Gcn2 programming of pparγ2 will specifically dictate the future Expression of Fsp27 and Cidea and Hepatic Triglyceride storage but not that of Adipose Tissue.']	N/A	N/A	[('PR_000007896', 'glucokinase regulatory protein', 0, 'GCN2'), ('GO_0010467', 'gene expression', 64, 'expression'), ('PR_000007690', 'ferritin heavy chain', 78, 'FSP27'), ('CHEBI_34606', 'caldarchaeol', 88, 'CIDEA'), ('PR_000005439', 'charged multivesicular body protein 5', 88, 'CIDEA'), ('UBERON_0002107', 'liver', 98, 'hepatic'), ('CHEBI_17855', 'triglyceride', 106, 'triglyceride'), ('UBERON_0001013', 'adipose tissue', 143, 'adipose tissue')]
PMC3794936	10/2013	S297-PMC3794936	['Leptin and leptin Signaling are known to Regulate Fat Metabolism in part through communication between Adipose Tissue, the Brain, and Liver[48],[49].']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Leptin'), ('GO_0023051', 'regulation of signaling', 18, 'signaling'), ('GO_0065007', 'biological regulation', 41, 'regulate'), ('GO_0006631', 'fatty acid metabolic process', 50, 'fat metabolism'), ('UBERON_0001013', 'adipose tissue', 103, 'adipose tissue'), ('UBERON_0000955', 'brain', 123, 'brain'), ('UBERON_0002107', 'liver', 134, 'liver')]
PMC3794936	10/2013	S303-PMC3794936	['for example, during fasting Triglycerides are released from Adipose Tissue as Fatty Acids, which are used by Peripheral Tissues for energy or re-esterified and stored in the Liver.']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 28, 'triglycerides'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue'), ('CHEBI_35366', 'fatty acid', 78, 'fatty acids'), ('UBERON_0001021', 'nerve', 109, 'peripheral tissues'), ('UBERON_0002107', 'liver', 174, 'liver')]
PMC3794936	10/2013	S307-PMC3794936	['Pparγ is a key Regulatory factor that Controls Lipid Metabolism and storage both in the Liver and Adipose Tissue.']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 0, 'PPARγ'), ('GO_0065007', 'biological regulation', 15, 'regulatory'), ('GO_0065007', 'biological regulation', 38, 'controls'), ('CHEBI_18059', 'lipid', 47, 'lipid'), ('GO_0006629', 'lipid metabolic process', 47, 'lipid metabolism'), ('UBERON_0002107', 'liver', 88, 'liver'), ('UBERON_0001013', 'adipose tissue', 98, 'adipose tissue')]
PMC3794936	10/2013	S357-PMC3794936	['lipolipase activities in Adipose Tissues of Mice of indicated genotypes in random Fed or 24-hour fasting state (mean ± sem, n\u200a=\u200a8).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 25, 'adipose tissues'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'mice'), ('GO_0007631', 'feeding behavior', 82, 'fed')]
PMC3794936	10/2013	S381-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Adipose Tissues of wild type (wt) and Gcn2 ko (ko) Mice, 8 months of age, (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs. wt).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0001013', 'adipose tissue', 79, 'adipose tissues'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 117, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 204, 'Gcn2')]
PMC3794936	10/2013	S383-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Adipose Tissues of Mice of indicated genotypes (normalized to db/db Mice, mean ± sem, n\u200a=\u200a8, *p<0.05, Gcn2;db dko vs. db/db ).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0001013', 'adipose tissue', 79, 'adipose tissues'), ('NCBITaxon_10088', 'Mus <genus>', 98, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 181, 'Gcn2')]
PMC3794936	10/2013	S385-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Adipose Tissues of Brain-specific knockout Mice ( brgcn2 ko ) and wildtype (wt) Mice (normalized to wt Mice, mean ± sem, n\u200a=\u200a4, *p<0.05, brgcn2 ko vs. wt).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0001013', 'adipose tissue', 79, 'adipose tissues'), ('UBERON_0000955', 'brain', 98, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mice')]
PMC3813450	10/2013	S50-PMC3813450	['the ultrasonographic imaging of Back-Fat is represented in the inset at the centre of the image.']	N/A	N/A	[('UBERON_0001137', 'dorsum', 32, 'back'), ('UBERON_0001013', 'adipose tissue', 37, 'fat')]
PMC3813450	10/2013	S55-PMC3813450	['mri scans were carried out at the ucm veterinary teaching hospital, by means of a panorama 0.23t scanner with a body/Spine Xl coil (philips medical systems, best, netherland).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 117, 'spine'), ('UBERON_0004198', 'comma-shaped body', 123, 'XL')]
PMC3813450	10/2013	S122-PMC3813450	['in the same way, the values obtained by measuring the Subcutaneous Back-Fat depth by ultrasonography, monthly from 60 to 240 days-old, were similar in overfed and underfed offspring and significantly higher in these groups than in control and late-underfed Pigs (p<0.0005;figure 3a; numerical data reported in thetable s2), without significant differences when comparing offspring from the same sex.']	N/A	N/A	[('UBERON_0002023', 'claustrum of brain', 54, 'subcutaneous'), ('UBERON_0001137', 'dorsum', 67, 'back'), ('UBERON_0001013', 'adipose tissue', 72, 'fat'), ('NCBITaxon_10088', 'Mus <genus>', 257, 'pigs')]
PMC3828638	11/2013	S33-PMC3828638	['Eaten Food can be stored on the body as Adipose Tissue depots, while hoarded Food is stored in the home or burrow for later Consumption during energetic deficits.']	N/A	N/A	[('GO_0001837', 'epithelial to mesenchymal transition', 0, 'Eaten'), ('CHEBI_33290', 'food', 6, 'food'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_33290', 'food', 77, 'food'), ('GO_0007631', 'feeding behavior', 124, 'consumption')]
PMC3828638	11/2013	S171-PMC3828638	['in addition, leptin functions Perinatally as a neurotrophic factor to facilitate the development of the Neural Circuits that Govern Metabolism, Adipose Tissue distribution and Ingestive behavior (reviewed by cottrell and ozanne,2007,2008; breton,2013).']	N/A	N/A	[('GO_0030253', 'protein secretion by the type I secretion system', 30, 'perinatally'), ('UBERON_0012101', 'perinatal stage', 30, 'perinatally'), ('UBERON_0024914', 'circuit part of central nervous system', 104, 'neural circuits'), ('GO_0065007', 'biological regulation', 125, 'govern'), ('GO_0008152', 'metabolic process', 132, 'metabolism'), ('UBERON_0001013', 'adipose tissue', 144, 'adipose tissue'), ('GO_0007631', 'feeding behavior', 176, 'ingestive')]
PMC3868354	4/2013	S14-PMC3868354	['Ovarian Estradiol promotes the conversion of energy into Adipose Tissue [4], which is mobilized during Gestation and Lactation [5].']	N/A	N/A	[('UBERON_0000992', 'ovary', 0, 'Ovarian'), ('CHEBI_23965', 'estradiol', 8, 'estradiol'), ('UBERON_0001013', 'adipose tissue', 57, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 103, 'gestation'), ('GO_0007595', 'lactation', 117, 'lactation')]
PMC3868354	4/2013	S133-PMC3868354	['those who were chronologically younger and gaining significant height preferentially acquired lean mass, both in a season of relative energy abundance and in a season of relative energy constraint, mobilizing Adipose Tissue during the hungry season.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 209, 'adipose tissue')]
PMC3946277	3/2014	S9-PMC3946277	['early Gestational undernutrition induced lower Hepatic Expression of Gluconeogenic factors in fetuses and reduced in vivo Adipose Tissue Insulin sensitivity in Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'gestational'), ('UBERON_0002107', 'liver', 47, 'hepatic'), ('GO_0010467', 'gene expression', 55, 'expression'), ('GO_0006094', 'gluconeogenesis', 69, 'gluconeogenic'), ('UBERON_0001013', 'adipose tissue', 122, 'adipose tissue'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('UBERON_0000113', 'post-juvenile adult stage', 160, 'adulthood')]
PMC3946277	3/2014	S10-PMC3946277	['in males, Undernutrition in early Gestation increased Adipose Tissue Lipid Handling mechanisms (lipoprotein lipase, Glucocorticoid receptor Expression) and Hepatic methylation within the Imprinted Control region of Insulin-Like Growth Factor 2 Receptor in Adulthood.']	N/A	N/A	[('GO_0019653', 'anaerobic purine nucleobase catabolic process', 10, 'undernutrition'), ('GO_0007565', 'female pregnancy', 34, 'gestation'), ('UBERON_0001013', 'adipose tissue', 54, 'adipose tissue'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006629', 'lipid metabolic process', 69, 'lipid handling'), ('CHEBI_24261', 'glucocorticoid', 116, 'glucocorticoid'), ('GO_0010467', 'gene expression', 140, 'expression'), ('UBERON_0002107', 'liver', 156, 'hepatic'), ('GO_0071514', 'genetic imprinting', 187, 'imprinted'), ('GO_0065007', 'biological regulation', 197, 'control'), ('PR_000001364', 'interleukin-1 receptor type II', 215, 'insulin-like growth factor 2 receptor'), ('UBERON_0000113', 'post-juvenile adult stage', 256, 'adulthood')]
PMC3946277	3/2014	S99-PMC3946277	['laboratory analysis\n\nmrna Expression analysis\ntotal rna was extracted from Adult muscle, Adult Adipose Tissue and fetal and Adult Left and right Liver Lobe using the trizol method and Reverse Transcribed into cdna.']	N/A	N/A	[('GO_0010467', 'gene expression', 26, 'expression'), ('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_0007023', 'adult organism', 89, 'adult'), ('UBERON_0001013', 'adipose tissue', 95, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 124, 'adult'), ('UBERON_0002079', 'left cardiac atrium', 130, 'left ...'), ('UBERON_0001113', 'lobe of liver', 145, 'liver lobe'), ('GO_0001171', 'reverse transcription', 184, 'reverse transcribed')]
PMC3946277	3/2014	S100-PMC3946277	['real-time rt pcr (abl prism 7700 and 7500 sequence detection system, applied biosystems step one plus) was used to measure mrna Expression for ir in all Adult and fetal Tissues, Glut4 in Adult muscle and Adipose Tissue, gr in Adult Adipose Tissue and Adult and fetal Liver, Lpl and Ppar-γ in Adult Adipose Tissue, Pepck and g6pase in Adult and fetal Liver, igfii and Igf2R in the Left Lobe Of adult Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 128, 'expression'), ('UBERON_0007023', 'adult organism', 153, 'adult'), ('UBERON_0000479', 'tissue', 169, 'tissues'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 178, 'GLUT4'), ('UBERON_0007023', 'adult organism', 187, 'adult'), ('UBERON_0001013', 'adipose tissue', 204, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 226, 'adult'), ('UBERON_0001013', 'adipose tissue', 232, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 251, 'adult'), ('UBERON_0002107', 'liver', 267, 'liver'), ('PR_000009880', 'Lon protease, mitochondrial', 274, 'LPL'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 282, 'PPAR-'), ('UBERON_0007023', 'adult organism', 292, 'adult'), ('UBERON_0001013', 'adipose tissue', 298, 'adipose tissue'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 314, 'PEPCK'), ('UBERON_0007023', 'adult organism', 334, 'adult'), ('UBERON_0002107', 'liver', 350, 'liver'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 367, 'IGF2R'), ('UBERON_0001115', 'left lobe of liver', 380, 'left lobe of ... liver')]
PMC3946277	3/2014	S102-PMC3946277	['gr in Adult Adipose Tissue, igfii and Igf2R Gene Expression and Expression of housekeeping Genes were measured using Sybr Green (jumpstart taq readymix, sigma aldrich s4438).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 6, 'adult'), ('UBERON_0001013', 'adipose tissue', 12, 'adipose tissue'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 38, 'IGF2R'), ('GO_0010467', 'gene expression', 44, 'gene expression'), ('SO_0000704', 'gene', 44, 'gene'), ('GO_0010467', 'gene expression', 64, 'expression'), ('SO_0000704', 'gene', 91, 'genes'), ('CHEBI_51461', 'SYBR Green I', 117, 'SYBR Green')]
PMC3946277	3/2014	S103-PMC3946277	['Gene Expression in Adult muscle and Adipose Tissues was normalised to the geometric mean of Β-Actin and Glyceraldehyde 3-Phosphate dehydrogenase (gapdh) mrna Expression, as determined using a genorm normalising kit (primer design, southampton, uk) validated for use in the Sheep.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0007023', 'adult organism', 19, 'adult'), ('UBERON_0001013', 'adipose tissue', 36, 'adipose tissues'), ('PR_000003676', 'actin, cytoplasmic 1', 92, 'β-actin'), ('CHEBI_17138', 'glyceraldehyde 3-phosphate', 104, 'glyceraldehyde 3-phosphate'), ('GO_0010467', 'gene expression', 158, 'expression'), ('NCBITaxon_10088', 'Mus <genus>', 273, 'sheep')]
PMC3946277	3/2014	S105-PMC3946277	['gr Gene Expression in Adult Adipose Tissue was performed before the genorm kit became available so these data were normalised to 18S mrna Expression.']	N/A	N/A	[('GO_0010467', 'gene expression', 3, 'gene expression'), ('SO_0000704', 'gene', 3, 'gene'), ('UBERON_0007023', 'adult organism', 22, 'adult'), ('UBERON_0001013', 'adipose tissue', 28, 'adipose tissue'), ('SO_0000407', 'cytosolic_18S_rRNA', 129, '18S'), ('GO_0010467', 'gene expression', 138, 'expression')]
PMC3946277	3/2014	S116-PMC3946277	['Plasma Lipid analysis\nPlasma nefa and Tag concentrations during gtt at 1.5 and 2.5 years were measured to assess Insulin-induced inhibition of Lipolysis in Adipose Tissue.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_18059', 'lipid', 7, 'lipid'), ('UBERON_0001969', 'blood plasma', 22, 'Plasma'), ('CHEBI_17855', 'triglyceride', 38, 'TAG'), ('PR_000045358', 'insulin family protein', 113, 'insulin'), ('GO_0016042', 'lipid catabolic process', 143, 'lipolysis'), ('UBERON_0001013', 'adipose tissue', 156, 'adipose tissue')]
PMC3946277	3/2014	S120-PMC3946277	['therefore, gas chromatography (hp 6890 series gc system equipped with a flame ionisation detector and 7683b series injector) was used, following separation of Lipid classes by solid phase extraction, to measure Plasma Tag concentrations (extracted from 0.4 g Plasma, made up to 0.8 ml) or adipose total Lipid content (extracted from 20 mg Adipose Tissue), as described previously[48].']	N/A	N/A	[('CHEBI_18059', 'lipid', 159, 'lipid'), ('UBERON_0001969', 'blood plasma', 211, 'plasma'), ('CHEBI_17855', 'triglyceride', 218, 'TAG'), ('UBERON_0001969', 'blood plasma', 259, 'plasma'), ('CHEBI_18059', 'lipid', 303, 'lipid'), ('UBERON_0001013', 'adipose tissue', 339, 'adipose tissue')]
PMC3946277	3/2014	S149-PMC3946277	['Adipose Tissue Lipid content was also reduced (p<0.05) in cu compared to cc females at 2.5 years (table 2).10.1371/journal.pone.0090994.t002\n\ncaption (table-Wrap): table 2\nGenes of interest in Liver and Adipose Tissue of mature (2.5 years) Adult male and female Sheep.malesfemalescccuucuucccuucuu n \u200a=\u200a13 n \u200a=\u200a7 n \u200a=\u200a8 n \u200a=\u200a11 n \u200a=\u200a9 n \u200a=\u200a7 n \u200a=\u200a9 n \u200a=\u200a11liver – left Lobe:gr mrnax,z3.41±0.492.85±0.403.41±0.403.35±0.492.73±0.372.20±0.292.32±0.142.37±0.24ir mrna0.187±0.0230.222±0.0660.304±0.0810.282±0.0560.268±0.0300.203±0.0250.276±0.0410.228±0.041pepck mrnay,z0.258±0.0490.190±0.0210.313±0.0330.294±0.0550.166±0.0360.194±0.0380.224±0.0410.140±0.027g6pase mrna0.485±0.0510.521±0.1160.463±0.0590.522±0.1000.536±0.0840.486±0.0780.471±0.0780.455±0.060gr methylation0.013±0.0040.021±0.0120.010±0.0020.018±0.0040.013±0.0040.011±0.0050.049±0.0430.013±0.004igfii mrna0.512±0.0760.523±0.0970.552±0.1360.513±0.0560.380±0.0590.405±0.0410.378±0.0670.426±0.041igf2r mrna0.015±0.0060.006±0.0020.023±0.0110.017±0.0060.062±0.0560.011±0.0030.017±0.0010.040±0.023liver – right Lobe:gr mrnax7.18±0.677.57±0.666.68±0.947.42±1.443.67±0.563.51±0.303.75±0.603.77±0.47ir mrna0.234±0.0410.302±0.0500.238±0.0640.266±0.0390.203±0.0170.217±0.0240.250±0.0510.242±0.019pepck mrna0.198±0.0290.219±0.0460.307±0.0720.182±0.0270.106±0.0080.150±0.0250.126±0.0170.141±0.021g6pase mrna0.512±0.0760.523±0.0970.552±0.1360.513±0.0560.380±0.0590.405±0.0410.378±0.0670.426±0.041gr Dna Methylation0.015±0.0060.006±0.0020.023±0.0110.017±0.0060.062±0.0560.011±0.0030.017±0.0010.040±0.023adipose Tissue:ir mrna1.63±0.151.75±0.251.56±0.171.29±0.101.55±0.241.37±0.191.54±0.191.35±0.18glut4 mrna1.55±0.161.66±0.121.38±0.181.51±0.131.06±0.181.28±0.181.42±0.151.49±0.32Pparγ mrna1.85±0.171.83±0.241.82±0.151.68±0.150.97±0.160.88±0.110.96±0.090.97±0.14lipid content (mmol.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_18059', 'lipid', 15, 'lipid'), ('PR_000017453', 'protein Wnt-9b', 157, 'WRAP'), ('SO_0000704', 'gene', 172, 'Genes'), ('UBERON_0002107', 'liver', 193, 'liver'), ('UBERON_0001013', 'adipose tissue', 203, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 240, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 262, 'sheep'), ('UBERON_0009912', 'anatomical lobe', 368, 'lobe'), ('UBERON_0009912', 'anatomical lobe', 1062, 'lobe'), ('GO_0006309', 'apoptotic DNA fragmentation', 1442, 'DNA methylation0'), ('UBERON_0000479', 'tissue', 1553, 'tissue'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 1719, '32PPARγ')]
PMC3946277	3/2014	S152-PMC3946277	['values given have arbitrary units and are normalised to geometric means of Β-Actin, gapdh and Rpl-19 (Liver) or Β Actin and gapdh (Adipose Tissue).']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 75, 'β-actin'), ('PR_000014170', 'replication protein A 70 kDa DNA-binding subunit', 94, 'RPL-19'), ('UBERON_0002107', 'liver', 102, 'liver'), ('PR_000003676', 'actin, cytoplasmic 1', 112, 'β actin'), ('UBERON_0001013', 'adipose tissue', 131, 'adipose tissue')]
PMC3946277	3/2014	S155-PMC3946277	['this was not associated with an effect on Adipose Tissue Lipid content (table 2).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('CHEBI_18059', 'lipid', 57, 'lipid')]
PMC3946277	3/2014	S157-PMC3946277	['2) and gr mrna (1.49±0.05 vs. 0.97±0.05 arbitrary units) levels in Adipose Tissue at 2.5 years were significantly (p<0.001) higher in males than females.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 67, 'adipose tissue')]
PMC3946277	3/2014	S163-PMC3946277	['Adipose Tissue factors are unaffected by post-weaning undernutrition\nthere were no significant effects of post-weaning Nutrient restriction on mrna levels of Pparγ, Lpl or gr in Adipose Tissue of either male or female Sheep at 2.5 years (fig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_33284', 'nutrient', 119, 'nutrient'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 158, 'PPARγ'), ('PR_000009880', 'Lon protease, mitochondrial', 165, 'LPL'), ('UBERON_0001013', 'adipose tissue', 178, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'sheep')]
PMC3946277	3/2014	S175-PMC3946277	['4), Adipose Tissue or Liver (table 2), or on Hepatic gr, Pepck or G6Pase mrna levels (fig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 4, 'adipose tissue'), ('UBERON_0002107', 'liver', 22, 'liver'), ('UBERON_0002107', 'liver', 45, 'hepatic'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 57, 'PEPCK'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 66, 'G6Pase')]
PMC3994635	8/2010	S100-PMC3994635	['caption (table-wrap): table 3\n\nchanges in maternal body weight and bone Mineral status at the Whole Body, Lumbar Spine, and Radius at 13 and 52 wk Postpartum 1percentage change from 2 wk 2 13 wk52 wk p3 Calcium groupplacebo groupcalcium groupplacebo grouptimegrouptime × group interactionbody weight \u2003n 61626060\u2003weight−1.0 ± 0.8−1.3 ± 0.8−4.8 ± 0.8 45 −3.9 ± 0.8 46 ≤0.0010.40.5whole body \u2003n 29273839\u2003bmc−1.6 ± 0.7−1.8 ± 0.7 7 −5.0 ± 0.7 45 −2.9 ± 0.7 4 ≤0.0010.90.03\u2003ba−0.7 ± 0.6−1.1 ± 0.6−2.5 ± 0.6 46 −1.2 ± 0.6≤0.0010.50.1\u2003bmd−0.9 ± 0.3 8 −0.7 ± 0.3−2.6 ± 0.3 45 −1.7 ± 0.3 46 ≤0.0010.40.1\u2003sa-bmc−0.9 ± 0.3 7 −0.7 ± 0.3−2.6 ± 0.3 45 −1.7 ± 0.3 46 ≤0.0010.060.1lumbar Spine \u2003n 29294039\u2003bmc−5.3 ± 0.9 4 −2.1 ± 0.9 7 −3.5 ± 1.0 8 −0.2 ± 0.9≤0.0010.90.02\u2003ba−0.5 ± 0.40.2 ± 0.40.5 ± 0.5 9 0.1 ± 0.40.0060.70.5\u2003bmd−4.8 ± 0.7 4 −2.3 ± 0.7 8 −4.1 ± 0.8 4 −1.1 ± 0.7≤0.0010.60.01\u2003sa-bmc−4.5 ± 0.7 4 −2.4 ± 0.7 8 −3.6 ± 0.8 4 −1.2 ± 0.7≤0.0010.50.05distal Radius \u2003n 53544845\u2003bmc−1.2 ± 1.00.1 ± 1.0−4.0 ± 1.1 89 −0.2 ± 1.10.020.060.06\u2003bw0.7 ± 0.60.5 ± 0.61.2 ± 0.60.2 ± 0.60.20.80.4\u2003bmd−1.9 ± 1.1−0.6 ± 1.1−5.2 ± 1.2 49 −0.5 ± 1.20.0040.20.02\u2003sa-bmc−1.4 ± 1.0−0.1 ± 1.0−4.3 ± 1.1 49 −0.3 ± 1.10.010.080.03midshaft radius \u2003n 54554845\u2003bmc0.6 ± 0.80.3 ± 0.8−0.3 ± 0.80.4 ± 0.80.90.20.7\u2003bw0.2 ± 0.40.3 ± 0.4−0.2 ± 0.50.6 ± 0.50.70.60.5\u2003bmd0.5 ± 0.80.0 ± 0.8−0.7 ± 0.9−0.2 ± 0.90.80.50.9\u2003sa-bmc0.6 ± 0.80.2 ± 0.8−0.2 ± 0.80.3 ± 0.80.70.90.8\nradius scans were conducted by single-Photon absorptiometry (spa), and Spine and Whole-body scans were conducted by dual-energy x-ray absorptiometry.']	N/A	N/A	[('CHEBI_46662', 'mineral', 72, 'mineral'), ('UBERON_0000468', 'multicellular organism', 94, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 106, 'lumbar spine'), ('UBERON_0001423', 'radius bone', 124, 'radius'), ('GO_0007565', 'female pregnancy', 147, 'postpartum'), ('CHEBI_31341', 'calcium dihydroxide', 203, 'Calcium'), ('UBERON_0001013', 'adipose tissue', 671, 'spine'), ('UBERON_0001423', 'radius bone', 950, 'radius'), ('CHEBI_30212', 'photon', 1467, 'photon'), ('UBERON_0001013', 'adipose tissue', 1500, 'spine'), ('UBERON_0007688', 'anlage', 1510, 'whole')]
PMC4026680	3/2014	S35-PMC4026680	['peripherally, Glucocorticoids enhance the activity of lipoprotein lipase in Adipose Tissue, leading to an increase in fat storage (bjorntorp, 1996,2001).']	N/A	N/A	[('CHEBI_36597', 'phthalazine', 14, 'glucocorticoids'), ('UBERON_0001013', 'adipose tissue', 76, 'adipose tissue')]
PMC4090565	6/2014	S184-PMC4090565	['tnf α and Il-6 are produced by Adipose Tissue Monocytes and Macrophages and also by the Placenta.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 10, 'IL-6'), ('CL_0002615', 'adipocyte of omentum tissue', 31, 'adipose tissue monocytes'), ('UBERON_0001013', 'adipose tissue', 31, 'adipose tissue'), ('CL_0000235', 'macrophage', 60, 'macrophages'), ('UBERON_0001987', 'placenta', 88, 'placenta')]
PMC4100392	6/2014	S16-PMC4100392	['Adipose Tissue produces circulating Bioactive Substances named adipokines (such as leptin, adiponectin, and resistin) and inflammatory markers (such as Interleukin (Il) 6 and tumor necrosis factor α (Tnf- Α ) [12]).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_15620', 'N-ethylglycine', 36, 'bioactive substances'), ('PR_000001470', 'interleukin-28B', 152, 'interleukin ...'), ('PR_000001470', 'interleukin-28B', 165, 'IL ... 6'), ('PR_000000134', 'tumor necrosis factor alpha', 200, 'TNF- α')]
PMC4100392	6/2014	S151-PMC4100392	['Adipose Tissues from Murine obesity models show increased mrna levels of pro-inflammatory cytokines, which are restored to normal levels after treatment with Tudca, a chemical chaperone that inhibits Er stress [106].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissues'), ('NCBITaxon_39107', 'Murinae', 21, 'murine'), ('CHEBI_86939', 's perillic acid', 158, 'TUDCA'), ('GO_0005783', 'endoplasmic reticulum', 200, 'ER')]
PMC4113768	7/2014	S329-PMC4113768	['dxa reference site was Spine for bp <50 years and Hip for bp ≥ 50 years.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 23, 'spine'), ('UBERON_0001464', 'hip', 50, 'hip')]
PMC4113768	7/2014	S1612-PMC4113768	['in a linear regression model for bmd of the Spine, this interaction effect was not significant.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 44, 'spine')]
PMC4132016	8/2014	S62-PMC4132016	['Epididymal White Adipose Tissue (Wat) was collected from areas surrounding the Epididymis and Testis, Brown Adipose Tissue (Bat) was collected from the Interscapular region and separated from the attached white Adipose Tissue, and Gastrocnemius was dissected.']	N/A	N/A	[('UBERON_0001301', 'epididymis', 0, 'Epididymal'), ('UBERON_0001347', 'white adipose tissue', 11, 'white adipose tissue'), ('UBERON_0006337', 'distal early tubule', 33, 'WAT'), ('UBERON_0001301', 'epididymis', 79, 'epididymis'), ('UBERON_0000473', 'testis', 94, 'testis'), ('UBERON_0001348', 'brown adipose tissue', 102, 'Brown adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 124, 'BAT'), ('UBERON_2000452', 'urohyal', 152, 'interscapular'), ('UBERON_0001013', 'adipose tissue', 211, 'adipose tissue'), ('UBERON_0001388', 'gastrocnemius', 231, 'Gastrocnemius')]
PMC4132016	8/2014	S152-PMC4132016	['a, b) mrna Expression levels of Genes encoding proteins involved in the Mitochondrial function in (a) brown Adipose Tissue (Bat) and (b) White Adipose Tissue (Wat) from 7-months-old f1-cd and f1-lpd males Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 11, 'expression'), ('SO_0000704', 'gene', 32, 'genes'), ('GO_0005739', 'mitochondrion', 72, 'mitochondrial'), ('UBERON_0001013', 'adipose tissue', 108, 'Adipose Tissue'), ('UBERON_0001348', 'brown adipose tissue', 124, 'BAT'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 137, 'White Adipose Tissue'), ('UBERON_0006337', 'distal early tubule', 159, 'WAT'), ('NCBITaxon_10088', 'Mus <genus>', 205, 'mice')]
PMC4142888	4/2014	S21-PMC4142888	['another technique to improve Spine deformity in children with eos is Spine-based Growing rod surgery.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 29, 'spine'), ('UBERON_0001013', 'adipose tissue', 69, 'spine'), ('GO_0040007', 'growth', 81, 'growing')]
PMC4142888	4/2014	S22-PMC4142888	['these Growing rod constructs include Pedicle screws, hooks, and wires fixed to the Spine and Rods that are periodically lengthened.']	N/A	N/A	[('GO_0040007', 'growth', 6, 'growing'), ('GO_0044316', 'cone cell pedicle', 37, 'pedicle'), ('UBERON_0001013', 'adipose tissue', 83, 'spine'), ('CL_0000604', 'retinal rod cell', 93, 'rods')]
PMC4154213	5/2014	S262-PMC4154213	['the mcf-7 Cell Proliferation assay has been used to measure Estrogenic activity in extracts of Adipose Tissue in Breast cancer cases and controls (fernandez et al.']	N/A	N/A	[('GO_0008283', 'cell proliferation', 10, 'cell proliferation'), ('CHEBI_59715', 'sodium squarate', 60, 'estrogenic'), ('UBERON_0001013', 'adipose tissue', 95, 'adipose tissue'), ('UBERON_0000310', 'breast', 113, 'breast')]
PMC4154213	5/2014	S546-PMC4154213	['2009), Adipose Tissue (e.g.,covaci et al.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 7, 'adipose tissue')]
PMC4210519	10/2014	S0-PMC4210519	['Metabolic programming of Adipose Tissue structure and function in male Rat offspring by Prenatal undernutrition\n\nabstract\n\nbackground\na number of different pathways to obesity with different Metabolic outcomes are recognised.']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolic'), ('UBERON_0001013', 'adipose tissue', 25, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 71, 'rat'), ('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0008152', 'metabolic process', 191, 'metabolic')]
PMC4210519	10/2014	S10-PMC4210519	['Metabolic responses were investigated in Adipose Tissue explants stimulated by Insulin and Beta3Receptor Agonists ex vivo.']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolic'), ('UBERON_0001013', 'adipose tissue', 41, 'adipose tissue'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('PR_000001997', 'C-C motif chemokine 26', 91, 'beta3receptor'), ('CHEBI_33252', 'atomic nucleus', 105, 'agonists')]
PMC4210519	10/2014	S14-PMC4210519	['the Insulin Response of Adipose Tissue was reduced in Scat, and statistically absent in rpat of un Rats compared with control.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 4, 'insulin'), ('GO_0060033', 'anatomical structure regression', 12, 'response'), ('UBERON_0001013', 'adipose tissue', 24, 'adipose tissue'), ('PR_000014450', 'histone deacetylase complex subunit SAP30L', 54, 'ScAT'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 99, 'rats')]
PMC4210519	10/2014	S35-PMC4210519	['moreover, different Adipose Tissue depots have distinct physiological and Metabolic properties.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 20, 'adipose tissue'), ('GO_0008152', 'metabolic process', 74, 'metabolic')]
PMC4210519	10/2014	S55-PMC4210519	['subcutaneous Adipose Tissue (Scat) samples were collected from the Inguinal Region and Retroperitoneal Adipose Tissue (rpat) was obtained from the Abdominal Cavity, avoiding contamination with the Perirenal Fat.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('UBERON_0002893', 'nucleus of lateral olfactory tract', 29, 'ScAT'), ('UBERON_0008337', 'inguinal part of abdomen', 67, 'inguinal region'), ('UBERON_4000104', 'ganoine', 87, 'retroperitoneal adipose tissue'), ('UBERON_0003684', 'abdominal cavity', 147, 'abdominal cavity'), ('UBERON_0001845', 'perilymph', 197, 'perirenal fat')]
PMC4210519	10/2014	S57-PMC4210519	['fresh Adipose Tissue samples were collected for the ex vivo incubation studies, and additional Tissue aliquots were snap-frozen in liquid nitrogen and stored at -80°c.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 6, 'adipose tissue'), ('UBERON_0000479', 'tissue', 95, 'tissue')]
PMC4210519	10/2014	S61-PMC4210519	['ex vivo incubation studies\n\ngeneral method\nAdipose Tissue pieces (20-25 mg) were incubated in 0.5 ml dulbecco´s modified eagle medium (dmem) at 37°c and agitated at 400 rpm (3 mm amplitude; eppendorf thermomixer).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 43, 'Adipose tissue')]
PMC4210519	10/2014	S62-PMC4210519	['Adipose Tissue incubations were performed in triplicate for each Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0000479', 'tissue', 65, 'tissue')]
PMC4210519	10/2014	S67-PMC4210519	['the decrease in medium Glucose concentration in control and Insulin-supplemented incubations was considered equal to the Glucose Uptake by the Adipose Tissue (0.225 g/l before incubation – × g/l after incubation\u2009=\u2009Glucose Uptake).']	N/A	N/A	[('CHEBI_17234', 'glucose', 23, 'glucose'), ('PR_000045358', 'insulin family protein', 60, 'insulin'), ('CHEBI_17234', 'glucose', 121, 'glucose'), ('GO_0046323', 'glucose import', 121, 'glucose uptake'), ('UBERON_0001013', 'adipose tissue', 143, 'adipose tissue'), ('CHEBI_17234', 'glucose', 214, 'glucose'), ('GO_0046323', 'glucose import', 214, 'glucose uptake')]
PMC4210519	10/2014	S68-PMC4210519	['Glucose Uptake was then corrected for Adipose Tissue weight (final Glucose Uptake rate in μg/mg/2.5h).']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('GO_0042352', 'GDP-L-fucose salvage', 0, 'Glucose uptake'), ('UBERON_0001013', 'adipose tissue', 38, 'adipose tissue'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('GO_0046323', 'glucose import', 67, 'glucose uptake')]
PMC4210519	10/2014	S72-PMC4210519	['the Glycerol concentration of the media was corrected for Adipose Tissue weight.']	N/A	N/A	[('CHEBI_17754', 'glycerol', 4, 'glycerol'), ('UBERON_0001013', 'adipose tissue', 58, 'adipose tissue')]
PMC4210519	10/2014	S78-PMC4210519	['the individual areas (μm2) of 400 Adipose Cells in total were measured per Adipose Tissue depot using leica application suite software for histometry (leica, switzerland).']	N/A	N/A	[('CL_0000136', 'fat cell', 34, 'adipose cells'), ('UBERON_0001013', 'adipose tissue', 75, 'adipose tissue')]
PMC4210519	10/2014	S79-PMC4210519	['western blot determination of marker proteins of Insulin Signalling and Lipolysis\n30- 50 mg of frozen Adipose Tissue was homogenised in 1 ml of prechilled homogenisation buffer (50 mmol/l Hepes, ph 7.4, 0.1% Triton x-100, 4 mmol/l egta, 10 mmol/l edta, 100 mmol/l β-Glycerophosphate, 15 mmol/l Tetrasodium Pyrophosphate, 5 mmol/l Sodium Orthovanadate, 25 mmol/l Sodium Fluoride, and protease inhibitors (roche, mannheim, germany); homogenates were shaken for 2 h at 4°c and subsequently passed 20x through a syringe with a 26 gauge needle followed by 20x with a 22 gauge needle.']	N/A	N/A	[('GO_0031129', 'inductive cell-cell signaling', 49, 'insulin signalling'), ('PR_000045358', 'insulin family protein', 49, 'insulin'), ('GO_0016042', 'lipid catabolic process', 72, 'lipolysis'), ('UBERON_0001013', 'adipose tissue', 102, 'adipose tissue'), ('CHEBI_46756', 'HEPES', 188, 'HEPES'), ('CHEBI_29236', 'protium atom', 208, 'Triton'), ('CHEBI_16890', 'glycerol monophosphate', 266, 'glycerophosphate'), ('CHEBI_35030', 'trimipramine maleate', 294, 'tetrasodium pyrophosphate'), ('CHEBI_62956', 'sodium dimethylarsinate', 330, 'sodium orthovanadate'), ('CHEBI_26710', 'sodium chloride', 362, 'sodium fluoride')]
PMC4210519	10/2014	S109-PMC4210519	['Adipose Tissue cell size\nAdipocyte mean, minimum and maximum cell sizes were significantly higher in un offspring in both the scat and the rpat Depot (table\xa02).']	N/A	N/A	[('CL_0002615', 'adipocyte of omentum tissue', 0, 'Adipose tissue'), ('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CL_0000136', 'fat cell', 25, 'Adipocyte'), ('UBERON_0002387', 'pes', 144, 'depot')]
PMC4210519	10/2014	S113-PMC4210519	['there were no differences in the weight of Retroperitoneal Adipose Tissue depots between the two experimental groups either as Tissue weight or when calculated as a percentage of body weight (table\xa01).']	N/A	N/A	[('UBERON_0003693', 'retroperitoneal space', 43, 'retroperitoneal'), ('UBERON_0001013', 'adipose tissue', 59, 'adipose tissue'), ('UBERON_0000479', 'tissue', 127, 'tissue')]
PMC4210519	10/2014	S114-PMC4210519	['caption (table-wrap): table 2\n\nAdipose Tissue cell sizes of Rat offspring ofad libitum-Fed (ad) and undernourished (un) mothersaduntwo way anova1(μm2)scatrpatscatrpatpnatimean5779a7709b7606b10021ccell size±274±353±373±519p < 0.001p < 0.0001n.s.minimum1832a2352b2743b3349ccell size2±132±189±199±282p < 0.001p < 0.01n.s.maximum15525a23462b19053b34269ccell size2±1344±1961±932±1848p < 0.001p < 0.001p < 0.01\nvalues are given as mean ± sem; n = 16/group; scat = subcutaneous Adipose Tissue, rpat = Retroperitoneal Adipose Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 31, 'Adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 60, 'rat'), ('GO_0007631', 'feeding behavior', 87, 'fed'), ('UBERON_0001013', 'adipose tissue', 471, 'adipose tissue'), ('UBERON_0003693', 'retroperitoneal space', 494, 'retroperitoneal'), ('UBERON_0001013', 'adipose tissue', 510, 'adipose tissue')]
PMC4210519	10/2014	S115-PMC4210519	['1factor pn = Prenatal nutrition; factor at = Adipose Tissue; i = interaction; means marked with different upper case letters (a, b and c) are significantly different with at least p<0.05; fisher´s plsd posthoc test).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'prenatal'), ('UBERON_0001013', 'adipose tissue', 45, 'adipose tissue')]
PMC4210519	10/2014	S117-PMC4210519	['caption (fig): figure 2\n\ncell sizes of subcutaneous (a; scat) and Retroperitoneal (b; rpat) Adipose Tissues related to body weight in Prenatally adequately nourished ad (black boxes, n\u2009=\u200916) and Prenatally undernourished un (grey triangles, n\u2009=\u200916) offspring.']	N/A	N/A	[('UBERON_0003693', 'retroperitoneal space', 66, 'retroperitoneal'), ('UBERON_0001013', 'adipose tissue', 92, 'adipose tissues'), ('GO_0019230', 'proprioception', 134, 'prenatally'), ('GO_0019230', 'proprioception', 195, 'prenatally')]
PMC4210519	10/2014	S120-PMC4210519	['Glucose Disposal in different Adipose Tissue depots in ad and un offspring\nresults of the Glucose Uptake in ex vivo Adipose Tissue explants are shown in figure\xa03a-c.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('GO_0000024', 'maltose biosynthetic process', 0, 'Glucose disposal'), ('UBERON_0001013', 'adipose tissue', 30, 'adipose tissue'), ('CHEBI_17234', 'glucose', 90, 'glucose'), ('GO_0046323', 'glucose import', 90, 'glucose uptake'), ('UBERON_0001013', 'adipose tissue', 116, 'adipose tissue')]
PMC4210519	10/2014	S123-PMC4210519	['the Insulin-dependent increase in Glucose Uptake in Adipose Tissue explants was lower in rpat compared with scat, with the un group rpat showing clearly and significantly reduced response (figure\xa03c).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 4, 'insulin'), ('CHEBI_17234', 'glucose', 34, 'glucose'), ('GO_0046323', 'glucose import', 34, 'glucose uptake'), ('UBERON_0001013', 'adipose tissue', 52, 'adipose tissue')]
PMC4210519	10/2014	S125-PMC4210519	['c shows the Insulin-dependent increase in Glucose Uptake in Adipose Tissue explants.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 12, 'insulin'), ('CHEBI_17234', 'glucose', 42, 'glucose'), ('GO_0046323', 'glucose import', 42, 'glucose uptake'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue')]
PMC4210519	10/2014	S132-PMC4210519	['caption (fig): figure 4\n\nprotein Expression of key components of Insulin Signalling Pathways in subcutaneous (scat) and Retroperitoneal (rpat) Adipose Tissues of Prenatally adequately nourished ad and Prenatally undernourished un Rat offspring.']	N/A	N/A	[('GO_0010467', 'gene expression', 33, 'expression'), ('GO_0019051', 'induction by virus of host apoptotic process', 65, 'insulin signalling pathways'), ('PR_000045358', 'insulin family protein', 65, 'insulin'), ('UBERON_0013531', 'retrosplenial region', 120, 'retroperitoneal ...'), ('UBERON_0001013', 'adipose tissue', 143, 'adipose tissues'), ('GO_0019230', 'proprioception', 162, 'prenatally'), ('GO_0019230', 'proprioception', 201, 'prenatally'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 230, 'rat')]
PMC4210519	10/2014	S139-PMC4210519	['beta3-adrenergic stimulation of Lipolysis in Adipose Tissues was observed in Scat and Rpat of ad and un offspring as indicated by increased Glycerol release (figure\xa05a and b).']	N/A	N/A	[('GO_0016042', 'lipid catabolic process', 32, 'lipolysis'), ('UBERON_0001013', 'adipose tissue', 45, 'adipose tissues'), ('PR_000014450', 'histone deacetylase complex subunit SAP30L', 77, 'ScAT'), ('PR_000012999', 'DNA-directed RNA polymerases I, II, and III subunit RPABC5', 86, 'RpAT'), ('CHEBI_17754', 'glycerol', 140, 'glycerol')]
PMC4210519	10/2014	S142-PMC4210519	['caption (fig): figure 5\n\nLipolytic response as assess by Glycerol release to beta3-adrenergic stimulation in subcutaneous (scat, a) and Retroperitoneal (rpat, b) Adipose Tissue explantsex vivoof Prenatally adequately nourished ad and Prenatally undernourished un Rat offspring.']	N/A	N/A	[('GO_0019468', 'nopaline catabolic process', 25, 'Lipolytic'), ('CHEBI_17754', 'glycerol', 57, 'glycerol'), ('UBERON_0003693', 'retroperitoneal space', 136, 'retroperitoneal'), ('UBERON_0001013', 'adipose tissue', 162, 'adipose tissue'), ('GO_0019230', 'proprioception', 195, 'prenatally'), ('GO_0019230', 'proprioception', 234, 'prenatally'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 263, 'rat')]
PMC4210519	10/2014	S169-PMC4210519	['increasing Adipocyte size through enhanced Triglyceride storage (hypertrophy) is a key feature in the growth of Adipose Tissue during obesity development [22].']	N/A	N/A	[('CL_0000136', 'fat cell', 11, 'adipocyte'), ('CHEBI_17855', 'triglyceride', 43, 'triglyceride'), ('UBERON_0001013', 'adipose tissue', 112, 'adipose tissue')]
PMC4210519	10/2014	S173-PMC4210519	['Insulin responsiveness of Adipose Tissues\nin the ex vivo studies, the basal Glucose Uptake in Rpat was similar in both ad and un offspring.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('UBERON_0001013', 'adipose tissue', 26, 'adipose tissues'), ('CHEBI_17234', 'glucose', 76, 'glucose'), ('GO_0046323', 'glucose import', 76, 'glucose uptake'), ('PR_000012999', 'DNA-directed RNA polymerases I, II, and III subunit RPABC5', 94, 'RpAT')]
PMC4224012	11/2014	S37-PMC4224012	['for sitting height, the child was seated on a custom-made stool with the base of the Spine touching the stadiometer and Head in the frankfort plane.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 85, 'spine'), ('UBERON_0000033', 'head', 120, 'head')]
PMC4277409	12/2014	S9-PMC4277409	['in conclusion, Gsk3 activity is increased in gdm Adipose Tissue and Skeletal muscle and Regulates infection- and inflammation-induced pro-Inflammatory Mediators.']	N/A	N/A	[('PR_000008288', 'glycogen synthase kinase-3 beta', 15, 'GSK3'), ('UBERON_0001013', 'adipose tissue', 49, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 68, 'skeletal'), ('GO_0065007', 'biological regulation', 88, 'regulates'), ('CHEBI_64664', '(2-nitrophenyl)azo group', 137, '-inflammatory mediators')]
PMC4277409	12/2014	S24-PMC4277409	['Gsk3 activity is increased in Skeletal muscle samples and/or Adipose Tissue from Insulin resistance states[25],[29].']	N/A	N/A	[('PR_000008288', 'glycogen synthase kinase-3 beta', 0, 'GSK3'), ('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('UBERON_0001013', 'adipose tissue', 61, 'adipose tissue'), ('PR_000045358', 'insulin family protein', 81, 'insulin')]
PMC4277409	12/2014	S45-PMC4277409	['dissected fragments were stored at −80°c until assayed as detailed below.10.1371/journal.pone.0115854.t001\n\ncaption (table-wrap): table 1\nclinical characteristics of the Adipose Tissue study group.ngt (n\u200a=\u200a12)gdm-diet (n\u200a=\u200a12)maternal age (years)31.8±1.734.9±1.5maternal bmi at ∼12 wks (kg/m2)33.3±3.430.6±2.1maternal bmi at Delivery (kg/m2)36.8±2.933.1±1.6gestational weight gain (kg)9.4±1.86.7±2.5gestational age at Birth (weeks)38.6±0.138.6±0.2fetal Birth weight (g)3761±1863277±153fetal gender6 female; 6 male7 female; 5 malematernal ogtt at ∼28 weeks Gestation…fasting Plasma ogtt (mmol/l)4.5±0.15.3±0.2*§…1 hour Plasma ogtt (mmol/l)7.5±0.610.3±0.3*…2 hour Plasma ogtt (mmol/l)5.9±0.48.8±0.5*\nogtt, oral Glucose tolerance test.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 170, 'adipose tissue'), ('GO_0007567', 'parturition', 325, 'delivery'), ('GO_0007567', 'parturition', 418, 'birth'), ('GO_0007567', 'parturition', 453, 'birth'), ('GO_0007565', 'female pregnancy', 556, 'gestation'), ('UBERON_0001969', 'blood plasma', 574, 'plasma'), ('UBERON_0001969', 'blood plasma', 618, 'plasma'), ('UBERON_0001969', 'blood plasma', 662, 'plasma'), ('CHEBI_17234', 'glucose', 709, 'glucose')]
PMC4277409	12/2014	S51-PMC4277409	['for these studies, Adipose Tissue and Skeletal muscle was obtained from non-obese ngt Pregnant women, and Tissue explants were performed as previously described[12],[13].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 38, 'skeletal'), ('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('UBERON_0000479', 'tissue', 106, 'tissue')]
PMC4277409	12/2014	S52-PMC4277409	['briefly, Adipose Tissue and Skeletal muscle was finely diced and placed in dmem at 37°c in a humidified atmosphere of 21% O2And 5% Co2For 1 h. Tissues were blotted dry on sterile filter paper and transferred to 24-well Tissue culture plates (100 mg for Adipose Tissue and 50 mg for skeletal muscle).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 28, 'skeletal'), ('CHEBI_29020', 'neral', 122, 'O2and'), ('CHEBI_86192', 'butyl anthranilate', 131, 'CO2for'), ('UBERON_0000479', 'tissue', 143, 'Tissues'), ('UBERON_0000479', 'tissue', 219, 'tissue'), ('UBERON_0001013', 'adipose tissue', 253, 'adipose tissue')]
PMC4277409	12/2014	S53-PMC4277409	['dissected Adipose Tissue and Skeletal Muscle Tissues were incubated in 1 ml dmem (with 100 u/ml Penicillin G and 100 µg/ml Streptomycin).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 10, 'adipose tissue'), ('UBERON_0004502', 'skeletal muscle tissue of biceps brachii', 29, 'skeletal muscle tissues'), ('CHEBI_66739', 'Peucedanone', 96, 'penicillin G'), ('CHEBI_17076', 'streptomycin', 123, 'streptomycin')]
PMC4277409	12/2014	S54-PMC4277409	['Tissues were incubated in the absence or presence of 10 µm Chir99021 (selleck chemicals; houston, tx, usa) for 60 min before the addition of 10 µg/ml Lps (derived from escherichia coli 026:b6; sigma-aldrich, st. louis, mo, usa) or 1 ng/ml Il-1Β (peprotech; rocky hill, nj, usa) for 20 h. for Adipose Tissue, additional explants were performed using another Gsk3 Inhibitor sb216763 (selleck chemicals; houston, tx, usa).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('CHEBI_64066', 'CGP 78608(1+)', 59, 'CHIR99021'), ('CHEBI_16412', 'lipopolysaccharide', 150, 'LPS'), ('PR_000001383', 'interleukin-22', 239, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 292, 'adipose tissue'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 357, 'GSK3'), ('CHEBI_35222', 'inhibitor', 362, 'inhibitor')]
PMC4277409	12/2014	S55-PMC4277409	['for these studies, Adipose Tissue was incubated in the absence or presence of 20 µm Sb216763 for 60 min before the addition of 10 µg/ml Lps for 20 h. after final incubation, Tissue and media were collected separately and stored at −80°c for further analysis as detailed below.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('CHEBI_8978', 'SB 221284', 84, 'SB216763'), ('CHEBI_16412', 'lipopolysaccharide', 136, 'LPS'), ('UBERON_0000479', 'tissue', 174, 'tissue')]
PMC4277409	12/2014	S87-PMC4277409	['data were expressed as mean ± standard error of the mean (sem).10.1371/journal.pone.0115854.g001\n\ncaption (fig): figure 1\nphosphorylated Gskβ Expression in Adipose Tissue from ngt and gdm women.']	N/A	N/A	[('PR_000008288', 'glycogen synthase kinase-3 beta', 137, 'GSKβ'), ('GO_0010467', 'gene expression', 142, 'expression'), ('UBERON_0001013', 'adipose tissue', 156, 'adipose tissue')]
PMC4277409	12/2014	S98-PMC4277409	['representative western blot from 3 ngt and 3 diet-Controlled gdm patients is also shown.10.1371/journal.pone.0115854.g003\n\ncaption (fig): figure 3\neffect of Gsk3 Inhibitor Chir99021 on Lps-induced pro-inflammatory cytokines in Adipose Tissue.']	N/A	N/A	[('GO_0065007', 'biological regulation', 50, 'controlled'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 157, 'GSK3'), ('CHEBI_35222', 'inhibitor', 162, 'inhibitor'), ('CHEBI_64066', 'CGP 78608(1+)', 172, 'CHIR99021'), ('CHEBI_16412', 'lipopolysaccharide', 185, 'LPS'), ('UBERON_0001013', 'adipose tissue', 227, 'adipose tissue')]
PMC4277409	12/2014	S115-PMC4277409	['* p<0.05 vs. Lps (one-way anova).10.1371/journal.pone.0115854.g005\n\ncaption (fig): figure 5\neffect of Gsk3 Inhibitor Chir99021 on Il-1Β-induced pro-inflammatory cytokine Il-6 in Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 13, 'LPS'), ('CHEBI_77828', "guanosine 3',5'-bis(diphosphate)(5-)", 102, 'GSK3 inhibitor'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 102, 'GSK3'), ('CHEBI_64066', 'CGP 78608(1+)', 117, 'CHIR99021'), ('PR_000001383', 'interleukin-22', 130, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 170, 'IL-6'), ('UBERON_0001013', 'adipose tissue', 178, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 197, 'skeletal')]
PMC4277409	12/2014	S123-PMC4277409	['* p<0.05 vs. Il-1Β (one-way anova).10.1371/journal.pone.0115854.g006\n\ncaption (fig): figure 6\neffect of Gsk3 Inhibitor Chir99021 on Lps-induced pro-inflammatory chemokines in Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('PR_000001383', 'interleukin-22', 13, 'IL-1β'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 104, 'GSK3'), ('CHEBI_35222', 'inhibitor', 109, 'inhibitor'), ('CHEBI_64066', 'CGP 78608(1+)', 119, 'CHIR99021'), ('CHEBI_16412', 'lipopolysaccharide', 132, 'LPS'), ('UBERON_0001013', 'adipose tissue', 175, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 194, 'skeletal')]
PMC4277409	12/2014	S131-PMC4277409	['* p<0.05 vs. Lps (one-way anova).10.1371/journal.pone.0115854.g007\n\ncaption (fig): figure 7\neffect of Gsk3 Inhibitor Chir99021 on Il-1Β induced pro-inflammatory chemokines in Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 13, 'LPS'), ('CHEBI_77828', "guanosine 3',5'-bis(diphosphate)(5-)", 102, 'GSK3 inhibitor'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 102, 'GSK3'), ('CHEBI_64066', 'CGP 78608(1+)', 117, 'CHIR99021'), ('PR_000001383', 'interleukin-22', 130, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 175, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 194, 'skeletal')]
PMC4277409	12/2014	S139-PMC4277409	['* p<0.05 vs. Il-1Β (one-way anova).10.1371/journal.pone.0115854.g008\n\ncaption (fig): figure 8\neffect of Gsk3 Inhibitor Chir99021 on Lps-induced adhesion Molecules in Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('PR_000001383', 'interleukin-22', 13, 'IL-1β'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 104, 'GSK3'), ('CHEBI_35222', 'inhibitor', 109, 'inhibitor'), ('CHEBI_64066', 'CGP 78608(1+)', 119, 'CHIR99021'), ('CHEBI_16412', 'lipopolysaccharide', 132, 'LPS'), ('CHEBI_36357', 'polyatomic entity', 153, 'molecules'), ('UBERON_0001013', 'adipose tissue', 166, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 185, 'skeletal')]
PMC4277409	12/2014	S147-PMC4277409	['* p<0.05 vs. Lps (one-way anova).10.1371/journal.pone.0115854.g009\n\ncaption (fig): figure 9\neffect of Gsk3 Inhibitor Chir99021 on Il-1Β-induced adhesion Molecules in Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 13, 'LPS'), ('CHEBI_77828', "guanosine 3',5'-bis(diphosphate)(5-)", 102, 'GSK3 inhibitor'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 102, 'GSK3'), ('CHEBI_64066', 'CGP 78608(1+)', 117, 'CHIR99021'), ('PR_000001383', 'interleukin-22', 130, 'IL-1β'), ('CHEBI_36357', 'polyatomic entity', 153, 'molecules'), ('UBERON_0001013', 'adipose tissue', 166, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 185, 'skeletal')]
PMC4277409	12/2014	S156-PMC4277409	['results\n\nGsk3Α/β activity is increased in Adipose Tissue and Skeletal muscle from obese Pregnant women and women with gdm\nAdipose Tissue and Skeletal muscle was obtained from 12 women with ngt (6 non-obese and 6 obese), 12 bmi-matched women with gdm Controlled by diet (6 non-obese and 6 obese).']	N/A	N/A	[('PR_000008288', 'glycogen synthase kinase-3 beta', 9, 'GSK3α'), ('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 61, 'skeletal'), ('GO_0007565', 'female pregnancy', 88, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 122, 'Adipose tissue'), ('UBERON_0004288', 'skeleton', 141, 'skeletal'), ('GO_0065007', 'biological regulation', 250, 'controlled')]
PMC4277409	12/2014	S157-PMC4277409	['demographic data of all participants involved in this study are summarised intable 1for Adipose Tissue andtable 2for Skeletal muscle.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 88, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 117, 'skeletal')]
PMC4277409	12/2014	S163-PMC4277409	['for both Adipose Tissue and Skeletal muscle, total Gsk3Β was used for normalisation of the phosphorylated Gsk3 data.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 28, 'skeletal'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 51, 'GSK3β'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 106, 'GSK3')]
PMC4277409	12/2014	S165-PMC4277409	['1, p-Gsk3Β was lower in Adipose Tissue obtained from non-obese and obese women with gdm when compared to bmi-matched ngt controls.']	N/A	N/A	[('PR_000008288', 'glycogen synthase kinase-3 beta', 5, 'GSK3β'), ('UBERON_0001013', 'adipose tissue', 24, 'adipose tissue')]
PMC4277409	12/2014	S178-PMC4277409	['for Lps treatment, the data for Adipose Tissue and Skeletal muscle are depicted infigs.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 4, 'LPS'), ('UBERON_0001013', 'adipose tissue', 32, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 51, 'skeletal')]
PMC4277409	12/2014	S179-PMC4277409	['3and4, respectively; the data for Il-1Β for Adipose Tissue and Skeletal muscle are shown infig.']	N/A	N/A	[('PR_000001383', 'interleukin-22', 34, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 44, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 63, 'skeletal')]
PMC4277409	12/2014	S181-PMC4277409	['treatment with Lps induced a significant increase in Tnf-Α, Il-1Β and Il-6 mrna Expression and secretion in both Adipose Tissue and Skeletal muscle (figs.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 15, 'LPS'), ('PR_000000134', 'tumor necrosis factor alpha', 53, 'TNF-α'), ('PR_000001383', 'interleukin-22', 60, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 70, 'IL-6'), ('GO_0010467', 'gene expression', 80, 'expression'), ('UBERON_0001013', 'adipose tissue', 113, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 132, 'skeletal')]
PMC4277409	12/2014	S189-PMC4277409	['for both Adipose Tissue (fig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue')]
PMC4277409	12/2014	S194-PMC4277409	['7a–dfor Adipose Tissue andfig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 8, 'adipose tissue')]
PMC4277409	12/2014	S196-PMC4277409	['in Adipose Tissue, Chir99021 significantly decreased Il-8 and Mcp-1 mrna Expression and Mcp-1 secretion (fig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 3, 'adipose tissue'), ('CHEBI_64066', 'CGP 78608(1+)', 19, 'CHIR99021'), ('PR_000001470', 'interleukin-28B', 53, 'IL-8'), ('PR_000010439', 'myeloid leukemia factor 1', 62, 'MCP-1'), ('GO_0010467', 'gene expression', 73, 'expression'), ('PR_000010439', 'myeloid leukemia factor 1', 88, 'MCP-1')]
PMC4277409	12/2014	S198-PMC4277409	['there was however, no effect of Chir99021 on Il-1Β induced Il-8 Release in Adipose Tissue (fig.']	N/A	N/A	[('CHEBI_64066', 'CGP 78608(1+)', 32, 'CHIR99021'), ('PR_000001383', 'interleukin-22', 45, 'IL-1β'), ('GO_0070757', 'interleukin-35-mediated signaling pathway', 59, 'IL-8 release'), ('PR_000001470', 'interleukin-28B', 59, 'IL-8'), ('UBERON_0001013', 'adipose tissue', 75, 'adipose tissue')]
PMC4277409	12/2014	S208-PMC4277409	['treatment of Adipose Tissue (figs.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue')]
PMC4277409	12/2014	S221-PMC4277409	['sb216763 significantly decreased Lps-induced mrna Expression and secretion of pro-inflammatory cytokines (Tnf-Α, Il-1Β and Il-6) and chemokines (Il-8 and Mcp-1).10.1371/journal.pone.0115854.g010\n\ncaption (fig): figure 10\neffect of Gsk3 inhibitor sb216763 on Lps-induced pro-inflammatory cytokines and chemokines in Adipose Tissue.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 33, 'LPS'), ('GO_0010467', 'gene expression', 50, 'expression'), ('PR_000000134', 'tumor necrosis factor alpha', 106, 'TNF-α'), ('PR_000001383', 'interleukin-22', 113, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 123, 'IL-6'), ('PR_000001470', 'interleukin-28B', 145, 'IL-8'), ('PR_000010439', 'myeloid leukemia factor 1', 154, 'MCP-1'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 231, 'GSK3'), ('CHEBI_16412', 'lipopolysaccharide', 258, 'LPS'), ('UBERON_0001013', 'adipose tissue', 315, 'adipose tissue')]
PMC4277409	12/2014	S248-PMC4277409	['it is now well-established that Pregnant Adipose Tissue Expresses and Secretes a variety of pro-inflammatory cytokines and chemokines[12]–[18],[38]–[40].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 41, 'adipose tissue'), ('GO_0010467', 'gene expression', 56, 'expresses'), ('GO_0046903', 'secretion', 70, 'secretes')]
PMC4277409	12/2014	S254-PMC4277409	['in support, Tnf-Α induces pro-inflammatory cytokine Expression in Human Placenta, and Adipose Tissue and Skeletal muscle from Pregnant women[13].']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 12, 'TNF-α'), ('GO_0010467', 'gene expression', 52, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('UBERON_0001987', 'placenta', 72, 'placenta'), ('UBERON_0001013', 'adipose tissue', 86, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007565', 'female pregnancy', 126, 'pregnant')]
PMC4277409	12/2014	S256-PMC4277409	['indeed, in vitro , bacterial endotoxin Lps induces the Expression of pro-inflammatory cytokines in Adipose Tissue and Skeletal muscle from Pregnant women[13],[15].']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 39, 'LPS'), ('GO_0010467', 'gene expression', 55, 'expression'), ('UBERON_0001013', 'adipose tissue', 99, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 118, 'skeletal'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC4277409	12/2014	S260-PMC4277409	['Lps) induced the Expression and secretion of pro-inflammatory cytokines from Human Pregnant Adipose Tissue and Skeletal muscle.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 0, 'LPS'), ('GO_0010467', 'gene expression', 17, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 92, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 111, 'skeletal')]
PMC4292443	1/2015	S272-PMC4292443	['the systemic inflammatory response to diet or weight gain is derived from excess Macrophage infiltration to the Adipose Tissue and subsequent excess production of pro-inflammatory cytokines.']	N/A	N/A	[('CL_0000235', 'macrophage', 81, 'macrophage'), ('UBERON_0001013', 'adipose tissue', 112, 'adipose tissue')]
PMC4311629	1/2015	S14-PMC4311629	['it is defined as an accumulation of Adipose Tissue that is of sufficient magnitude to impair health (who,2014).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 36, 'adipose tissue')]
PMC4311629	1/2015	S29-PMC4311629	['two different types of Adipose Tissue have been described: Brown Adipose Tissue (Bat), composed mainly of Brown Adipocytes, and White Adipose Tissue (Wat), defined by a majority of White Adipocytes, both Tissues being able to accumulate Lipids in Intracellular droplets.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 23, 'adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 59, 'brown adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 81, 'BAT'), ('CL_0000449', 'brown fat cell', 106, 'brown'), ('CL_0000136', 'fat cell', 112, 'adipocytes'), ('UBERON_0001347', 'white adipose tissue', 128, 'white adipose tissue'), ('UBERON_0006337', 'distal early tubule', 150, 'WAT'), ('CL_0000738', 'leukocyte', 181, 'white adipocytes'), ('UBERON_0000479', 'tissue', 204, 'tissues'), ('CHEBI_18059', 'lipid', 237, 'lipids'), ('GO_0005622', 'intracellular anatomical structure', 247, 'intracellular')]
PMC4311629	1/2015	S78-PMC4311629	['similar observations were obtained by Adipose Tissue-specific Overexpression of Pr-Domain-Containing 16 (Prdm16) in Mice.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 38, 'adipose tissue'), ('GO_0007308', 'oocyte construction', 62, 'overexpression'), ('PR_000013100', 'protein phosphatase 1M', 80, 'PR-domain-containing 16'), ('SO_0000417', 'polypeptide_domain', 83, 'domain'), ('PR_000013180', 'PR domain zinc finger protein 10', 105, 'PRDM16'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'mice')]
PMC4354412	3/2015	S125-PMC4354412	['caption (table-wrap): table 2\n\nmilk composition (gram per liter) of control and enterococcus faecium ncimb 10415 feed supplemented sows during the Suckling period .controlef p -value day 3 post Partum fat113\u2009±\u200917109\u2009±\u2009300.682protein65\u2009±\u20091258\u2009±\u200950.070lactose44\u2009±\u2009549\u2009±\u200950.058 day 17 post Partum fat95\u2009±\u20091389\u2009±\u2009170.351protein50\u2009±\u2009453\u2009±\u200960.183lactose53\u2009±\u2009253\u2009±\u200930.479 day 26 post Partum fat82\u2009±\u20092595\u2009±\u2009210.155Protein53\u2009±\u2009553\u2009±\u200950.923lactose47\u2009±\u2009752\u2009±\u20092 0.030\n\ncellular composition of milk\nthe samples from the sows Fed e. faecium showed significantly lower cell numbers compared to the samples from the control sows ( p \u2009=\u20090.005).']	N/A	N/A	[('GO_0001967', 'suckling behavior', 147, 'suckling'), ('GO_0007567', 'parturition', 194, 'partum'), ('UBERON_0001013', 'adipose tissue', 287, 'partum'), ('UBERON_0001013', 'adipose tissue', 377, 'partum'), ('PR_000029880', 'zinc finger CCCH domain-containing protein 7A', 403, '155Protein53'), ('GO_0007631', 'feeding behavior', 512, 'fed')]
PMC4363193	3/2015	S14-PMC4363193	['Subcutaneous Adipose Tissue from em offspring differed significantly from controls, with elevated mrna levels of Lipogenic ( Cd36 , Acacb and Lpl ), Nutrient transporters ( Fabp4 and Glut4 ), Lipolysis ( hsl and Atgl ), Adipocyte size ( mest) and inflammation ( Pai-1) indicators.']	N/A	N/A	[('UBERON_0002281', 'vestibular membrane of cochlear duct', 0, 'Subcutaneous'), ('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('GO_0008610', 'lipid biosynthetic process', 113, 'lipogenic'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 125, 'CD36'), ('PR_000003585', 'actin-binding LIM protein 2', 132, 'ACACB'), ('PR_000009880', 'Lon protease, mitochondrial', 142, 'LPL'), ('CHEBI_33284', 'nutrient', 149, 'nutrient'), ('PR_000007380', 'putative F-box/LRR-repeat protein 21', 173, 'FABP4'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 183, 'GLUT4'), ('GO_0016042', 'lipid catabolic process', 192, 'lipolysis'), ('PR_000004410', 'protein Atg16l2', 212, 'ATGL'), ('CL_0000136', 'fat cell', 220, 'adipocyte'), ('PR_000014702', 'plasminogen activator inhibitor 1', 262, 'PAI-1')]
PMC4363193	3/2015	S35-PMC4363193	['maternal undernutrition during mid Gestation results in offspring Renal and Adipose Tissue dysfunction [12,13].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'gestation'), ('UBERON_0000361', 'red bone marrow', 66, 'renal ...'), ('UBERON_0001013', 'adipose tissue', 76, 'adipose tissue')]
PMC4363193	3/2015	S53-PMC4363193	['Subcutaneous Adipose Tissue is the largest Fat Depot in young Pigs [22].']	N/A	N/A	[('UBERON_0002281', 'vestibular membrane of cochlear duct', 0, 'Subcutaneous'), ('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('UBERON_0012349', 'digital pad', 43, 'fat depot'), ('NCBITaxon_10088', 'Mus <genus>', 62, 'pigs')]
PMC4363193	3/2015	S58-PMC4363193	['the Porcine foetal Subcutaneous Adipose Tissue undergoes rapid development in mid to late Gestation (day 50 to Parturition (day 115)) with Lipid deposition commencing by day 60 Gestation, opening of Adipocyte cluster by day 75 and growth of configured Adipocytes from day 105 Gestation [28].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'porcine'), ('UBERON_0002023', 'claustrum of brain', 19, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 32, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 90, 'gestation'), ('GO_0019230', 'proprioception', 111, 'parturition'), ('CHEBI_18059', 'lipid', 139, 'lipid'), ('GO_0007565', 'female pregnancy', 177, 'gestation'), ('CL_0000136', 'fat cell', 199, 'adipocyte'), ('CL_0000136', 'fat cell', 252, 'adipocytes'), ('GO_0007565', 'female pregnancy', 276, 'gestation')]
PMC4363193	3/2015	S105-PMC4363193	['Tissue sampling, rna extraction and cdna synthesis\neighteen representative Pigs from each treatment (9 female (3 light, 3 medium, 3 heavy birthweight) and 9 males (3 light, 3 medium, 3 heavy birthweight)) were selected randomly at slaughter for Adipose Tissue sampling .']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'pigs'), ('UBERON_0001013', 'adipose tissue', 245, 'adipose tissue')]
PMC4363193	3/2015	S106-PMC4363193	['Subcutaneous Adipose Tissue (0.5\xa0cm in depth) was excised from at the Backfat measurement position, immersed in rna-later (ambion inc., u.s.a.) and stored at 4°c overnight.']	N/A	N/A	[('UBERON_0002281', 'vestibular membrane of cochlear duct', 0, 'Subcutaneous'), ('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('UBERON_0004082', 'cerebellum vermis lobule VIII', 70, 'backfat')]
PMC4363193	3/2015	S108-PMC4363193	['total rna was extracted by homogenisation of approximately 75\xa0mg Adipose Tissue using the agencourt rnadvance Tissue protocol according to the manufacturer’s instructions (beckmann coutler, u.s.a.) which included a dnaase1 treatment (20units/sample) step.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 65, 'adipose tissue'), ('UBERON_0000479', 'tissue', 110, 'Tissue')]
PMC4363193	3/2015	S111-PMC4363193	['rna extractions were performed in duplicate for each Adipose Tissue sample.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 53, 'adipose tissue')]
PMC4363193	3/2015	S209-PMC4363193	['figures\xa02,3and4detail levels of Lipid Metabolism, Adipocyte hypertrophy and inflammation mrna markers, compared to Ribosomal rplpo mrna levels, in offspring subcutaneous Adipose Tissue.']	N/A	N/A	[('CHEBI_18059', 'lipid', 32, 'lipid'), ('GO_0006629', 'lipid metabolic process', 32, 'lipid metabolism'), ('CL_0000136', 'fat cell', 50, 'adipocyte'), ('GO_0005840', 'ribosome', 115, 'ribosomal'), ('UBERON_0001013', 'adipose tissue', 170, 'adipose tissue')]
PMC4363193	3/2015	S217-PMC4363193	['caption (fig): figure 2\n\nmessenger rna levels ofglut4,Fabp4,Cd36,Hsl,atglandlplin offspring subcutaneous Adipose Tissue.']	N/A	N/A	[('PR_000007380', 'putative F-box/LRR-repeat protein 21', 54, 'FABP4'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 60, 'CD36'), ('PR_000008794', 'heat shock factor protein 5', 65, 'HSL'), ('UBERON_0001013', 'adipose tissue', 105, 'adipose tissue')]
PMC4363193	3/2015	S223-PMC4363193	['caption (fig): figure 3\n\nmessenger rna levels ofacacb,Lep,Ppargc1,caspase,Mcp1Andil-18In offspring subcutaneous Adipose Tissue.']	N/A	N/A	[('PR_000009751', 'lymphoid enhancer-binding factor 1', 54, 'LEP'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 58, 'PPARGC1'), ('PR_000010229', 'membrane-bound transcription factor site-1 protease', 74, 'MCP1andIL-18in'), ('UBERON_0001013', 'adipose tissue', 112, 'adipose tissue')]
PMC4363193	3/2015	S229-PMC4363193	['caption (fig): figure 4\n\nmessenger rna levels ofpai1andmestin offspring subcutaneous Adipose Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 85, 'adipose tissue')]
PMC4363193	3/2015	S238-PMC4363193	['leptin (lep) and Caspase1 mrna levels in offspring Subcutaneous Adipose Tissue were unaffected by treatment of mother (figure\xa03).']	N/A	N/A	[('PR_000005015', 'calpain-2 catalytic subunit', 17, 'CASPASE1'), ('UBERON_0002023', 'claustrum of brain', 51, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 64, 'adipose tissue')]
PMC4363193	3/2015	S241-PMC4363193	['the subcutaneous Adipose Tissue of em offspring had significantly less Ppargc1A mrna Transcripts than subcutaneous Adipose Tissue from l offspring (p\u2009<\u20090.01) (figure\xa03).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 17, 'adipose tissue'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 71, 'PPARGC1A'), ('SO_0000673', 'transcript', 85, 'transcripts'), ('UBERON_0001013', 'adipose tissue', 115, 'adipose tissue')]
PMC4363193	3/2015	S242-PMC4363193	['offspring Born to treatment e (4 fold decrease, p\u2009<\u20090.01) and m (3,5 fold decrease, p\u2009<\u20090.05) had lower levels, in Adipose Tissue, of the Gene coding for Monocyte Chemoattractant Protein-1 ( Mcp1 ) than offspring Born to treatment c (figure\xa03).']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'born'), ('UBERON_0001013', 'adipose tissue', 115, 'adipose tissue'), ('SO_0000704', 'gene', 138, 'gene'), ('CL_0000576', 'monocyte', 154, 'Monocyte'), ('PR_000010433', 'makorin-3', 154, 'Monocyte Chemoattractant Protein-1'), ('PR_000010220', 'mannose-binding protein C', 191, 'MCP1'), ('GO_0007567', 'parturition', 213, 'born')]
PMC4363193	3/2015	S244-PMC4363193	['the cytokine Il-18 is produced by non Fat Cells in Adipose Tissue [45].']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 13, 'IL-18'), ('CL_0000136', 'fat cell', 38, 'fat cells'), ('UBERON_0001013', 'adipose tissue', 51, 'adipose tissue')]
PMC4363193	3/2015	S246-PMC4363193	['treatment e (1.5 fold decrease, p\u2009<\u20090.05), treatment m (1.6 fold decrease, p\u2009<\u20090.05) and treatment l (1.7 fold decrease, p\u2009<\u20090.01) offspring had lower levels of Il-18 mrna in their subcutaneous Adipose Tissue than offspring from treatment c (figure\xa03).']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 161, 'IL-18'), ('UBERON_0001013', 'adipose tissue', 194, 'adipose tissue')]
PMC4363193	3/2015	S247-PMC4363193	['treatment em offspring had elevated levels of Pai-1 mrna (2.4 fold increase, p\u2009<\u20090.001) in their subcutaneous Adipose Tissue compared to treatment c offspring (figure\xa04).']	N/A	N/A	[('PR_000014702', 'plasminogen activator inhibitor 1', 46, 'PAI-1'), ('UBERON_0001013', 'adipose tissue', 110, 'adipose tissue')]
PMC4363193	3/2015	S251-PMC4363193	['Subcutaneous Adipose Tissue of females also had higher levels of Fabp4 (1.3 fold increase, p\u2009<\u20090.001) and Glut4 (1.7 fold increase, p\u2009<\u20090.01) mrna than males (data not shown).']	N/A	N/A	[('UBERON_0002281', 'vestibular membrane of cochlear duct', 0, 'Subcutaneous'), ('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('PR_000007380', 'putative F-box/LRR-repeat protein 21', 65, 'FABP4'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 106, 'GLUT4')]
PMC4363193	3/2015	S254-PMC4363193	['doubling maternal Food allowance for 55\xa0days in Gestation, combining both early and mid Gestation time periods, elevated Lipogenic, Nutrient transporters, Lipolysis and Adipocyte size markers in offspring subcutaneous Adipose Tissue.']	N/A	N/A	[('CHEBI_33290', 'food', 18, 'food'), ('GO_0007565', 'female pregnancy', 48, 'gestation'), ('GO_0007565', 'female pregnancy', 88, 'gestation'), ('GO_0008610', 'lipid biosynthetic process', 121, 'lipogenic'), ('CHEBI_33284', 'nutrient', 132, 'nutrient'), ('GO_0016042', 'lipid catabolic process', 155, 'lipolysis'), ('CL_0000136', 'fat cell', 169, 'adipocyte'), ('UBERON_0001013', 'adipose tissue', 218, 'adipose tissue')]
PMC4363193	3/2015	S285-PMC4363193	['at the transcriptional level, our em offspring subcutaneous Adipose Tissue differed significantly from controls with increased levels of all Lipogenic ( Cd36 , Acacb and Lpl ), Nutrient transporters ( Fabp4 and Glut4 ) and Lipolysis ( Hsl and Atgl ) indicators tested.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue'), ('GO_0008610', 'lipid biosynthetic process', 141, 'lipogenic'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 153, 'CD36'), ('PR_000003585', 'actin-binding LIM protein 2', 160, 'ACACB'), ('PR_000009880', 'Lon protease, mitochondrial', 170, 'LPL'), ('CHEBI_33284', 'nutrient', 177, 'nutrient'), ('PR_000007380', 'putative F-box/LRR-repeat protein 21', 201, 'FABP4'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 211, 'GLUT4'), ('GO_0016042', 'lipid catabolic process', 223, 'lipolysis'), ('PR_000008794', 'heat shock factor protein 5', 235, 'HSL'), ('PR_000004410', 'protein Atg16l2', 243, 'ATGL')]
PMC4363193	3/2015	S341-PMC4363193	['increasing maternal Food allowance in early and mid Gestation combined, resulted in offspring whose Subcutaneous Adipose Tissue, at adolescence, exhibited elevated mrna levels of Lipogenic, Nutrient transporters, Lipolysis and Adipocyte size indicators compared to controls.']	N/A	N/A	[('CHEBI_33290', 'food', 20, 'food'), ('GO_0007565', 'female pregnancy', 52, 'gestation'), ('UBERON_0002023', 'claustrum of brain', 100, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 113, 'adipose tissue'), ('GO_0008610', 'lipid biosynthetic process', 179, 'lipogenic'), ('CHEBI_33284', 'nutrient', 190, 'nutrient'), ('GO_0016042', 'lipid catabolic process', 213, 'lipolysis'), ('CL_0000136', 'fat cell', 227, 'adipocyte')]
PMC4377870	3/2015	S192-PMC4377870	['in obesity, Macrophage and Mast Cell infiltration into Adipose Tissue is upregulated [142].']	N/A	N/A	[('CL_0000235', 'macrophage', 12, 'macrophage'), ('CL_0000097', 'mast cell', 27, 'mast cell'), ('UBERON_0001013', 'adipose tissue', 55, 'adipose tissue')]
PMC4383546	4/2015	S0-PMC4383546	['Perinatal overnutrition exacerbates Adipose Tissue inflammation caused by high-fat feeding in c57bl/6j Mice\n\nabstract\nobesity causes White Adipose Tissue (Wat) inflammation and Insulin resistance in some, but not all Individuals.']	N/A	N/A	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('UBERON_0001013', 'adipose tissue', 36, 'Adipose Tissue'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'Mice'), ('UBERON_0001347', 'white adipose tissue', 133, 'white adipose tissue'), ('UBERON_0006337', 'distal early tubule', 155, 'WAT'), ('PR_000045358', 'insulin family protein', 177, 'insulin'), ('NCBITaxon_1', 'root', 217, 'individuals')]
PMC4383546	4/2015	S25-PMC4383546	['Adipose Tissue Macrophages are central contributors to Metainflammation [22], whereby obesity leads to an influx of Proinflammatory Type 1 Macrophage (M1) that overcome the decreasing proportion of resident and anti-inflammatory Type 2 Macrophages (M2) [23–25].']	N/A	N/A	[('CL_0002605', 'astrocyte of the cerebral cortex', 0, 'Adipose tissue macrophages'), ('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0008152', 'metabolic process', 55, 'metainflammation'), ('CL_0002175', 'primary follicular cell of ovary', 116, 'proinflammatory'), ('CL_0000861', 'elicited macrophage', 132, 'type 1 macrophage'), ('CL_0011107', 'Muller cell', 151, 'M1'), ('CL_0002214', 'type IIa muscle cell', 229, 'type 2 macrophages'), ('CL_0000485', 'mucosal type mast cell', 249, 'M2')]
PMC4383546	4/2015	S41-PMC4383546	['Epididymal (Ewat) and subcutaneous (Swat) Adipose Tissue was collected at p21, and Ewat, Retroperitoneal (Rwat), and Inguinal (Iwat) Fat Depots were collected at 17 weeks of age and weighed (n = 9–13 per group from ≥ 6 litters).']	N/A	N/A	[('UBERON_0004360', 'cauda epididymis', 0, 'Epididymal ...'), ('UBERON_0001301', 'epididymis', 12, 'eWAT ...'), ('UBERON_0001463', 'manual digit 1', 36, 'sWAT ...'), ('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('UBERON_0007376', 'outer epithelium', 83, 'eWAT'), ('UBERON_0013531', 'retrosplenial region', 89, 'retroperitoneal ...'), ('UBERON_0013691', 'buttock', 106, 'rWAT ...'), ('UBERON_0008337', 'inguinal part of abdomen', 117, 'inguinal ...'), ('UBERON_0013623', 'pedal autopod pad', 127, 'iWAT ... fat depots')]
PMC4383546	4/2015	S61-PMC4383546	['Adipose Tissue was minced and incubated at 37°c in 1mg/ml collagenase (type iv; worthington biochemical, lakewood, nj).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue')]
PMC4383546	4/2015	S92-PMC4383546	['we next investigated Adipose Tissue Macrophage infiltration using immunostaining for the Macrophage marker F4/80.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 21, 'adipose tissue'), ('CL_0000235', 'macrophage', 36, 'macrophage'), ('CL_0000235', 'macrophage', 89, 'macrophage'), ('PR_000001900', 'neuropilin-1', 107, 'F4/80')]
PMC4383546	4/2015	S95-PMC4383546	['because obesity induces a phenotypic switch in Adipose Tissue Macrophage polarization from an m2-polarized state to an m1 pro-inflammatory state [23], we also assessed m1- and m2-related Gene Expression in Swat of sl and nl at p21.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 47, 'adipose tissue'), ('CL_0000235', 'macrophage', 62, 'macrophage'), ('GO_0010467', 'gene expression', 187, 'gene expression'), ('SO_0000704', 'gene', 187, 'gene'), ('UBERON_0009889', 'secondary heart field', 206, 'sWAT')]
PMC4383546	4/2015	S100-PMC4383546	['b-c : mass ( b ) and mean Adipocyte areas ( c ) of Epididymal (Ewat) and subcutaneous (Swat) Adipose Tissue of p21 sl and nl Mice (n = 4–5 per group from ≥ 5 litters).']	N/A	N/A	[('CL_0000136', 'fat cell', 26, 'adipocyte'), ('UBERON_0004360', 'cauda epididymis', 51, 'epididymal ...'), ('UBERON_0001301', 'epididymis', 63, 'eWAT ...'), ('UBERON_0001463', 'manual digit 1', 87, 'sWAT ...'), ('UBERON_0001013', 'adipose tissue', 93, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 125, 'mice')]
PMC4383546	4/2015	S143-PMC4383546	['to better characterize the phenotype of Adipose Tissue Macrophages, we next sorted Cd45+Cd64+Macrophages based on heterogeneous Expression of Cd11C and Cd301.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CL_0000235', 'macrophage', 55, 'macrophages'), ('PR_000001309', 'CD70 molecule', 83, 'CD45'), ('PR_000001309', 'CD70 molecule', 88, 'CD64'), ('CL_0000235', 'macrophage', 93, 'macrophages'), ('GO_0010467', 'gene expression', 128, 'expression'), ('PR_000001309', 'CD70 molecule', 142, 'CD11c'), ('PR_000005169', 'CMRF35-like molecule 9', 152, 'CD301')]
PMC4388824	4/2015	S4-PMC4388824	['Er stress markers Ire1Α, Grp78 and xbp-1S were significantly increased in Adipose Tissue of obese compared to lean Pregnant women.']	N/A	N/A	[('GO_0005783', 'endoplasmic reticulum', 0, 'ER'), ('PR_000029559', 'interleukin-36 beta', 18, 'IRE1α'), ('PR_000008210', 'glutathione peroxidase 1', 25, 'GRP78'), ('PR_000000034', 'BMP', 38, '-1s'), ('UBERON_0001013', 'adipose tissue', 74, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 115, 'pregnant')]
PMC4388824	4/2015	S8-PMC4388824	['treatment with Anti-Diabetic Drugs Metformin and Glibenclamide also reduced Il-1Α and Il-1Β secretion in infection and cytokine-primed Adipose Tissue.']	N/A	N/A	[('CHEBI_35829', 'arsenic(5+)', 15, 'anti-diabetic drugs'), ('CHEBI_6801', 'metformin', 35, 'metformin'), ('CHEBI_5383', 'glimepiride', 49, 'glibenclamide'), ('PR_000001388', 'interleukin-32', 76, 'IL-1α'), ('PR_000001383', 'interleukin-22', 86, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 135, 'adipose tissue')]
PMC4388824	4/2015	S44-PMC4388824	['Adipose Tissue was obtained from the following groups: (i) normal Glucose tolerant (ngt) women who entered Pregnancy lean (bmi between 18-<25 kg/m2; n = 6 patients); (ii) ngt women who entered Pregnancy obese (bmi ≥30 kg/m2; n = 6 patients); (iii) women with gdm were managed by diet alone (n = 6 lean and n = 6 obese); and (iv) women with gdm were managed by Insulin in addition to diet (n = 6 lean and n = 6 obese).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy'), ('PR_000045358', 'insulin family protein', 360, 'insulin')]
PMC4388824	4/2015	S49-PMC4388824	['Adipose Tissue was processed within 15 min of collection, thoroughly washed in ice-cold pbs to remove any Blood.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC4388824	4/2015	S52-PMC4388824	['for these studies, Adipose Tissue was obtained from ngt non-obese Pregnant women, and Tissue explants were performed as previously described [9].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('UBERON_0000479', 'tissue', 86, 'tissue')]
PMC4388824	4/2015	S53-PMC4388824	['briefly, Adipose Tissues was finely diced and placed in dmem at 37°c in a humidified atmosphere of 21% O2And 5% Co2For 1 h. Tissues were blotted dry on sterile filter paper and transferred to 24-well Tissue culture plates (100 mg wet weight/well).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissues'), ('CHEBI_29020', 'neral', 103, 'O2and'), ('CHEBI_86192', 'butyl anthranilate', 112, 'CO2for'), ('UBERON_0000479', 'tissue', 124, 'Tissues'), ('UBERON_0000479', 'tissue', 200, 'tissue')]
PMC4388824	4/2015	S57-PMC4388824	['additional experiments were also performed whereby Adipose Tissue was pre-treated with 20 μm of the Caspase-1 Inhibitor Ac-Yvad-Cho, 10 μm of the connexin/Pannexin-1 channel Blocker Carbenoxolone, or with two Anti-Diabetic Drugs, 25 μm Glibenclamide or 0.5 mm Metformin prior to the addition of Lps, Poly(I:c) or Tnf-Α.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 51, 'adipose tissue'), ('PR_000002310', 'caspase-10', 100, 'caspase-1'), ('CHEBI_35222', 'inhibitor', 110, 'inhibitor'), ('CHEBI_2787', 'Apovincamine', 120, 'Ac-YVAD-'), ('CHEBI_17883', 'hydrogen chloride', 128, 'CHO'), ('PR_000012528', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF3', 155, 'pannexin-1'), ('CHEBI_35225', 'buffer', 174, 'blocker'), ('CHEBI_51687', 'chrysene', 182, 'carbenoxolone'), ('CHEBI_35829', 'arsenic(5+)', 209, 'anti-diabetic drugs'), ('CHEBI_5383', 'glimepiride', 236, 'glibenclamide'), ('CHEBI_6801', 'metformin', 260, 'metformin'), ('CHEBI_16412', 'lipopolysaccharide', 295, 'LPS'), ('CHEBI_37311', 'einsteinium molecular entity', 300, 'poly'), ('CHEBI_51686', 'haematoxylin', 305, 'I'), ('PR_000000134', 'tumor necrosis factor alpha', 313, 'TNF-α')]
PMC4388824	4/2015	S60-PMC4388824	['each treatment was performed from Adipose Tissue obtained from at least five patients.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 34, 'adipose tissue')]
PMC4388824	4/2015	S93-PMC4388824	['data were expressed as mean ± standard error of the mean (sem).10.1371/journal.pone.0122633.g001\n\ncaption (fig): fig 1\nEr stress is increased in Adipose Tissue from obese Pregnant women and with gdm.']	N/A	N/A	[('GO_0005783', 'endoplasmic reticulum', 119, 'ER'), ('UBERON_0001013', 'adipose tissue', 145, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 171, 'pregnant')]
PMC4388824	4/2015	S94-PMC4388824	['Adipose Tissue was obtained from ngt lean (n = 6 patients) and obese (n = 6 patients) Pregnant women at the time of term caesarean section.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0007565', 'female pregnancy', 86, 'pregnant')]
PMC4388824	4/2015	S100-PMC4388824	['Adipose Tissue were also obtained from (d-f) lean and (g-i) obese Pregnant women with ngt (n = 6 patients per group), diet-controlled gdm (n = 6 patients per group), Insulin-controlled gdm (n = 6 patients) and combined gdm (n = 12 patients per group) at the time of term caesarean section.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('PR_000045358', 'insulin family protein', 166, 'insulin')]
PMC4388824	4/2015	S106-PMC4388824	['Adipose Tissue was incubated in the absence or presence of (a-f) 10 μg/ml Lps (n = 6 patients), (g-l) 20 μg/ml Poly(I:c) (n = 6 patients), or (m-r) 10 ng/ml tnf-α.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_16412', 'lipopolysaccharide', 74, 'LPS'), ('CHEBI_37311', 'einsteinium molecular entity', 111, 'poly'), ('CHEBI_51686', 'haematoxylin', 116, 'I')]
PMC4388824	4/2015	S113-PMC4388824	['Adipose Tissue was incubated in the absence or presence of 10 μm Ac-Yvad-Cho (yvad) for 60 min prior to the addition of (a-c) 10 μg/ml Lps, (d-f) 20 μg/ml Poly(I:c) or (g-i) 10 ng/ml Tnf-Α.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_37527', 'acid', 65, 'Ac'), ('CHEBI_79374', 'ibho#22', 68, 'YVAD'), ('CHEBI_17883', 'hydrogen chloride', 73, 'CHO'), ('CHEBI_16412', 'lipopolysaccharide', 135, 'LPS'), ('CHEBI_37311', 'einsteinium molecular entity', 155, 'poly'), ('CHEBI_51686', 'haematoxylin', 160, 'I'), ('PR_000000134', 'tumor necrosis factor alpha', 183, 'TNF-α')]
PMC4388824	4/2015	S118-PMC4388824	['Adipose Tissue was incubated in the absence or presence of 10 μm Carbenoxolone (Carb) for 60 min prior to the addition of (a-c) 10 μg/ml Lps, (d-f) 20 μg/ml Poly(I:c) or (g-i) 10 ng/ml Tnf-Α.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_51687', 'chrysene', 65, 'carbenoxolone'), ('CHEBI_82156', 'Chlorfensulphide', 80, 'Carb'), ('CHEBI_16412', 'lipopolysaccharide', 137, 'LPS'), ('CHEBI_37311', 'einsteinium molecular entity', 157, 'poly'), ('CHEBI_51686', 'haematoxylin', 162, 'I'), ('PR_000000134', 'tumor necrosis factor alpha', 185, 'TNF-α')]
PMC4388824	4/2015	S123-PMC4388824	['Adipose Tissue was incubated in the absence or presence of 0.5 mm Metformin (metf) or 25 μm Glibenclamide (glib)for 60 min prior to the addition of (a-c) 10 μg/ml Lps, (d-f) 20 μg/ml Poly(I:C) or (g-i) 10 ng/ml Tnf-Α.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_6801', 'metformin', 66, 'metformin'), ('CHEBI_5383', 'glimepiride', 92, 'glibenclamide'), ('CHEBI_16412', 'lipopolysaccharide', 163, 'LPS'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 183, 'poly(I:C'), ('PR_000000134', 'tumor necrosis factor alpha', 211, 'TNF-α')]
PMC4388824	4/2015	S128-PMC4388824	['results\n\ner stress is increased in Adipose Tissue from obese women\nAdipose Tissue was obtained from 12 ngt women at the time of term caesarean section (in the absence of labour).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 35, 'adipose tissue'), ('UBERON_0001013', 'adipose tissue', 67, 'Adipose tissue')]
PMC4388824	4/2015	S135-PMC4388824	['as presented infig 1, the protein Expression of these Er stress markers was assessed by western blotting in Adipose Tissue of ngt Pregnant women.']	N/A	N/A	[('GO_0010467', 'gene expression', 34, 'expression'), ('GO_0005783', 'endoplasmic reticulum', 54, 'ER'), ('UBERON_0001013', 'adipose tissue', 108, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 130, 'pregnant')]
PMC4388824	4/2015	S148-PMC4388824	['as shown infig 1i, there was a non-significant increase in the Expression of xbp-1S in Adipose Tissue obtained from gdm diet and gdm Insulin patients when compared to ngt patients ( p = 0.06).']	N/A	N/A	[('GO_0010467', 'gene expression', 63, 'expression'), ('PR_000000034', 'BMP', 80, '-1s'), ('UBERON_0001013', 'adipose tissue', 87, 'adipose tissue'), ('PR_000045358', 'insulin family protein', 133, 'insulin')]
PMC4388824	4/2015	S155-PMC4388824	['Lps induced a significant increase in both Il-1Α and Il-1Β mrna Expression (fig2aand2b) and secretion (fig2dand2e) in Adipose Tissue.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 0, 'LPS'), ('PR_000001388', 'interleukin-32', 43, 'IL-1α'), ('PR_000001383', 'interleukin-22', 53, 'IL-1β'), ('GO_0010467', 'gene expression', 64, 'expression'), ('UBERON_0001013', 'adipose tissue', 118, 'adipose tissue')]
PMC4388824	4/2015	S161-PMC4388824	['Poly(I:c) treatment of Adipose Tissue also induced a significant increase in Il-1Α, Il-1Β and Il-6 mrna Expression (fig2g–2i) and secretion (fig2j–2l).']	N/A	N/A	[('CHEBI_66759', 'Plastoquinone 1', 0, 'Poly(I'), ('UBERON_0001013', 'adipose tissue', 23, 'adipose tissue'), ('PR_000001388', 'interleukin-32', 77, 'IL-1α'), ('PR_000001383', 'interleukin-22', 84, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 94, 'IL-6'), ('GO_0010467', 'gene expression', 104, 'expression')]
PMC4388824	4/2015	S164-PMC4388824	['in contrast to Lps and Poly(I:C) treatments, Tnf-Α increased Il-1Α and Il-1Β mrna Expression (fig2mand2n) but not secretion (fig2pand2q) in Pregnant Adipose Tissue.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 15, 'LPS'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 23, 'poly(I:C'), ('PR_000000134', 'tumor necrosis factor alpha', 45, 'TNF-α'), ('PR_000001388', 'interleukin-32', 61, 'IL-1α'), ('PR_000001383', 'interleukin-22', 71, 'IL-1β'), ('GO_0010467', 'gene expression', 82, 'expression'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 149, 'adipose tissue')]
PMC4388824	4/2015	S165-PMC4388824	['thapsigargin did not have an additive effect on Il-1Α and Il-1Β mrna Expression in Tnf-Α-stimulated Adipose Tissues (fig2mand2n); however, secretion of both Il-1Α and Il-1Β was significantly increased following Thapsigargin treatment (fig2pand2q).']	N/A	N/A	[('PR_000001388', 'interleukin-32', 48, 'IL-1α'), ('PR_000001383', 'interleukin-22', 58, 'IL-1β'), ('GO_0010467', 'gene expression', 69, 'expression'), ('PR_000000134', 'tumor necrosis factor alpha', 83, 'TNF-α'), ('UBERON_0001013', 'adipose tissue', 100, 'adipose tissues'), ('PR_000001388', 'interleukin-32', 157, 'IL-1α'), ('PR_000001383', 'interleukin-22', 167, 'IL-1β'), ('CHEBI_9516', 'thapsigargin', 211, 'thapsigargin')]
PMC4388824	4/2015	S170-PMC4388824	['pre-treatment with the specific Caspase-1 Inhibitor Ac-Yvad-Cho significantly attenuated Thapsigargin-induced Il-1Α and Il-1Β in Adipose Tissue primed with Lps (fig3aand3b), poly(i:c) (fig3dand3e) or Tnf-Α (fig3gand3h).']	N/A	N/A	[('PR_000002310', 'caspase-10', 32, 'caspase-1'), ('CHEBI_35222', 'inhibitor', 42, 'inhibitor'), ('CHEBI_60884', 'poly(N-n-propylacrylamide) polymer', 52, 'Ac-YVAD'), ('CHEBI_17883', 'hydrogen chloride', 60, 'CHO'), ('CHEBI_9516', 'thapsigargin', 89, 'thapsigargin'), ('PR_000001388', 'interleukin-32', 110, 'IL-1α'), ('PR_000001383', 'interleukin-22', 120, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 129, 'adipose tissue'), ('CHEBI_16412', 'lipopolysaccharide', 156, 'LPS'), ('PR_000000134', 'tumor necrosis factor alpha', 200, 'TNF-α')]
PMC4388824	4/2015	S178-PMC4388824	['pre-treatment with Metformin or Glibenclamide significantly attenuated thapsigargin-enhanced Il-1Α and Il-1Β secretion in Adipose Tissue primed with Lps (fig5aand5b), poly(i:c) (fig5dand5e) or Tnf-Α (fig5gand5h).']	N/A	N/A	[('CHEBI_6801', 'metformin', 19, 'metformin'), ('CHEBI_5383', 'glimepiride', 32, 'glibenclamide'), ('PR_000001388', 'interleukin-32', 93, 'IL-1α'), ('PR_000001383', 'interleukin-22', 103, 'IL-1β'), ('UBERON_0001013', 'adipose tissue', 122, 'adipose tissue'), ('CHEBI_16412', 'lipopolysaccharide', 149, 'LPS'), ('PR_000000134', 'tumor necrosis factor alpha', 193, 'TNF-α')]
PMC4388824	4/2015	S187-PMC4388824	['markers of Er stress including Grp78 are upregulated in Adipose Tissue of obese Mice [28].']	N/A	N/A	[('GO_0005783', 'endoplasmic reticulum', 11, 'ER'), ('PR_000008210', 'glutathione peroxidase 1', 31, 'GRP78'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mice')]
PMC4388824	4/2015	S189-PMC4388824	['moreover, treatment of obese and diabetic Mice with Er stress Inhibitors improved Insulin sensitivity in the Liver, Muscles and Adipose Tissues [15].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mice'), ('GO_0005783', 'endoplasmic reticulum', 52, 'ER'), ('CHEBI_35222', 'inhibitor', 62, 'inhibitors'), ('PR_000045358', 'insulin family protein', 82, 'insulin'), ('UBERON_0002107', 'liver', 109, 'liver'), ('UBERON_0005090', 'muscle structure', 116, 'muscles'), ('UBERON_0001013', 'adipose tissue', 128, 'adipose tissues')]
PMC4388824	4/2015	S219-PMC4388824	['indeed, Caspase-1 activation is increased in Adipose Tissue of gdm women [9].']	N/A	N/A	[('PR_000002310', 'caspase-10', 8, 'caspase-1'), ('UBERON_0001013', 'adipose tissue', 45, 'adipose tissue')]
PMC4390148	4/2015	S30-PMC4390148	['in male Rat offspring at Postnatal day (pnd)19, maternal obesity enhanced Adipose Tissue differentiation and upregulated Lipogenic Genes [17].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 8, 'rat'), ('GO_0007567', 'parturition', 25, 'postnatal'), ('UBERON_0001013', 'adipose tissue', 74, 'adipose tissue'), ('GO_0008610', 'lipid biosynthetic process', 121, 'lipogenic'), ('SO_0000704', 'gene', 131, 'genes')]
PMC4390148	4/2015	S36-PMC4390148	['in patients with type 2 diabetes, exercise training increased Glut4 Expression in Adipose Tissue [23].']	N/A	N/A	[('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 62, 'GLUT4'), ('GO_0010467', 'gene expression', 68, 'expression'), ('UBERON_0001013', 'adipose tissue', 82, 'adipose tissue')]
PMC4418750	6/2015	S189-PMC4418750	['no differences were observed in the levels of 4E-Bp1 or S6 Ribosomal protein in offspring Yolk Sac Tissue between dietary groups.']	N/A	N/A	[('PR_000006897', 'endothelin-1', 46, '4E-BP1'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 56, 'S6 ribosomal'), ('GO_0005840', 'ribosome', 59, 'ribosomal'), ('UBERON_0001013', 'adipose tissue', 90, 'yolk sac tissue')]
PMC4429565	5/2015	S3-PMC4429565	["maternal nutritional manipulations reprogram offspring's Adipose Tissue resulting in series of alterations: enhanced Adipogenesis and Lipogenesis, impaired sympathetic activity with reduced noradrenergic innervations and Thermogenesis as well as low-grade inflammation."]	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 57, 'adipose tissue'), ('GO_0060612', 'adipose tissue development', 117, 'adipogenesis'), ('GO_0008610', 'lipid biosynthetic process', 134, 'lipogenesis'), ('GO_0031649', 'heat generation', 221, 'thermogenesis')]
PMC4429565	5/2015	S21-PMC4429565	["caption (fig): figure 1\n\nschematic representation of programmed mechanisms in offspring's Adipose Tissue of malnourished dams ."]	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 90, 'adipose tissue')]
PMC4429565	5/2015	S22-PMC4429565	['overall, offspring from malnourished dams display increased Adipogenesis/Lipogenesis and inflammation as well as decreased Lipolysis within Adipose Tissue.']	N/A	N/A	[('GO_0060612', 'adipose tissue development', 60, 'adipogenesis'), ('GO_0008610', 'lipid biosynthetic process', 73, 'lipogenesis'), ('GO_0016042', 'lipid catabolic process', 123, 'lipolysis'), ('UBERON_0001013', 'adipose tissue', 140, 'adipose tissue')]
PMC4429565	5/2015	S35-PMC4429565	['in this context, we provide a brief overview on the repercussion of Perinatal nutritional manipulations on Adipose Tissue functionality in programmed offspring.']	N/A	N/A	[('GO_0036268', 'swimming', 68, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('UBERON_0001013', 'adipose tissue', 107, 'adipose tissue')]
PMC4429565	5/2015	S65-PMC4429565	['during this period, Adipose Tissue expansion is due both to hyperplasia (i.e., higher Preadipocyte and Stromal Cell numbers) and hypertrophy (i.e., enhanced Lipogenesis such as lpl activity) within Wat.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 20, 'adipose tissue'), ('CL_0007002', 'precementoblast', 86, 'preadipocyte ...'), ('CL_0000499', 'stromal cell', 103, 'stromal cell'), ('UBERON_0003891', 'stroma', 103, 'stromal'), ('GO_0008610', 'lipid biosynthetic process', 157, 'lipogenesis'), ('UBERON_0006337', 'distal early tubule', 198, 'WAT')]
PMC4429565	5/2015	S75-PMC4429565	['offspring of malnourished dams show increased inflammatory response in Adipose Tissue\noffspring of malnourished dams displayed chronic low-grade obesity-associated inflammation characterized by elevation of inflammatory factors in Plasma (i.e., Tnf-Α, Il-6 and Mcp-1) and Expression of pro-Inflammatory Mediators in Wat.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 71, 'adipose tissue'), ('UBERON_0001969', 'blood plasma', 231, 'plasma'), ('PR_000000134', 'tumor necrosis factor alpha', 245, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 252, 'IL-6'), ('PR_000010439', 'myeloid leukemia factor 1', 261, 'MCP-1'), ('GO_0010467', 'gene expression', 272, 'expression'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 290, 'inflammatory mediators'), ('UBERON_0006337', 'distal early tubule', 316, 'WAT')]
PMC4429565	5/2015	S104-PMC4429565	['this phenomenon takes place in utero during early fetal Development Of Adipose Tissue in female but not male Primate (guo et al.,2013).']	N/A	N/A	[('GO_0042748', 'circadian sleep/wake cycle, non-REM sleep', 56, 'development of adipose tissue'), ('UBERON_0001013', 'adipose tissue', 71, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 109, 'primate')]
PMC4448820	5/2015	S983-PMC4448820	['overweight and obesity are inflammatory in nature because Adipose Tissue releases a number of Inflammatory Mediators (508).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 58, 'adipose tissue'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 94, 'inflammatory mediators')]
PMC4448820	5/2015	S989-PMC4448820	['Adipose Tissue is in fact a large Endocrine Organ Secreting the proinflammatory hormone leptin and the hormones visfatin and resistin, which cause Insulin resistance (509–511).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0006397', 'mRNA processing', 34, 'endocrine'), ('UBERON_0002049', 'vasculature', 34, 'endocrine'), ('UBERON_0000062', 'organ', 44, 'organ'), ('GO_0046903', 'secretion', 50, 'secreting'), ('PR_000045358', 'insulin family protein', 147, 'insulin')]
PMC4448820	5/2015	S1058-PMC4448820	['● Macrophage infiltration of Adipose Tissue and the Placenta is characteristic of established obesity.']	N/A	N/A	[('CL_0000235', 'macrophage', 2, 'Macrophage'), ('UBERON_0001013', 'adipose tissue', 29, 'adipose tissue'), ('UBERON_0001987', 'placenta', 52, 'placenta')]
PMC4463023	2/2015	S4-PMC4463023	['weight gain with a high-fat diet was attenuated in male offspring of older mothers Fed lp (interaction of maternal age and diet; p \xa0=\xa00·011) and Adipose Tissue deposition was lower with lp Feeding in both males and females ( p \xa0<\xa00·05).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 83, 'fed'), ('UBERON_0001013', 'adipose tissue', 145, 'adipose tissue'), ('GO_0007631', 'feeding behavior', 189, 'feeding')]
PMC4463023	2/2015	S49-PMC4463023	['Adipose Tissue was dissected from the perirenal and Gonadal Depots and carefully weighed.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0003428', 'gonadal fat pad', 52, 'gonadal depots')]
PMC4463023	2/2015	S51-PMC4463023	['Adipocyte measurements\nsnap-frozen samples of Adipose Tissue were sectioned using a cryostat and mounted onto microscope slides.']	N/A	N/A	[('CL_0000136', 'fat cell', 0, 'Adipocyte'), ('UBERON_0001013', 'adipose tissue', 46, 'adipose tissue')]
PMC4463828	5/2015	S19-PMC4463828	['increased nutritional supply promotes Adipose Tissue hypertrophy, which initiates a Dysregulated Immune Response and stimulates Migration of Proinflammatory Macrophages thereby initiating localized Insulin resistance (chawla et\xa0al.2011; lumeng and saltiel2011).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 38, 'adipose tissue'), ('GO_0060203', 'clathrin-sculpted glutamate transport vesicle membrane', 84, 'dysregulated'), ('GO_0006955', 'immune response', 97, 'immune response'), ('UBERON_0002405', 'immune system', 97, 'immune'), ('GO_0007601', 'visual perception', 128, 'migration'), ('CL_0000836', 'promyelocyte', 141, 'proinflammatory macrophages'), ('GO_0042637', 'catagen', 157, 'macrophages'), ('PR_000045358', 'insulin family protein', 198, 'insulin')]
PMC4488777	5/2015	S59-PMC4488777	['obesity, vd accumulation in Adipose Tissue, and sunbathing avoidance due to hirsutism results in 65%–87% rate of vd deficiency in pcos patients [27].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 28, 'adipose tissue')]
PMC4490503	6/2015	S41-PMC4490503	['inflammation and biomarkers in obesity\nsince the discovery of leptin in 1994, Adipose Tissue is widely regarded as an Endocrine Organ, capable of Secreting various adipokines [14].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 78, 'adipose tissue'), ('UBERON_0002049', 'vasculature', 118, 'endocrine'), ('UBERON_0000062', 'organ', 128, 'organ'), ('GO_0046903', 'secretion', 146, 'secreting')]
PMC4490503	6/2015	S42-PMC4490503	['adipokines are proteins Secreted by Adipose Tissue that act as paracrine factors in Adipose Tissue and as endocrine hormones in Liver, Muscles and the Central Nervous System [15].']	N/A	N/A	[('GO_0046903', 'secretion', 24, 'secreted'), ('UBERON_0001013', 'adipose tissue', 36, 'adipose tissue'), ('UBERON_0001013', 'adipose tissue', 84, 'adipose tissue'), ('UBERON_0002107', 'liver', 128, 'liver'), ('UBERON_0005090', 'muscle structure', 135, 'muscles'), ('UBERON_0001017', 'central nervous system', 151, 'central nervous system')]
PMC4490503	6/2015	S44-PMC4490503	['in obesity, adipokines Secreted by Adipocytes and Macrophages also act in an autocrine fashion to further exacerbate Adipose Tissue inflammation, and decrease muscle and Liver Insulin sensitivity [17].']	N/A	N/A	[('GO_0046903', 'secretion', 23, 'secreted'), ('CL_0000136', 'fat cell', 35, 'adipocytes'), ('CL_0000235', 'macrophage', 50, 'macrophages'), ('UBERON_0001013', 'adipose tissue', 117, 'adipose tissue'), ('UBERON_0002107', 'liver', 170, 'liver'), ('PR_000045358', 'insulin family protein', 176, 'insulin')]
PMC4490503	6/2015	S47-PMC4490503	['the functional activity of Adipose Tissue Macrophages is proportional to the degree of obesity.']	N/A	N/A	[('CL_0002617', 'adipocyte of breast', 27, 'adipose tissue macrophages'), ('UBERON_0001013', 'adipose tissue', 27, 'adipose tissue')]
PMC4490503	6/2015	S79-PMC4490503	['expansion of Adipose Tissue leads to further enhanced Macrophage recruitment and production of pro-inflammatory cytokines such as Tnf-Α and Il-6.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('CL_0000235', 'macrophage', 54, 'macrophage'), ('PR_000000134', 'tumor necrosis factor alpha', 130, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 140, 'IL-6')]
PMC4490503	6/2015	S166-PMC4490503	['leptin is released into the circulation by Adipose Tissue in proportion to Lipid stores [5].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 43, 'adipose tissue'), ('CHEBI_18059', 'lipid', 75, 'lipid')]
PMC4490503	6/2015	S191-PMC4490503	['adiponectin\nadiponectin is an abundant Plasma protein Secreted exclusively from Adipose Tissue and is decreased in obesity [17].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 39, 'plasma'), ('GO_0046903', 'secretion', 54, 'secreted'), ('UBERON_0001013', 'adipose tissue', 80, 'adipose tissue')]
PMC4494359	11/2013	S130-PMC4494359	['the most common lesions recorded are fractures of the Ribs or the Spine.']	N/A	N/A	[('UBERON_0002228', 'rib', 54, 'ribs'), ('UBERON_0001013', 'adipose tissue', 66, 'spine')]
PMC4641416	11/2015	S29-PMC4641416	['leptin is an Adipocyte Secreted circulating polypeptide hormone Expressed in the Adipose Tissue [21] that was first discovered in 1994.']	N/A	N/A	[('CL_0000136', 'fat cell', 13, 'adipocyte'), ('GO_0046903', 'secretion', 23, 'secreted'), ('GO_0010467', 'gene expression', 64, 'expressed'), ('UBERON_0001013', 'adipose tissue', 81, 'adipose tissue')]
PMC4661480	10/2015	S16-PMC4661480	['antenatal ultrasound at 21 weeks followed by Antenatal magnetic resonance imaging revealed multiple congenital anomalies consisting of Corpus Collusum agenesis with no Cavum Septum Pellucidum, marked dilatation of the right greater then Left Lateral Ventricle with a thin rim of surrounding Brain Parenchyma, and an absent Nasal Cavity and left Orbit with an unremarkable Spine (figs.']	N/A	N/A	[('GO_0007567', 'parturition', 45, 'antenatal'), ('UBERON_0001906', 'subthalamic nucleus', 135, 'corpus collusum'), ('UBERON_0009857', 'cavum septum pellucidum', 168, 'cavum septum pellucidum'), ('UBERON_0002084', 'heart left ventricle', 237, 'left lateral ventricle'), ('UBERON_0005205', 'lamina propria of vagina', 291, 'brain parenchyma'), ('UBERON_0001707', 'nasal cavity', 323, 'nasal cavity'), ('UBERON_0000978', 'leg', 345, 'orbit'), ('UBERON_0001013', 'adipose tissue', 372, 'spine')]
PMC4670104	12/2015	S186-PMC4670104	['lumican (lum), Cartilage Oligomeric Matrix Protein (Comp), Tetranectin (Clec3B), Osteomodulin (omd), and collagen α-1 and -3 type vi (Col6A1/3) are enriched in cartilage, bone Matrix, Skeletal muscle and Adipose Tissues [68–72].']	N/A	N/A	[('PR_000005890', 'crooked neck-like protein 1', 15, 'cartilage oligomeric matrix protein'), ('GO_0031012', 'extracellular matrix', 36, 'matrix'), ('PR_000005733', 'coatomer subunit alpha', 52, 'COMP'), ('PR_000000035', 'BMP receptor type-1A', 59, 'tetranectin'), ('PR_000005563', 'C-type lectin domain family 18 member C', 72, 'CLEC3B'), ('PR_000012084', 'OTU domain-containing protein 7B', 81, 'osteomodulin'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 134, 'COL6A1'), ('GO_0031012', 'extracellular matrix', 176, 'matrix'), ('UBERON_0004288', 'skeleton', 184, 'skeletal'), ('UBERON_0001013', 'adipose tissue', 204, 'adipose tissues')]
PMC4682819	12/2015	S23-PMC4682819	['adiponectin was described as an Adipose Tissue-specific Secreted protein and is a Serum-abundant protein [30].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 32, 'adipose tissue'), ('GO_0046903', 'secretion', 56, 'secreted'), ('UBERON_0001977', 'blood serum', 82, 'serum')]
PMC4728639	1/2016	S4-PMC4728639	['at day 20 of Gestation, maternal Plasma, Liver, Adipose Tissue, and Placenta Fa profiles were determined.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('UBERON_0001987', 'placenta', 68, 'placenta'), ('CHEBI_30751', 'formic acid', 77, 'FA')]
PMC4728639	1/2016	S7-PMC4728639	['in Adipose Tissue, Myristic Acid was elevated, whereas Dha and La proportions were reduced in all mothers.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 3, 'adipose tissue'), ('CHEBI_25459', 'myrtenic acid', 19, 'myristic acid'), ('CHEBI_17874', 'dihydrozeatin', 55, 'DHA'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 63, 'LA')]
PMC4728639	1/2016	S8-PMC4728639	['further, Adipose Tissue Stearic Acid proportions were elevated in hf2, hf3, and hfg mothers; with Oleic Acid increased in hf1 and hfg mothers.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue'), ('CHEBI_28842', 'octadecanoic acid', 24, 'stearic acid'), ('CHEBI_30814', 'digallic acid', 98, 'oleic acid')]
PMC4728639	1/2016	S35-PMC4728639	['Maternal Plasma, Hepatic, Adipose Tissue, and Placenta Fa profiles were determined.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('UBERON_0001133', 'cardiac muscle tissue', 17, 'hepatic ...'), ('UBERON_0001013', 'adipose tissue', 26, 'adipose tissue'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('CHEBI_30751', 'formic acid', 55, 'FA')]
PMC4728639	1/2016	S131-PMC4728639	['further, Adipose Tissue la was reduced in hfg mothers compared to hf1, hf2, and hf3 mothers (figure 6).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue')]
PMC4728639	1/2016	S132-PMC4728639	['in addition, Adipose Tissue Stearic Acid was elevated in hf2, hf3, and hfg mothers relative to control mothers, and in hfg mothers compared to hf1 mothers (figure 6).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 13, 'adipose tissue'), ('CHEBI_28842', 'octadecanoic acid', 28, 'stearic acid')]
PMC4728639	1/2016	S133-PMC4728639	['Adipose Tissue Oleic Acid was elevated in hf1 and hfg mothers compared to control mothers (figure 6).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_30814', 'digallic acid', 15, 'oleic acid')]
PMC4728639	1/2016	S134-PMC4728639	['further, Adipose Tissue Palmitic Acid was elevated in hf3 relative to hf1 mothers (figure 6).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue'), ('CHEBI_15756', 'hexadecanoic acid', 24, 'palmitic acid')]
PMC4728639	1/2016	S140-PMC4728639	['caption (fig): figure 6\n\nAdipose Tissue Fatty Acids (g/100 g Fatty Acids).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 25, 'Adipose tissue'), ('CHEBI_35366', 'fatty acid', 40, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 61, 'fatty acids')]
PMC4728639	1/2016	S181-PMC4728639	['the reduced Dha in mothers maintained on a hfd for the third week of Gestation or throughout Gestation in the Plasma, Liver, Adipose Tissue, and Placenta may predispose their offspring to Metabolic disease.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 12, 'DHA'), ('GO_0007565', 'female pregnancy', 69, 'gestation'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0001969', 'blood plasma', 110, 'plasma'), ('UBERON_0002107', 'liver', 118, 'liver'), ('UBERON_0001013', 'adipose tissue', 125, 'adipose tissue'), ('UBERON_0001987', 'placenta', 145, 'placenta'), ('GO_0008152', 'metabolic process', 188, 'metabolic')]
PMC4728639	1/2016	S196-PMC4728639	['conclusions\nmothers maintained on a hfd for the final week of Gestation or throughout Gestation had reduced Dha in Plasma, Liver, Adipose Tissue, and Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'gestation'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 108, 'DHA'), ('UBERON_0001969', 'blood plasma', 115, 'plasma'), ('UBERON_0002107', 'liver', 123, 'liver'), ('UBERON_0001013', 'adipose tissue', 130, 'adipose tissue'), ('UBERON_0001987', 'placenta', 150, 'placenta')]
PMC4730776	1/2016	S37-PMC4730776	['Pregnancy is characterized by a series of specific Metabolic changes such as the stimulation of accretion of Adipose Tissue in early Pregnancy and increased Insulin resistance later in Pregnancy [38].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0008152', 'metabolic process', 51, 'metabolic'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0042695', 'thelarche', 117, 'tissue'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('PR_000045358', 'insulin family protein', 157, 'insulin'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4785305	3/2016	S114-PMC4785305	['the technician positions the laser light so that it is centred about 2\u2005cm below the Iliac Crest (or Umbilicus/Belly button) on the child, and observes the emerging image to ensure that the Spine is centrally positioned and straight, and that the top of the Iliac Crests and all of L5 are visible.']	N/A	N/A	[('UBERON_4300127', 'nuchal crest', 84, 'iliac crest'), ('UBERON_0007118', 'umbilicus', 100, 'umbilicus'), ('UBERON_0000916', 'abdomen', 110, 'belly'), ('UBERON_0001013', 'adipose tissue', 189, 'spine'), ('UBERON_0034873', 'bodily gas', 257, 'iliac crests'), ('UBERON_0004621', 'lumbar vertebra 5', 281, 'L5')]
PMC4835505	4/2016	S392-PMC4835505	['Milk zn concentrations from control and premutation donors decreased with the post-Partum period, ranging from 30 ± 3 μm at 6–8 weeks to 15 ± 2 μm at 18–20 weeks.']	N/A	N/A	[('UBERON_0001913', 'milk', 0, 'Milk'), ('GO_0007567', 'parturition', 83, 'partum'), ('UBERON_0001013', 'adipose tissue', 83, 'partum')]
PMC4859539	5/2016	S36-PMC4859539	['inter- and intra-assay coefficients of variation for the Hip and Spine phantoms were 1% or less.']	N/A	N/A	[('UBERON_0001464', 'hip', 57, 'hip'), ('UBERON_0001013', 'adipose tissue', 65, 'spine')]
PMC4865387	5/2016	S81-PMC4865387	['these women display worsened Insulin resistance in Skeletal muscle (75), Liver, and Adipose Tissue (2,3,76,77) by the third trimester.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 29, 'insulin'), ('UBERON_0004288', 'skeleton', 51, 'skeletal'), ('UBERON_0002107', 'liver', 73, 'liver'), ('UBERON_0001013', 'adipose tissue', 84, 'adipose tissue')]
PMC4865387	5/2016	S86-PMC4865387	['it serves as a suppressor of ffa release (Lipolysis) From stored Triglyceride in Adipose Tissue.']	N/A	N/A	[('GO_0016042', 'lipid catabolic process', 42, 'lipolysis'), ('GO_0007601', 'visual perception', 53, 'from ...'), ('CHEBI_17855', 'triglyceride', 65, 'triglyceride'), ('UBERON_0001013', 'adipose tissue', 81, 'adipose tissue')]
PMC4882683	5/2016	S109-PMC4882683	['in Human infants, the majority of Adipose Tissue is laid down in the 3rd trimester.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'human'), ('UBERON_0001013', 'adipose tissue', 34, 'adipose tissue')]
PMC4892656	6/2016	S74-PMC4892656	['body weight (table 1) was consistently highest for ec.10.1371/journal.pone.0156700.t001\n\ncaption (table-wrap): table 1\neffects of pre- and Postnatal nutrition and sex on Organ and Adipose Tissue weights in 2½ year old Sheep.parameters (actual weight, g or % of total body weight)treatments groups based on the combinations of pre- and Postnatal nutrition*sex p valueshigh-hchfhigh-convlow-hchflow-convnorm-hchfnorm-convecmalefemaleedldsexed*ldbody weight, kg94.7±2.9bc98.1±3abc99±2.7ab91.2±2.4c92.1±3.5bc91.13±2.9c103.3±2.7a99.4±1.2a92.9±1.4b0.0920.920.00040.011subcutaneous fat, g540±96686±97.7688±88.9554±84.6726±117.6535±96833±88.9358±52.6b892±48a0.920.14<0.00010.25subcutaneous fat %0.59±0.090.71±0.100.69±0.090.60±0.080.78±0.120.60±0.100.82±0.090.36±0.05b0.95±0.05a0.980.15<0.00010.19mescenteric fat, g3736±5243854±5233698±4862686±4533939±6423019±5243899±4852632±287b4227±262a0.710.0350.00050.55mescenteric fat %4.0±0.524.0±0.573.7±0.482.9±0.434.3±0.643.4±0.523.8±0.482.6±0.30b4.6±0.26a0.620.034<0.00010.71perirenal fat, g1551±263b2542±265a1715±245b2152±230ab1888±325ab1831±265b2586±243.8a1252±144b2724±132a0.590.29<0.00010.033perirenal fat %1.67±0.272.65±0.291.71±0.252.37±0.222.07±0.332.04±0.272.52±0.251.20±0.2b2.90±0.10a0.810.17<0.00010.055sternal fat, g253±48261±48243±44194±41212±59215±48316±44142±26b327±24a0.60.39<0.00010.79sternal fat %0.27±0.050.27±0.050.24±0.050.21±0.040.23±0.060.24±0.050.31±0.050.14±0.03b0.35±0.02a0.680.41<0.00010.98pericardial fat, g166±20227±21201±19177±18218±25212±25218±19178±11b220±11a0.590.620.020.12pericardial fat %0.18±0.020.23±0.020.20±0.020.20±0.020.24±0.020.24±0.030.21±0.020.18±0.01b0.24±0.10a0.320.590.00080.26thyroids, g4.7±0.816.1±0.904.9±0.756.1±0.705.2±0.996.2±0.815.9±0.815.6±0.505.6±0.400.940.080.780.92thyroids %0.005±0.0010.006±0.0010.005±0.0010.007±0.0010.006±0.0010.007±0.0010.006±0.0010.006±0.0010.006±0.0050.930.120.770.94adrenals, g3.1±0.54.5±0.54.1±0.54.2±0.43.0±0.64.0±0.54.7±0.53.6±0.3b4.4±0.3a0.420.0620.030.29adrenals %0.003±0.00050.005±0.00060.004±0.00050.005±0.00040.003±0.00070.004±0.00050.005±0.00050.004±0.0003b0.005±0.0003a0.410.0530.0270.78pancreas, g71.4±11.064.9±11.068.3±10.274±10.083.2±13.586±11.069.5±10.279.4±6.2a68.2±5.5b0.310.830.0060.85pancreas %0.077±0.0120.065±0.0130.069±0.0100.080±0.0100.090±0.0150.094±0.0120.067±0.0110.080±0.0070.07±0.0060.190.90.400.53liver, g808±35.5824±35.7846±33.0797±33.2745±43.5805±35.5932±35.5902±20.0a765±18.2b0.480.29<0.00010.2liver %0.85±0.030.84±0.030.86±0.030.86±0.030.81±0.040.88±0.030.89±0.030.90±0.02a0.80±0.01b0.880.20.00040.29kidney, g160±8.8155±8.8169±8.1178±7.6156±10.9164±8.9177±8.9181±4.9a155±4.6b0.370.36<0.00010.78kidney %0.17±0.010.16±0.010.17±0.010.20±0.010.17±0.010.18±0.010.17±0.010.18±0.01a0.17±0.01b0.150.30.030.15heart, g347±19.1319±19.4327±17.6303±16.8320±27.1340±19.1329±17.6350±10.8a305±9.5b0.230.90.0010.46heart %0.37±0.020.32±0.020.33±0.020.33±0.020.34±0.030.37±0.020.32±0.020.35±0.010.33±0.010.360.920.090.22 Longissimus Dorsi , g1110±601218±591193±561079±521088±731037±601166±561250±33a1029±30b0.270.71<0.00010.13 Longissimus Dorsi %1.18±0.061.24±0.061.21±0.051.19±0.051.18±0.071.14±0.061.13±0.051.30±0.03a1.10±0.03b0.80.750.0030.85 Biceps Femoris , g666±37749±36723±34672±32625±45688±37743±34734±20a669±19b0.440.170.020.17 Biceps Femoris %0.71±0.040.77±0.040.73±0.030.74±0.030.68±0.040.75±0.040.72±0.030.74±0.010.72±0.010.730.120.450.76\ndata are presented as least square means±sem.']	N/A	N/A	[('GO_0007567', 'parturition', 139, 'postnatal'), ('UBERON_0000062', 'organ', 170, 'organ'), ('UBERON_0001013', 'adipose tissue', 180, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'sheep'), ('GO_0007567', 'parturition', 335, 'postnatal'), ('UBERON_0001401', 'longissimus thoracis muscle', 2952, 'Longissimus dorsi'), ('UBERON_0001401', 'longissimus thoracis muscle', 3058, 'Longissimus dorsi'), ('UBERON_0001374', 'biceps femoris', 3177, 'Biceps femoris'), ('UBERON_0001530', 'common carotid artery plus branches', 3268, 'Biceps'), ('UBERON_0000981', 'femur', 3275, 'femoris')]
PMC4892656	6/2016	S86-PMC4892656	['in all the other Adipose Tissues (including subf), Tissue weights increased 2–3 fold in hchf Sheep from 6 months to 2½ years of age, and in conv Sheep weights of all Adipose Tissues (including Prf) were increased 12-16-fold in Adults over that observed in Lambs [4] (table 1,s1 table).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 17, 'adipose tissues'), ('UBERON_0000479', 'tissue', 51, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 93, 'sheep'), ('NCBITaxon_10088', 'Mus <genus>', 145, 'sheep'), ('UBERON_0001013', 'adipose tissue', 166, 'adipose tissues'), ('UBERON_0006145', 'dorsal digital artery of pes', 193, 'PRF'), ('UBERON_0007023', 'adult organism', 227, 'adults'), ('NCBITaxon_33208', 'Metazoa', 256, 'lambs')]
PMC4896250	4/2016	S2380-PMC4896250	['methods: Human Adipose Tissue-derived Stem Cells (Hadscs) were cultured in dmem/f12 medium containing 10% fbs, 10 ng/ml Egf and 2 ng/ml Bfgf.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 9, 'Human'), ('CL_0002617', 'adipocyte of breast', 15, 'adipose tissue ... stem cells'), ('UBERON_0001013', 'adipose tissue', 15, 'adipose tissue'), ('CL_0000855', 'sensory hair cell', 50, 'hADSCs'), ('PR_000006901', 'early endosome antigen 1', 120, 'EGF'), ('PR_000006910', 'elongation factor 2 kinase', 136, 'bFGF')]
PMC4896250	4/2016	S3326-PMC4896250	['methods: Mscs were isolated from Human Palatine Tonsil (T-Msc) and Adipose Tissues (asc), and the Surface markers were analyzed.']	N/A	N/A	[('CL_0000186', 'myofibroblast cell', 9, 'MSCs'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('UBERON_0002373', 'palatine tonsil', 39, 'palatine tonsil'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 56, 'T'), ('CL_0000186', 'myofibroblast cell', 58, 'MSC'), ('UBERON_0001013', 'adipose tissue', 67, 'adipose tissues'), ('GO_0009986', 'cell surface', 98, 'surface')]
PMC4905827	1/2016	S8-PMC4905827	['in a Perinatal neb state, the Liver Triglyceride (tg) and Blood free Fatty Acid (nefa) levels increase [19,26] to compensate for the insufficient energy by degrading the fat accumulated in Adipose Tissues and mobilizing it to the Liver.']	N/A	N/A	[('GO_0036268', 'swimming', 5, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 5, 'perinatal'), ('UBERON_0002107', 'liver', 30, 'liver'), ('CHEBI_17855', 'triglyceride', 36, 'triglyceride'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_35366', 'fatty acid', 69, 'fatty acid'), ('UBERON_0001013', 'adipose tissue', 189, 'adipose tissues'), ('UBERON_0002107', 'liver', 230, 'liver')]
PMC4933662	4/2016	S85-PMC4933662	['further, supplementing with higher protein (55% vs. 20% in control) during Rat Gestation and weaning reduces Birth weight by 7% by a reduction in Adipose Tissue (31%) (desclee de maredsous et\xa0al .,2016).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 75, 'rat'), ('GO_0007565', 'female pregnancy', 79, 'gestation'), ('GO_0007567', 'parturition', 109, 'birth'), ('UBERON_0001013', 'adipose tissue', 146, 'adipose tissue')]
PMC4939564	8/2015	S29-PMC4939564	['secondary maternal outcomes included Gestational diabetes; fetal distress in Pregnancy or labor; post-Partum hemorrhage; caesarean Birth; infection (including wound, Urinary Tract, Perineum, Chest and Breast); and weight (loss/gain/no change) [28].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 37, 'gestational'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007567', 'parturition', 102, 'partum'), ('UBERON_0001013', 'adipose tissue', 102, 'partum'), ('GO_0007567', 'parturition', 131, 'birth'), ('UBERON_0001553', 'medial tarsal artery', 166, 'urinary tract'), ('UBERON_0002356', 'perineum', 181, 'perineum'), ('UBERON_0001443', 'chest', 191, 'chest'), ('UBERON_0000310', 'breast', 201, 'breast')]
PMC4939564	8/2015	S69-PMC4939564	['Adipose Tissue Secretes enzymes needed for Steroid Hormone biosynthesis and metabolism, such as Estrone, which is converted to Estradiol in Peripheral Adipose Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0046903', 'secretion', 15, 'secretes'), ('CHEBI_26764', 'steroid hormone', 43, 'steroid hormone'), ('CHEBI_17263', 'estrone', 96, 'estrone'), ('CHEBI_23965', 'estradiol', 127, 'estradiol'), ('UBERON_0007862', 'perichordal tissue', 140, 'peripheral adipose tissue')]
PMC4939564	8/2015	S70-PMC4939564	['Adipose Tissue Expresses 11-Β-Hydroxysteroid Dehydrogenase Type 1 (11-Β-Hsd1), which converts Cortisone to Cortisol, as well as 5-α-reductase, which converts Cortisol to 5-Α-Tetrahydrocortisol.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('GO_0010467', 'gene expression', 15, 'expresses'), ('CHEBI_36844', '7-hydroxy steroid', 25, '11-β-hydroxysteroid'), ('PR_000003777', 'adiponectin', 25, '11-β-hydroxysteroid dehydrogenase type 1'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 67, '11-β-HSD1'), ('CHEBI_16962', 'cortisone', 94, 'cortisone'), ('CHEBI_17650', 'cortisol', 107, 'cortisol'), ('CHEBI_16382', 'iodide', 128, '5-'), ('CHEBI_17650', 'cortisol', 158, 'cortisol'), ('CHEBI_67297', '7-deacetyl-7-benzoylgedunin', 170, '5-α-tetrahydrocortisol')]
PMC4939564	8/2015	S121-PMC4939564	['Oxidation Of Fatty Acids generates Ketones that can be used as fuel by Skeletal and Cardiac Muscle, Liver, Kidney, and Adipose Tissue, thus sparing Glucose for continued utilization by Brain and Erythrocytes [64].']	N/A	N/A	[('GO_0035193', 'larval central nervous system remodeling', 0, 'Oxidation of fatty acids'), ('CHEBI_35366', 'fatty acid', 13, 'fatty acids'), ('CHEBI_17087', 'ketone', 35, 'ketones'), ('UBERON_0001442', 'skeleton of manus', 71, 'skeletal ...'), ('UBERON_0001133', 'cardiac muscle tissue', 84, 'cardiac muscle'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0002113', 'kidney', 107, 'kidney'), ('UBERON_0001013', 'adipose tissue', 119, 'adipose tissue'), ('CHEBI_17234', 'glucose', 148, 'glucose'), ('UBERON_0000955', 'brain', 185, 'brain'), ('CL_0000232', 'erythrocyte', 195, 'erythrocytes')]
PMC4940755	7/2015	S97-PMC4940755	['differential methylation at 15,627 cpgs, including in t2dm gwas loci Pparg , Kcnq1 , Tcf7L2 , and Irs1 in subcutaneous Adipose Tissue ( n \u2009=\u200956).']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 69, 'PPARG'), ('PR_000000728', 'voltage-gated potassium channel subunit KCNQ1', 77, 'KCNQ1'), ('PR_000016139', 'TATA box-binding protein-like 2', 85, 'TCF7L2'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 98, 'IRS1'), ('UBERON_0001013', 'adipose tissue', 119, 'adipose tissue')]
PMC4977046	3/2016	S261-PMC4977046	['2013), a phospholipase that is purported to Regulate Adipose Tissue growth (nishimura et al.']	N/A	N/A	[('GO_0065007', 'biological regulation', 44, 'regulate'), ('UBERON_0001013', 'adipose tissue', 53, 'adipose tissue')]
PMC4996908	5/2016	S4-PMC4996908	['computed tomography using 3-dimensional reconstruction serves to more clearly characterize the extensive Spine malsegmentation characteristic of spondylocostal dysostosis.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 105, 'spine')]
PMC4996908	5/2016	S31-PMC4996908	['her Pulmonary function remained relatively normal,\xa0and no orthopedic correction of her Spine or Rib deformities was performed.']	N/A	N/A	[('UBERON_0002048', 'lung', 4, 'pulmonary'), ('UBERON_0001013', 'adipose tissue', 87, 'spine'), ('UBERON_0002228', 'rib', 96, 'rib')]
PMC5025983	8/2015	S117-PMC5025983	['inappropriate Metabolic and Endocrine Responses occur in Organs like Brain, Adipose Tissue, muscle, Liver, and Pancreas [14].']	N/A	N/A	[('GO_0008152', 'metabolic process', 14, 'metabolic ...'), ('GO_0006897', 'endocytosis', 28, 'endocrine responses'), ('UBERON_0000062', 'organ', 57, 'organs'), ('UBERON_0000955', 'brain', 69, 'brain'), ('UBERON_0001013', 'adipose tissue', 76, 'adipose tissue'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0001264', 'pancreas', 111, 'pancreas')]
PMC5054850	8/2015	S23-PMC5054850	['in particular, use of the Biceps, Triceps, and Subscapular sites allows the evaluation of Pregnancy‐related changes in Adipose Tissue that are more independent of fetal growth9,14.']	N/A	N/A	[('UBERON_0004347', 'limb bud', 26, 'biceps'), ('UBERON_0001509', 'triceps brachii', 34, 'triceps'), ('UBERON_0001161', 'body of stomach', 47, 'subscapular'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('UBERON_0001013', 'adipose tissue', 119, 'adipose tissue')]
PMC5088205	11/2016	S304-PMC5088205	['for instance, inadequate nutritional conditions in early Life induce upregulation of Adipogenic Signaling Pathways, increased Expression of Genes involved in Adipocyte differentiation (guan et al.,2005), upregulation of Lipogenic transcription factors (desai et al.,2008) and alterations in sympathetic innervations of Adipose Tissue (garcía et al.,2011).']	N/A	N/A	[('UBERON_0000104', 'life cycle', 57, 'life'), ('GO_0034333', 'adherens junction assembly', 85, 'adipogenic signaling pathways'), ('GO_0010467', 'gene expression', 126, 'expression'), ('SO_0000704', 'gene', 140, 'genes'), ('CL_0000136', 'fat cell', 158, 'adipocyte'), ('GO_0008610', 'lipid biosynthetic process', 220, 'lipogenic'), ('UBERON_0001013', 'adipose tissue', 319, 'adipose tissue')]
PMC5187359	12/2016	S297-PMC5187359	['the Hypothalamus is able to cross-talk to other Metabolically relevant Tissues such as Liver and Adipose Tissue through Sympathetic Circuits and circulating signals (leptin, Insulin, Cck, Neurotrophins, Il-6) by the Homeostatic Regulation Of the Endocannabinoid Signaling system (das,2010; maccarrone et al.,2014; seoane-collazo et al.,2015).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0008152', 'metabolic process', 48, 'metabolically'), ('UBERON_0000479', 'tissue', 71, 'tissues'), ('UBERON_0002107', 'liver', 87, 'liver'), ('UBERON_0001013', 'adipose tissue', 97, 'adipose tissue'), ('UBERON_0003929', 'digestive tract epithelium', 120, 'sympathetic circuits'), ('PR_000045358', 'insulin family protein', 174, 'insulin'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 183, 'CCK'), ('PR_000021998', 'neurotrophin', 188, 'neurotrophins'), ('PR_000001470', 'interleukin-28B', 203, 'IL-6'), ('GO_0042592', 'homeostatic process', 216, 'homeostatic'), ('GO_0065007', 'biological regulation', 228, 'regulation of ...'), ('CHEBI_67198', 'retinoic acid receptor agonist', 246, 'endocannabinoid'), ('GO_0038002', 'endocrine signaling', 246, 'endocannabinoid signaling')]
PMC5283658	1/2017	S22-PMC5283658	['the Adipose Tissue of obese Mice has a 2- to 5-fold increase in Macrophage infiltration, along with higher systemic levels of Macrophage-Secreted inflammatory cytokines [22].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 4, 'adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 28, 'mice'), ('CL_0000235', 'macrophage', 64, 'macrophage'), ('CL_0000235', 'macrophage', 126, 'macrophage'), ('GO_0046903', 'secretion', 137, 'secreted')]
PMC5283658	1/2017	S25-PMC5283658	['Tnf-Α, Il-1Β and Il-6) and are the predominant type of Adipose Tissue Macrophages (atms) in dietary-induced obese (dio) Humans and Animals [25,26].']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 0, 'TNF-α'), ('PR_000001383', 'interleukin-22', 7, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 17, 'IL-6'), ('CL_0002617', 'adipocyte of breast', 55, 'adipose tissue macrophages'), ('UBERON_0001013', 'adipose tissue', 55, 'adipose tissue'), ('NCBITaxon_9606', 'Homo sapiens', 120, 'humans'), ('NCBITaxon_33208', 'Metazoa', 131, 'animals')]
PMC5283658	1/2017	S56-PMC5283658	['Adipose Tissue analysis\nexperimental offspring Mice were euthanized by Co2Inhalation.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('NCBITaxon_10088', 'Mus <genus>', 47, 'mice'), ('CHEBI_62809', 'trans-heme d hydroxychlorin gamma-spirolactone(1-)', 71, 'CO2inhalation')]
PMC5283658	1/2017	S87-PMC5283658	['results\n\nPrenatal lp offspring had lower Adipose Tissue mass and higher Adipose Tissue growth rate compared to np offspring\nlp offspring had lower body and Adipose Tissue weights at weaning compared to the np offspring (fig 1a and 1d).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'Prenatal'), ('UBERON_0001013', 'adipose tissue', 41, 'adipose tissue'), ('UBERON_0001013', 'adipose tissue', 72, 'adipose tissue'), ('UBERON_0001013', 'adipose tissue', 156, 'adipose tissue')]
PMC5283658	1/2017	S133-PMC5283658	['overall, lp did not change the number of Cd11C+cells in Adipose Tissue.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 41, 'CD11c'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissue')]
PMC5283658	1/2017	S159-PMC5283658	['isolated Adipose Tissue svcs were stained with anti-Cd11B/C percp-efluor®710, anti-Cd11C pe, anti-Cd206 Fitc for flow cytometry analysis.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 9, 'adipose tissue'), ('PR_000001309', 'CD70 molecule', 52, 'CD11b'), ('PR_000005000', 'calmodulin-binding transcription activator 1', 58, 'c'), ('PR_000001309', 'CD70 molecule', 83, 'CD11c'), ('PR_000001309', 'CD70 molecule', 98, 'CD206'), ('CHEBI_37926', 'fluorescein isothiocyanate', 104, 'FITC')]
PMC5283658	1/2017	S191-PMC5283658	['the increase of Adipose Tissue Cd206+Cd11C+ atms in offspring Fed he diet was reversed by Consuming a lp diet.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 16, 'adipose tissue'), ('PR_000001309', 'CD70 molecule', 31, 'CD206'), ('PR_000001309', 'CD70 molecule', 37, 'CD11c'), ('GO_0007631', 'feeding behavior', 62, 'fed'), ('GO_0007631', 'feeding behavior', 90, 'consuming')]
PMC5283658	1/2017	S225-PMC5283658	['Postnatal he increases the size of Adipocytes, which causes the recruitment of M1, especially M1B Macrophages to the Adipose Tissue.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('CL_0000136', 'fat cell', 35, 'adipocytes'), ('CL_0011107', 'Muller cell', 79, 'M1'), ('CL_0002372', 'myotube', 94, 'm1b'), ('CL_0000235', 'macrophage', 98, 'macrophages'), ('UBERON_0001013', 'adipose tissue', 117, 'adipose tissue')]
PMC5380514	11/2016	S20-PMC5380514	['functionally, excess N-6 Fa activates Adipogenesis in Adipocyte culture and drives Adipose Tissue expansion in rodents21–24.']	N/A	N/A	[('CHEBI_18320', '1,4-dithiothreitol', 21, 'n-6'), ('CHEBI_30751', 'formic acid', 25, 'FA'), ('GO_0060612', 'adipose tissue development', 38, 'adipogenesis'), ('CL_0000136', 'fat cell', 54, 'adipocyte'), ('UBERON_0001013', 'adipose tissue', 83, 'adipose tissue')]
PMC5387697	2/2017	S86-PMC5387697	['the lgc group presents with Insulin-resistance, dyslipidemia and low-level infiltration of Adipose Tissue with pro-inflammatory cytokine secreting Immunity Cells.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 28, 'insulin'), ('UBERON_0001013', 'adipose tissue', 91, 'adipose tissue'), ('CL_0000429', 'imaginal disc cell', 147, 'immunity cells')]
PMC5420136	5/2017	S98-PMC5420136	['Undernutrition during late Gestation\ncomplete fasting of Pregnant gilts for 10 d between d 100 and d\xa0114 of Gestation does not influence the body Fat of fetuses due to their naturally limited ability for Prenatal Fat Synthesis [50].']	N/A	N/A	[('GO_0070995', 'NADPH oxidation', 0, 'Undernutrition'), ('GO_0007565', 'female pregnancy', 27, 'gestation'), ('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('UBERON_0001013', 'adipose tissue', 146, 'fat'), ('GO_0007565', 'female pregnancy', 204, 'prenatal'), ('GO_0006634', 'hexadecanal biosynthetic process', 213, 'fat synthesis')]
PMC5439533	5/2017	S66-PMC5439533	['results\n\ndescriptive analysis\nfrom july 21st through december 4th 2014, we interviewed and collected surveys on 4808 post-Partum women.']	N/A	N/A	[('GO_0007567', 'parturition', 122, 'partum'), ('UBERON_0001013', 'adipose tissue', 122, 'partum')]
PMC544881	12/2004	S93-PMC544881	['in late Gestation, Adipose Tissue Lipolysis is greatly augmented generating Ffa and Glycerol, for further Hepatic Vldl Production, contributing to the flux of circulating Tg-fatty acids in Pregnancy [18,19].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'gestation'), ('GO_0070227', 'lymphocyte apoptotic process', 19, 'adipose tissue lipolysis'), ('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('CHEBI_30751', 'formic acid', 76, 'FFA'), ('CHEBI_17754', 'glycerol', 84, 'glycerol'), ('GO_0007568', 'aging', 106, 'hepatic'), ('UBERON_0002107', 'liver', 106, 'hepatic'), ('GO_0034397', 'telomere localization', 114, 'VLDL production'), ('CHEBI_17855', 'triglyceride', 171, 'TG'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC5472316	6/2017	S59-PMC5472316	['all piglets Born by Physiological Partum had no congenital changes.']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'born'), ('UBERON_0001608', 'dilatator pupillae', 20, 'physiological'), ('UBERON_0001013', 'adipose tissue', 34, 'partum')]
PMC5526977	7/2017	S267-PMC5526977	['low-grade, elevated inflammation is a result of obesity due to increased production of inflammatory cytokines by Adipose Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 113, 'adipose tissue')]
PMC5537904	7/2017	S77-PMC5537904	['this device uses a two-compartment model to estimate fat mass (Adipose Tissue; g and percent of total mass) and fat-free mass (Water, bone, etc.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 63, 'adipose tissue'), ('CHEBI_15377', 'water', 127, 'water')]
PMC5543438	8/2017	S32-PMC5543438	['in the remote model, continuity of care is offered to remote aboriginal women by the midwifery group practice from the Antenatal through to post-Partum period.']	N/A	N/A	[('GO_0007567', 'parturition', 119, 'antenatal'), ('GO_0007567', 'parturition', 145, 'partum'), ('UBERON_0001013', 'adipose tissue', 145, 'partum')]
PMC5562975	8/2017	S52-PMC5562975	['the fetal Ld and St Muscles were also dissected free of Connective and Fat Tissue.']	N/A	N/A	[('UBERON_0004084', 'genital labium', 10, 'LD ...'), ('UBERON_0000930', 'stomodeum', 17, 'ST muscles'), ('UBERON_0001777', 'substantia propria of cornea', 56, 'connective ...'), ('UBERON_0001013', 'adipose tissue', 71, 'fat tissue')]
PMC5594587	9/2017	S40-PMC5594587	['nutritional manipulations in our experiments were done during the late Gestation period (third trimester), which is the period of extensive quantitative foetal growth [13] where many Endocrine Organs and Tissues are matured, including Adipose Tissues [14].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 71, 'gestation'), ('GO_0006397', 'mRNA processing', 183, 'endocrine'), ('UBERON_0002049', 'vasculature', 183, 'endocrine'), ('UBERON_0000062', 'organ', 193, 'organs'), ('UBERON_0000479', 'tissue', 204, 'tissues'), ('UBERON_0001013', 'adipose tissue', 235, 'adipose tissues')]
PMC5594587	9/2017	S70-PMC5594587	['Adipose Tissue deposition\nin precocial Animal species such as Sheep, the major part of foetal Adipogenesis and Adipose Tissue differentiation takes place during the last part of Gestation [36–38].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('NCBITaxon_33208', 'Metazoa', 39, 'animal'), ('NCBITaxon_10088', 'Mus <genus>', 62, 'sheep'), ('GO_0060612', 'adipose tissue development', 94, 'adipogenesis'), ('UBERON_0001013', 'adipose tissue', 111, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 178, 'gestation')]
PMC5594587	9/2017	S82-PMC5594587	['3\n\nmorphology of van gieson-stained subcutaneous Adipose Tissue from 6 months old adolescent Lambs and 2\xa0years old Adult Sheep (obtained from nielsen et al.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 49, 'adipose tissue'), ('NCBITaxon_33208', 'Metazoa', 93, 'lambs'), ('UBERON_0007023', 'adult organism', 115, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 121, 'sheep')]
PMC5594587	9/2017	S140-PMC5594587	['it also increased the number of th receptors and deiodinase mrna Expression in different target Tissues such as Liver, Cardiac Muscle and Longissimus Dorsi Muscle but decreased the number of th receptors and deiodinase mrna Expression in Adipose Tissues [64].']	N/A	N/A	[('GO_0010467', 'gene expression', 65, 'expression'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0002107', 'liver', 112, 'liver'), ('UBERON_0001133', 'cardiac muscle tissue', 119, 'cardiac muscle'), ('UBERON_0001401', 'longissimus thoracis muscle', 138, 'longissimus dorsi muscle'), ('GO_0010467', 'gene expression', 224, 'expression'), ('UBERON_0001013', 'adipose tissue', 238, 'adipose tissues')]
PMC5627472	10/2017	S68-PMC5627472	['both diets resulted in a similar weight gain and an increased mean degree of methylation in Adipose Tissue.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 92, 'adipose tissue')]
PMC5678092	11/2017	S82-PMC5678092	['after decapitation, white Adipose Tissue (Gonadal, Retroperitoneal, Inguinal), muscle (Quadriceps, Tibialis, Soleus) and Liver were weighed.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 26, 'adipose tissue'), ('UBERON_0000991', 'gonad', 42, 'gonadal'), ('UBERON_0003693', 'retroperitoneal space', 51, 'retroperitoneal'), ('UBERON_0008337', 'inguinal part of abdomen', 68, 'inguinal ...'), ('UBERON_0001377', 'quadriceps femoris', 87, 'quadriceps'), ('UBERON_0008230', 'tibialis', 99, 'tibialis'), ('UBERON_0001389', 'soleus muscle', 109, 'soleus'), ('UBERON_0002107', 'liver', 121, 'liver')]
PMC5804559	10/2017	S30-PMC5804559	['for example, rodents exposed to high-fat diets in utero have altered epigenetic patterns and methylation status of particular Genes, for example those Expressed in and Secreted by Adipose Tissue such as adiponectin and leptin Genes [36].']	N/A	N/A	[('SO_0000704', 'gene', 126, 'genes'), ('GO_0010467', 'gene expression', 151, 'expressed'), ('GO_0046903', 'secretion', 168, 'secreted'), ('UBERON_0001013', 'adipose tissue', 180, 'adipose tissue'), ('SO_0000704', 'gene', 226, 'genes')]
PMC5924963	4/2018	S29-PMC5924963	['these factors drive proinflammatory response in Adipose Tissue, altering the resident Macrophage population (28).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('CL_0000235', 'macrophage', 86, 'macrophage')]
PMC6022422	6/2018	S13-PMC6022422	['intercellular nampt is substantially released by Embryonic, Amniotic, and Placental Membrane and Adipose Tissue.']	N/A	N/A	[('UBERON_0004716', 'conceptus', 49, 'embryonic ...'), ('UBERON_0013649', 'fused tarsal bones 1 and 2', 60, 'amniotic ...'), ('UBERON_0009002', 'placental membrane', 74, 'placental membrane'), ('UBERON_0001013', 'adipose tissue', 97, 'adipose tissue')]
PMC6039335	7/2018	S30-PMC6039335	['the process of Skeletal muscle and Adipose Tissue Development during the fetal stage in laboratory Animals and livestock including ruminants has been well described in reviews by du et al [16–18].']	N/A	N/A	[('UBERON_0004288', 'skeleton', 15, 'skeletal'), ('GO_0060612', 'adipose tissue development', 35, 'adipose tissue development'), ('UBERON_0001013', 'adipose tissue', 35, 'adipose tissue'), ('NCBITaxon_33208', 'Metazoa', 99, 'animals')]
PMC6039335	7/2018	S43-PMC6039335	['after Birth, the Adipogenic–Fibrogenic progenitor Cells re main on some parts of the Stromal Vascular Cells in Adipose Tissue, later serving as precursors to Preadipocytes and Adipocytes [16,22].']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'birth'), ('GO_0060612', 'adipose tissue development', 17, 'adipogenic'), ('CL_0000057', 'fibroblast', 28, 'fibrogenic'), ('CL_0000573', 'retinal cone cell', 50, 'cells'), ('CL_0002492', 'strial marginal cell', 85, 'stromal vascular cells'), ('UBERON_0003891', 'stroma', 85, 'stromal'), ('UBERON_0001013', 'adipose tissue', 111, 'adipose tissue'), ('CL_0002334', 'preadipocyte', 158, 'preadipocytes'), ('CL_0000136', 'fat cell', 176, 'adipocytes')]
PMC6039335	7/2018	S50-PMC6039335	['four major Adipose Tissue depots exist in Animals: Ab Dominal, subcutaneous, intermuscular, and intramuscular.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 11, 'adipose tissue'), ('NCBITaxon_33208', 'Metazoa', 42, 'animals'), ('UBERON_0000916', 'abdomen', 51, 'ab dominal')]
PMC6039335	7/2018	S160-PMC6039335	['the Fa De Novo Synthesis occurs mainly in Adipose Tissue in ruminants [84], whereas it occurs in the Liver in Humans and rodents.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 4, 'FA'), ('GO_0006747', 'FAD biosynthetic process', 4, 'FA de novo synthesis'), ('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('UBERON_0002107', 'liver', 101, 'liver'), ('NCBITaxon_9606', 'Homo sapiens', 110, 'humans')]
PMC6039335	7/2018	S170-PMC6039335	['these two enzymes are induced in Adipose Tissues of ruminants by increasing energy intake [89].']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 33, 'adipose tissues')]
PMC6039335	7/2018	S172-PMC6039335	['furthermore, imf has a higher Expression of Glucose Transporter 4, which is responsible for Uptake Of Glucose in Adipose Tissues, compared to Subcutaneous Fat (reviewed in [90]).']	N/A	N/A	[('GO_0010467', 'gene expression', 30, 'expression'), ('CHEBI_17234', 'glucose', 44, 'glucose'), ('PR_000015064', 'solute carrier family 2, facilitated glucose transporter member 2', 44, 'glucose transporter 4'), ('GO_0046323', 'glucose import', 92, 'uptake of glucose'), ('CHEBI_17234', 'glucose', 102, 'glucose'), ('UBERON_0001013', 'adipose tissue', 113, 'adipose tissues'), ('UBERON_0002190', 'subcutaneous adipose tissue', 142, 'subcutaneous fat')]
